JPWO2021194828A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021194828A5
JPWO2021194828A5 JP2022557823A JP2022557823A JPWO2021194828A5 JP WO2021194828 A5 JPWO2021194828 A5 JP WO2021194828A5 JP 2022557823 A JP2022557823 A JP 2022557823A JP 2022557823 A JP2022557823 A JP 2022557823A JP WO2021194828 A5 JPWO2021194828 A5 JP WO2021194828A5
Authority
JP
Japan
Prior art keywords
mmol
dcm
stirred
amino
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022557823A
Other languages
Japanese (ja)
Other versions
JP2023518851A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/022880 external-priority patent/WO2021194828A1/en
Publication of JP2023518851A publication Critical patent/JP2023518851A/en
Publication of JPWO2021194828A5 publication Critical patent/JPWO2021194828A5/ja
Pending legal-status Critical Current

Links

Description

工程1:ヘキサデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート
撹拌されている(tert-ブトキシカルボニル)-L-フェニルアラニン(10g、37.7mmol)のクロロホルム(70mL)混合液に、HATU(21.50g、56.5mmol)、ヘキサデカン-1-オール(9.14g、37.7mmol)、TEA(15.76mL、113mmol)及びイミダゾール(7.70g、113mmol)を0℃で加えた。反応混合物を室温で16時間撹拌した。LCMSは反応の完了を示した。反応混合物を水(100mL)でクエンチし、DCM(100mL×2)で抽出した。合わせた有機相をブライン(30mL)で洗浄し、NaSOで乾燥させ、真空下で濃縮した。残留物をフラッシュカラムクロマトグラフィー(シリカゲル、330g、石油エーテル:EA=10:1)により精製して、ヘキサデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(8.5g、純度100%、収率46.0%)を黄色の油状物として得た。LCMS (ESI) m/z calcd for C30H51NO4:489; found: 490 (M+H). 1H NMR (400 MHz, CDCl3) δ 7.38 - 7.12 (m, 5H), 5.00 (d, J = 11.2 Hz, 1H), 4.65 - 4.52 (m, 1H), 4.10(t, J = 8.8 Hz, 2H), 3.18 - 2.98(m, 2H), 1.71 - 1.52 (m, 4H), 1.50 - 1.19 (m, 33H), 0.97 - 0.83 (m , 3H).
Step 1: Hexadecyl(tert-butoxycarbonyl)-L-phenylalaninate To a stirred mixture of (tert-butoxycarbonyl)-L-phenylalanine (10 g, 37.7 mmol) in chloroform (70 mL) was added HATU (21. 50 g, 56.5 mmol), hexadecane-1-ol (9.14 g, 37.7 mmol), TEA (15.76 mL, 113 mmol) and imidazole (7.70 g, 113 mmol) were added at 0°C. The reaction mixture was stirred at room temperature for 16 hours. LCMS showed the reaction was complete. The reaction mixture was quenched with water (100 mL) and extracted with DCM (100 mL x 2). The combined organic phases were washed with brine (30 mL), dried over Na 2 SO 4 and concentrated under vacuum. The residue was purified by flash column chromatography (silica gel, 330 g, petroleum ether: EA = 10:1) to give hexadecyl(tert-butoxycarbonyl)-L-phenylalaninate (8.5 g, purity 100%, yield 46.0%) was obtained as a yellow oil . LCMS (ESI) m/z calcd for C 30 H 51 NO 4 :489; found: 490 (M+H). 1 H NMR (400 MHz, CDCl3) δ 7.38 - 7.12 (m, 5H), 5.00 (d, J = 11.2 Hz, 1H), 4.65 - 4.52 (m, 1H), 4.10(t, J = 8.8 Hz, 2H), 3.18 - 2.98(m, 2H), 1.71 - 1.52 (m, 4H), 1.50 - 1.19 (m, 33H), 0.97 - 0.83 (m, 3H).

工程2:ドコシル-L-フェニルアラニナート
空気中、25℃で撹拌されているドデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(6.3g、14.53mmol)のDCM(60mL)溶液に、TA(20mL、260mmol)を加えた。反応混合物を25℃で30分間撹拌した。LCMSは反応の完了を示した。反応を飽和NaHCO水溶液でクエンチし、pHを8に調整し、有機層を分離した。水相をDCM(30mL×3)で抽出した。合わせた有機層をブラインで洗浄し、無水硫酸ナトリウムで乾燥させ、真空下で濃縮乾固して、表題化合物(5g、79%、収率82%)を赤色の油状物として得た。LCMS (ESI) m/z calcd for C21H35NO2: 333; found: 334 (M+1). 1H NMR (400 MHz, Chloroform-d) δ 7.69 (s, 2H), 7.30 - 7.26 (m, 3H), 7.23 - 7.14 (m, 2H), 4.17 (t, J = 6.8 Hz, 1H), 4.04 (t, J = 6.8 Hz, 2H), 3.29 - 3.15 (m, 2H), 1.54 - 1.46 (m, 2H), 1.33 - 1.25 (m, 18H), 0.88 (t, J = 6.8 Hz, 3H).
Step 2: Docosyl-L-phenylalaninate A solution of dodecyl (tert-butoxycarbonyl)-L-phenylalaninate (6.3 g, 14.53 mmol) in DCM (60 mL) stirred at 25 °C in air. TFA (20 mL, 260 mmol) was added. The reaction mixture was stirred at 25°C for 30 minutes. LCMS showed the reaction was complete. The reaction was quenched with saturated aqueous NaHCO3 , pH was adjusted to 8, and the organic layer was separated. The aqueous phase was extracted with DCM (30 mL x 3). The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, and concentrated to dryness under vacuum to give the title compound (5 g, 79%, 82% yield) as a red oil. LCMS (ESI) m/z calcd for C 21 H 35 NO 2 : 333; found: 334 (M+1). 1 H NMR (400 MHz, Chloroform-d) δ 7.69 (s, 2H), 7.30 - 7.26 ( m, 3H), 7.23 - 7.14 (m, 2H), 4.17 (t, J = 6.8 Hz, 1H), 4.04 (t, J = 6.8 Hz, 2H), 3.29 - 3.15 (m, 2H), 1.54 - 1.46 (m, 2H), 1.33 - 1.25 (m, 18H), 0.88 (t, J = 6.8 Hz, 3H).

工程4:ドデシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
窒素下、25℃で撹拌されている((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メタノール(2.309g、2.76mmol)のピリジン(10mL)/THF(10mL)溶液に、1M tert-ブチルマグネシウムクロリド/THF(3.86mL、3.86mmol)溶液を滴下した。次いで、得られた反応混合物に、ドデシル(クロ(フェノキシ)ホスホリル)-L-フェニルアラニナート(1.4g、2.76mmol)のTHF(5mL)溶液を滴下した。反応混合物を25℃で1.5時間撹拌した。LCMSは反応の完了を示した。反応物を真空中で濃縮乾固した。粗生成物を逆相HPLC精製(C18、0.1% HNHCOを含む25~100% MeCN/水)に供して、表題化合物(1.6g、99%、収率:43.9%)を黄色の油状物として得た。LCMS (ESI) m/z calcd for C79H82FN6O9P: 1309; found: 1310 (M+1). 1H NMR (400 MHz, Chloroform-d) δ 7.72 - 7.26 (m, 12H), 7.26 - 6.90 (m, 21H), 6.83 - 6.70 (m, 4H), 6.15 - 6.11 (m, 1H), 4.51 (q, J = 6.4 Hz, 1H), 4.29 - 4.17 (m, 1H), 4.09 - 4.05 (m, 2H), 3.94 - 3.92 (m, 2H), 3.85 - 3.83 (m, 1H), 3.77 (s, 3H), 3.72 (s, 3H), 3.30 (t, J = 10.4 Hz, 1H), 2.99 - 2.77 (m, 3H), 1.94 - 1.92 (m, 1H), 1.84 - 1.72 (m, 1H), 1.65 (d, J = 7.2 Hz, 2H), 1.46 (d, J = 7.6 Hz, 2H), 1.27 - 1.22 (m, 18H), 0.88 (t, J = 6.8 Hz, 3H).
Step 4: Dodecyl (((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl) -3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate stirred at 25°C under nitrogen ((2R,3S,5R) -2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran To a solution of pyridine (10 mL)/THF (10 mL) of methanol (2.309 g, 2.76 mmol) was added dropwise a solution of 1M tert-butylmagnesium chloride/THF (3.86 mL, 3.86 mmol). Then, a solution of dodecyl( chloro (phenoxy)phosphoryl)-L-phenylalaninate (1.4 g, 2.76 mmol) in THF (5 mL) was added dropwise to the resulting reaction mixture. The reaction mixture was stirred at 25°C for 1.5 hours. LCMS showed the reaction was complete. The reaction was concentrated to dryness in vacuo. The crude product was subjected to reverse phase HPLC purification (C18, 25-100% MeCN/water with 0.1% HN HCO ) to give the title compound (1.6 g, 99%, yield: 43.9% ) was obtained as a yellow oil. LCMS (ESI) m/z calcd for C 79 H 82 FN 6 O 9 P: 1309; found: 1310 (M+1). 1 H NMR (400 MHz, Chloroform-d) δ 7.72 - 7.26 (m, 12H) , 7.26 - 6.90 (m, 21H), 6.83 - 6.70 (m, 4H), 6.15 - 6.11 (m, 1H), 4.51 (q, J = 6.4 Hz, 1H), 4.29 - 4.17 (m, 1H), 4.09 - 4.05 (m, 2H), 3.94 - 3.92 (m, 2H), 3.85 - 3.83 (m, 1H), 3.77 (s, 3H), 3.72 (s, 3H), 3.30 (t, J = 10.4 Hz, 1H ), 2.99 - 2.77 (m, 3H), 1.94 - 1.92 (m, 1H), 1.84 - 1.72 (m, 1H), 1.65 (d, J = 7.2 Hz, 2H), 1.46 (d, J = 7.6 Hz, 2H), 1.27 - 1.22 (m, 18H), 0.88 (t, J = 6.8 Hz, 3H).

工程3:デシル((((S)-1-(デシルオキシ)-1-オキソプロパン-2-イル)オキシ)(((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニル)メトキシ)テトラヒドロフラン-2-イル)メトキシ)ホスホリル)-L-フェニルアラニナート
窒素、室温で撹拌されている((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メタノール(1.0g、1.193mmol)のTHF(12mL)溶液に、tert-ブチルマグネシウムクロリド/THF(1.790mL、1.790mmol)溶液を加え、25℃で1時間撹拌した。次いで、デシル((((S)-1-(デシルオキシ)-1-オキソプロパン-2-イル)オキシ)(4-ニトロフェノキシ)ホスホリル)-L-フェニルアラニナート(1.716g、2.387mmol)を25℃で反応物に加えた。得られた混合物を室温で6時間撹拌した。LCMSは反応の完了を示した。反応混合物を濃縮し、残留物をシリカゲルカラム(120g、石油エーテル:EtOAc=1:1)により精製して、デシル((((S)-1-(デシルオキシ)-1-オキソプロパン-2-イル)オキシ)(((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニル)メトキシ)テトラヒドロフラン-2-イル)メトキシ)ホスホリル)-L-フェニルアラニナート(650mg、0.458mmol、収率38.4%)を黄色の固体として得た。LCMS (ESI) m/z calcd for C84H98FN6O11P: 1417; found: 1418 (M+1).
Step 3: Decyl(((S)-1-(decyloxy)-1-oxopropan-2-yl)oxy)((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6 -(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenyl)methoxy)tetrahydrofuran-2-yl)methoxy)phosphoryl)-L- Phenylalaninate ((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H- stirred at room temperature under nitrogen) To a solution of purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methanol (1.0 g, 1.193 mmol) in THF (12 mL) was added tert-butylmagnesium chloride/THF. (1.790 mL, 1.790 mmol) solution was added and stirred at 25° C. for 1 hour. Then, decyl((((S)-1-(decyloxy)-1-oxopropan-2-yl)oxy)(4-nitrophenoxy)phosphoryl)-L-phenylalaninate (1.716 g, 2.387 mmol) was added to the reaction at 25°C. The resulting mixture was stirred at room temperature for 6 hours. LCMS showed the reaction was complete. The reaction mixture was concentrated and the residue was purified by silica gel column (120 g, petroleum ether:EtOAc=1:1) to give decyl (((S)-1-(decyloxy)-1-oxopropan-2-yl). )oxy)(((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3 -((4-methoxyphenyl)diphenyl)methoxy)tetrahydrofuran-2-yl)methoxy)phosphoryl)-L-phenylalaninate (650 mg, 0.458 mmol, yield 38.4%) was obtained as a yellow solid. LCMS (ESI) m/z calcd for C 84 H 98 FN 6 O 11 P: 1417; found: 1418 (M+1).

工程4:デシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(((S)-1-(デシルオキシ)-1-オキソプロパン-2-イル)オキシ)ホスホリル)-L-フェニルアラニナート
デシル((((S)-1-(デシルオキシ)-1-オキソプロパン-2-イル)オキシ)(((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)ホスホリル)-L-フェニルアラニナート(650mg、0.298mmol)のDCM(6mL)溶液に、TFA(0.600mL)を0℃で加え、室温で2時間撹拌した。LCMSは反応の完了を示した。飽和NaHCO水溶液でpHを6~7に調整し、DCM(3×10mL)で抽出した。合わせた有機層をブラインで洗浄し、NaSOで乾燥させた。濾過後、濾液を濃縮し、残留物をシリカゲルカラム(80g、MeOH:DCM=1:19)で精製してデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(((S)-1-(デシルオキシ)-1-オキソプロパン-2-イル)オキシ)ホスホリル)-L-フェニルアラニナート(250mg)を黄色の油状物として得た。異性体を以下の条件(カラム:DAICEL Dcpak P4VP、4.6×50mm、3μm;移動相A:、移動相B:ACN:MeOH=80:20(20mM NH);流速:2mL/分;勾配:5%B;220nm;RT1:2.68;RT2:2.87)で分離して、所望の化合物を含む画分を濃縮して、2種の異性体を得た。最初に溶出する異性体(実施例10A、RT1:2.68)を1:1の比率のACN/HOから再結晶化させた。固体を濾過により回収し、太陽灯(45℃)で乾燥させて、60mg(0.066mmol、収率22.07%)を白色の結晶固体として得た。LCMS (ESI) m/z calcd for C44H66FN6O9P: 872; found: 873(m+1). 1H NMR (300 MHz CDCl3).δ 8.12 (s, 1H), 7.26 - 7.16 (m, 5H), 6.36 (s, 1H), 6.28 - 5.82 (m, 1H), 4.74 (t, J = 6 Hz, 2H), 4.35 - 4.06 (m, 7H), 3.85 (s, 1H), 3.58 (s, 1H), 3.07 - 2.98 (m, 2H), 2.72 (s, 3H),1.64 - 1.56 (m, 4H), 1.38 (d, J = 3 Hz, 4H), 1.25 (s, 27H), 0.88 (t, J = 6 Hz, 6H).2番目に溶出した異性体(実施例10B、RT2:2.87)をACN/HOから再結晶化させた。固体を濾過により回収し、太陽灯(45℃)で乾燥させて、48mg(0.051mmol、収率17.28%)を白色の非晶質固体として得た。LCMS (ESI) m/z calcd for C44H66FN6O9P: 872; found: 873(m+1). 1H NMR (300 MHz CDCl3).δ 8.09 (s, 1H), 7.26 (s, 3H), 7.23 - 7.14 (m, 2H), 6.35 (t, J = 6 Hz, 1H), 6.09 (s, 1H), 4.80 (s, 1H), 4.56 (t, J = 9 Hz, 1H), 4.31 - 4.08 (m, 7H), 3.81 (s, 1H), 3.55 - 3.47 (m, 1H), 3.16 (t, J = 3 Hz, 1H), 3.00 - 2.93 (m, 1H), 1.74 (t, J = 3 Hz, 3H), 2.03 (s, 1H),1.73-1.55 (m, 5H),1.49 (d, J = 3 Hz, 3H), 1.26 (br s, 27H), 0.88 (t, J = 6 Hz, 6H).
Step 4: Decyl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy) (((S)-1-(decyloxy)-1-oxopropan-2-yl)oxy)phosphoryl)-L-phenylalaninatedecyl (((S)-1-(decyloxy)-1-oxopropane- 2-yl)oxy)(((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl )-3-((4-methoxyphenyl) diphenylmethoxy )tetrahydrofuran-2-yl)methoxy)phosphoryl)-L-phenylalaninate (650 mg, 0.298 mmol) in DCM (6 mL) was added with TFA (0. 600 mL) was added at 0°C and stirred at room temperature for 2 hours. LCMS showed the reaction was complete. The pH was adjusted to 6-7 with saturated aqueous NaHCO 3 and extracted with DCM (3×10 mL). The combined organic layers were washed with brine and dried over Na2SO4 . After filtration, the filtrate was concentrated, and the residue was purified with a silica gel column (80 g, MeOH:DCM=1:19) to obtain decyl (((2R,3S,5R)-5-(6-amino-2-fluoro -9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(((S)-1-(decyloxy)-1-oxopropan-2-yl)oxy)phosphoryl) -L-phenylalaninate (250 mg) was obtained as a yellow oil. The isomers were separated under the following conditions (Column: DAICEL Dcpak P4VP, 4.6 x 50 mm, 3 μm; Mobile phase A:, Mobile phase B: ACN:MeOH = 80:20 (20 mM NH 3 ); Flow rate: 2 mL/min; Gradient : 5% B; 220 nm; RT1: 2.68; RT2: 2.87) and the fraction containing the desired compound was concentrated to obtain two isomers. The first eluting isomer (Example 10A, RT 1:2.68) was recrystallized from ACN/ H2O in a 1:1 ratio. The solid was collected by filtration and dried in a sun lamp (45° C.) to give 60 mg (0.066 mmol, 22.07% yield) as a white crystalline solid. LCMS (ESI) m/z calcd for C 44 H 66 FN 6 O 9 P: 872; found: 873(m+1). 1 H NMR (300 MHz CDCl 3 ).δ 8.12 (s, 1H), 7.26 - 7.16 (m, 5H), 6.36 (s, 1H), 6.28 - 5.82 (m, 1H), 4.74 (t, J = 6 Hz, 2H), 4.35 - 4.06 (m, 7H), 3.85 (s, 1H) , 3.58 (s, 1H), 3.07 - 2.98 (m, 2H), 2.72 (s, 3H),1.64 - 1.56 (m, 4H), 1.38 (d, J = 3 Hz, 4H), 1.25 (s, 27H) ), 0.88 (t, J = 6 Hz, 6H). The second eluting isomer (Example 10B, RT2: 2.87) was recrystallized from ACN/ H2O . The solid was collected by filtration and dried under a sun lamp (45° C.) to yield 48 mg (0.051 mmol, 17.28% yield) as a white amorphous solid. LCMS (ESI) m/z calcd for C 44 H 66 FN 6 O 9 P: 872; found: 873(m+1). 1 H NMR (300 MHz CDCl 3 ).δ 8.09 (s, 1H), 7.26 ( s, 3H), 7.23 - 7.14 (m, 2H), 6.35 (t, J = 6 Hz, 1H), 6.09 (s, 1H), 4.80 (s, 1H), 4.56 (t, J = 9 Hz, 1H ), 4.31 - 4.08 (m, 7H), 3.81 (s, 1H), 3.55 - 3.47 (m, 1H), 3.16 (t, J = 3 Hz, 1H), 3.00 - 2.93 (m, 1H), 1.74 ( t, J = 3 Hz, 3H), 2.03 (s, 1H),1.73-1.55 (m, 5H),1.49 (d, J = 3 Hz, 3H), 1.26 (br s, 27H), 0.88 (t, J = 6 Hz, 6H).

工程5:ドデシル((2-(ドデシルオキシ)-2-オキソエトキシ)(((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)ホスホリル)-L-フェニルアラニナート
((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メタノール(700mg×2、0.835mmol)のテトラヒドロフラン(7mL)混合液に、tert-ブチルマグネシウムクロリド/THF(1.253mL×2、1.253mmol)を窒素雰囲気下、0℃で加えた。反応混合物を室温で1時間撹拌した。反応混合物に、ドデシル((2-(ドデシルオキシ)-2-オキソエトキシ)(4-ニトロフェノキシ)ホスホリル)-L-フェニルアラニナート(1271mg×2、1.671mmol)を0℃で加えた。反応混合物を室温で12時間撹拌した。LCMSは反応の完了を示した。反応混合物をゲルシリカカラム(120g、石油エーテル:EtOAc=5:1)により精製し、ドデシル((2-(ドデシルオキシ)-2-オキソエトキシ)(((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)ホスホリル)-L-フェニルアラニナート(2g、1.233mmol、収率73.8%)を黄色固体として得た。LCMS (ESI) m/z calcd for C87H104FN6O11P: 1459; found: 1460 (M+H).
Step 5: Dodecyl ((2-(dodecyloxy)-2-oxoethoxy)(((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenyl) methyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)phosphoryl)-L-phenylalaninate ((2R,3S,5R) -2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran Tert-butylmagnesium chloride/THF (1.253 mL x 2, 1.253 mmol) was added to a mixture of methanol (700 mg x 2, 0.835 mmol) in tetrahydrofuran (7 mL) under a nitrogen atmosphere at 0°C. added. The reaction mixture was stirred at room temperature for 1 hour. Dodecyl((2-(dodecyloxy)-2-oxoethoxy)(4-nitrophenoxy)phosphoryl)-L-phenylalaninate (1271 mg×2, 1.671 mmol) was added to the reaction mixture at 0°C. The reaction mixture was stirred at room temperature for 12 hours. LCMS showed the reaction was complete. The reaction mixture was purified by a gel silica column (120 g, petroleum ether:EtOAc=5:1) and purified with dodecyl ((2-(dodecyloxy)-2-oxoethoxy)(((2R,3S,5R)-2-ethynyl -5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy )tetrahydrofuran- 2-yl)methoxy)phosphoryl)-L-phenylalaninate (2 g, 1.233 mmol, yield 73.8%) was obtained as a yellow solid. LCMS (ESI) m/z calcd for C 87 H 104 FN 6 O 11 P: 1459; found: 1460 (M+H).

工程6:ドデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(2-(ドデシルオキシ)-2-オキソエトキシ)ホスホリル)-L-フェニルアラニナート
室温で撹拌されているドデシル((2-(ドデシルオキシ)-2-オキソエトキシ)(((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)ホスホリル)-L-フェニルアラニナート(2g、1370mmol)のDCM(20mL)溶液に、TFA(2mL、26.0mmol)を滴下した。反応混合物を室温で1時間撹拌した。LCMSは反応の完了を示した。反応混合物を水でクエンチし、ジクロロメタン(20mL)で抽出した。有機相を飽和NaHCO溶液(20mL)及び飽和ブライン(20mL)で洗浄し、硫酸ナトリウムで乾燥させ、真空下でエバポレーションして、粗生成物を黄色の油状物として得た。粗生成物をシリカゲルカラム(120g、DCM:MeOH=10:1)により精製して、表題化合物(1g)を黄色の油状物として得た。異性体をSCF(カラム:CHIRALPAK AS-H、2.0×25cm L(5μm);移動相A:CO、移動相B:IPA;流速:80mL/分;勾配:50%B;220nm;RT1:3.01;RT2:4.45;注入量:2mL;実行数:11)により分離して、最初に溶出する異性体(実施例11A、309.5mg、RT:3.01)を白色固体として得:LCMS (ESI) m/z calcd for C47H72FN6O9P: 914; found: 915 (M+H). 1H NMR (400 MHz, Chloroform-d) δ 8.17 (s, 1H), 7.32 - 7.14 (m, 5H), 6.38 - 6.31 (m, 1H), 6.13 (s, 2H), 4.86 (t, J = 8.0 Hz, 1H), 4.39 (dd, J = 16.4, 10.0 Hz, 1H), 4.31 - 3.98 (m, 9H), 3.55 - 3.44 (m, 1H), 3.19 - 3.10 (m, 1H), 2.93 (dd, J = 13.6, 8.0 Hz, 1H), 2.79 - 2.70 (m, 3H), 1.66 - 1.56 (m, 4H), 1.34 - 1.22 (m, 36H), 0.92 - 0.84 (m, 6H)、2番目に溶出する異性体(実施例11B、265.9mg、RT:4.45)を白色固体として得た:LCMS (ESI) m/z calcd for C47H72FN6O9P: 914; found: 915 (M+H). 1H NMR (400 MHz, Chloroform-d) δ 8.07 (s, 1H), 7.29 - 7.14 (m, 5H), 6.39 - 6.11 (m, 3H), 4.71 (t, J = 7.6 Hz, 1H), 4.41 (dd, J = 16.0, 10.4 Hz, 1H), 4.26 - 4.04 (m, 8H), 3.83 - 3.73 (m, 2H), 3.16 - 3.06 (m, 1H), 2.93 (dd, J = 14.0, 8.0 Hz, 1H), 2.75 - 2.62 (m, 3H), 1.68 - 1.53 (m, 4H), 1.34 - 1.22 (m, 36H), 0.92 - 0.84 (m, 6H)。
Step 6: Dodecyl((((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(2-(dodecyloxy)-2-oxoethoxy)phosphoryl)-L-phenylalaninate To a solution of dodecyl((2-(dodecyloxy)-2-oxoethoxy)(((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl )diphenylmethoxy)tetrahydrofuran -2-yl)methoxy)phosphoryl)-L-phenylalaninate (2 g, 1370 mmol) in DCM (20 mL) stirred at room temperature was added TFA (2 mL, 26.0 mmol) dropwise. The reaction mixture was stirred at room temperature for 1 h. LCMS showed the reaction was complete. The reaction mixture was quenched with water and extracted with dichloromethane (20 mL). The organic phase was washed with saturated NaHCO3 solution (20 mL) and saturated brine (20 mL), dried over sodium sulfate, and evaporated under vacuum to give the crude product as a yellow oil. The crude product was purified by silica gel column (120 g, DCM:MeOH=10:1) to give the title compound (1 g) as a yellow oil. The isomers were separated by SCF (column: CHIRALPAK AS-H, 2.0×25 cm L (5 μm); mobile phase A: CO 2 , mobile phase B: IPA; flow rate: 80 mL/min; gradient: 50% B; 220 nm; RT1: 3.01; RT2: 4.45; injection volume: 2 mL; number of runs: 11) to give the first eluting isomer (Example 11A, 309.5 mg, RT: 3.01) as a white solid: LCMS (ESI) m/z calcd for C 47 H 72 FN 6 O 9 P: 914; found: 915 (M+H). 1 H NMR (400 MHz, Chloroform-d) δ 8.17 (s, 1H), 7.32 - 7.14 (m, 5H), 6.38 - 6.31 (m, 1H), 6.13 (s, 2H), 4.86 (t, J = 8.0 Hz, 1H), 4.39 (dd, J = 16.4, 10.0 Hz, 1H), 4.31 - 3.98 (m, 9H), 3.55 - 3.44 (m, 1H), 3.19 - 3.10 (m, 1H), 2.93 (dd, J = 13.6, 8.0 Hz, 1H), 2.79 - 2.70 (m, 3H), 1.66 - 1.56 (m, 4H), 1.34 - 1.22 (m, 36H), 0.92 - 0.84 (m, 6H), and the second eluting isomer (Example 11B, 265.9 mg, RT: 4.45) was obtained as a white solid: LCMS (ESI) m/z calcd for C47H72FN6O9P: 914; found: 915 (M+H). 1H NMR (400 MHz, Chloroform-d) δ 8.07 (s, 1H), 7.29 - 7.14 (m, 5H), 6.39 - 6.11 (m, 3H), 4.71 (t, J = 7.6 Hz, 1H), 4.41 (dd, J = 16.0, 10.4 Hz, 1H), 4.26 - 4.04 (m, 8H), 3.83 - 3.73 (m, 2H), 3.16 - 3.06 (m, 1H), 2.93 (dd, J = 14.0, 8.0 Hz, 1H), 2.75 - 2.62 (m, 3H), 1.68 - 1.53 (m, 4H), 1.34 - 1.22 (m, 36H), 0.92 - 0.84 (m, 6H).

工程3:デシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
デシルL-アラニネート(3g、13.08mmol)、TEA(1.823mL、13.08mmol)及びフェニルホスホロジクロリデート(2.76g、13.08mmol)のDCM(30mL)溶液を、窒素下、室温で1時間撹拌する。次いで、((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メタノール(1.5g、1.790mmol)及び1M tert-ブチルマグネシウムクロリド/THF(18.31mL、18.31mmol)のTHF(15mL)/ピリジン(15.0mL)溶液を室温で30分間撹拌し、上記の混合物に加えた。反応混合物を室温で一晩撹拌した。LCMSは反応の完了を示した。反応混合物を水でクエンチし、ジクロロメタン(100mL)と水(100mL)とで分配した。有機相を水(100mL)及び飽和ブライン(100mL)で洗浄し、硫酸ナトリウムで乾燥させ、真空下でエバポレーションして、粗生成物を白色固体として得た。残留物をゲルシリカカラム(330g、石油エーテル:EtOAc=1:1)により精製して、デシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(1g、純度93.9%、収率5.96%)の白色固体として得た。LCMS (ESI) m/z calcd for C71H74FN6O9P: 1204; found: 1205. 1H NMR (300 MHz, Chloroform-d) δ 7.80 - 7.68 (m, 1H), 7.62 - 7.51 (m, 4H), 7.47 - 7.02 (m, 25H), 6.92 - 6.73 (m, 4H), 6.25 - 6.06 (m, 1H), 4.65 - 4.53 (m, 1H), 4.38 - 4.28 (m, 2H), 4.20 - 4.02 (m, 4H), 3.82 - 3.72 (m, 6H), 3.57 - 3.46 (m, 1H), 2.89 - 2.83 (m, 1H), 2.04 - 1.94 (m, 1H), 1.92 - 1.84 (m, 1H), 1.78 - 1.69 (m, 2H), 1.51 - 1.41 (m, 2H), 1.32 - 1.24 (m, 15H), 0.90 (t, J = 6.0 Hz, 3H).
Step 3: Decyl (((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl) -3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninatedecyl L-alaninate (3 g, 13.08 mmol), TEA (1.823 mL, 13. A solution of phenylphosphorodichloridate (2.76 g, 13.08 mmol) in DCM (30 mL) is stirred at room temperature under nitrogen for 1 h. Then , ( (2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-( (4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methanol (1.5 g, 1.790 mmol) and 1M tert-butylmagnesium chloride/THF (18.31 mL, 18.31 mmol) in THF (15 mL)/pyridine. (15.0 mL) The solution was stirred at room temperature for 30 minutes and added to the above mixture. The reaction mixture was stirred at room temperature overnight. LCMS showed the reaction was complete. The reaction mixture was quenched with water and partitioned between dichloromethane (100 mL) and water (100 mL). The organic phase was washed with water (100 mL) and saturated brine (100 mL), dried over sodium sulfate, and evaporated under vacuum to give the crude product as a white solid. The residue was purified by gel silica column (330 g, petroleum ether:EtOAc=1:1) to give decyl (((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(( (4-methoxyphenyl)diphenylmethyl )amino )-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L- Alaninate (1 g, purity 93.9%, yield 5.96%) was obtained as a white solid. LCMS (ESI) m/z calcd for C 71 H 74 FN 6 O 9 P: 1204; found: 1205. 1 H NMR (300 MHz, Chloroform-d) δ 7.80 - 7.68 (m, 1H), 7.62 - 7.51 ( m, 4H), 7.47 - 7.02 (m, 25H), 6.92 - 6.73 (m, 4H), 6.25 - 6.06 (m, 1H), 4.65 - 4.53 (m, 1H), 4.38 - 4.28 (m, 2H), 4.20 - 4.02 (m, 4H), 3.82 - 3.72 (m, 6H), 3.57 - 3.46 (m, 1H), 2.89 - 2.83 (m, 1H), 2.04 - 1.94 (m, 1H), 1.92 - 1.84 (m , 1H), 1.78 - 1.69 (m, 2H), 1.51 - 1.41 (m, 2H), 1.32 - 1.24 (m, 15H), 0.90 (t, J = 6.0 Hz, 3H).

工程4:デシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
窒素下で撹拌されているデシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(1g、0.830mmol)のDCM(10mL)溶液に、室温でTFA(1mL、12.98mmol)を加えた。反応混合物を室温で1時間撹拌した。LCMSは反応の完了を示した。反応混合物を水でクエンチし、DCM(20mL)で抽出した。有機相を飽和炭酸ナトリウム(25mL)、水(25mL)及び飽和ブライン(25mL)で洗浄し、硫酸ナトリウムで乾燥させ、真空下でエバポレーションして、粗生成物を白色固体として得た。粗生成物を分取SFC(カラム:CHIRALPAK IA、2×25cm、5μm;移動相A:Hex:DCM=3:1(0.1% FA)-HPLC、移動相B:EtOH-HPLC;流速:15mL/分;勾配:10分で30Bから30B;220/254nm;RT1:5.582;RT2:7.933;注入量:1mL;実行数:6)によって精製して、最初に溶出する異性体(実施例13A、RT1:5.582、100mg)を白色固体として得(この固体を、アキラルカラム(DAICEL DCpak P4VP、20×250cm、5μm;移動相A:CO、移動相B:MeOH(8mmol/L NH/MeOH)-HPLC;流速:50mL/分;勾配:20%B;254nm;注入量:1.5mL;実行数:4)によって再精製して、最初に溶出する異性体(実施例13A、RT1:6.63、60.8mg)を白色固体として得た。):LCMS (ESI) m/z calcd for C31H42FN6O7P: 660; found: 661(M+H). 1H NMR (400 MHz, DMSO-d6) δ 8.25 (s, 1H), 7.85 (s, 2H), 7.35 - 7.26 (m, 2H), 7.18 - 7.09 (m, 3H), 6.28 (dd, J = 7.6, 4.8 Hz, 1H), 6.02 - 6.00 (m, 1H), 5.83 (d, J = 5.2 Hz, 1H), 4.66 - 4.64 (m, 1H), 4.21 (dd, J = 10.8, 5.6 Hz, 1H), 4.10 (dd, J = 11.2, 4.4 Hz, 1H), 3.98 - 3.89 (m, 2H), 3.72 - 3.64 (m, 2H), 2.83 - 2.74 (m, 1H), 1.49 - 1.44 (m, 2H), 1.28 - 1.08 (m, 17H), 0.89 - 0.81 (m, 3H)、2番目に溶出する異性体(実施例13B、RT:7.933、104.9mg)を白色固体として得た:LCMS (ESI) m/z calcd for C31H42FN6O7P: 660; found: 661(M+H). 1H NMR (300 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.85 (s, 2H), 7.38 - 7.26 (m, 2H), 7.22 - 7.08 (m, 3H), 6.28-6.24 (m, 1H), 6.03 - 6.00 (m, 1H), 5.86 - 5.73 (m, 1H), 4.66 - 4.56 (m, 1H), 4.24 (dd, J = 10.5, 5.7 Hz, 1H), 4.06 (dd, J = 11.1, 4.8 Hz, 1H), 3.99 - 3.71 (m, 3H), 3.64 (s, 1H), 2.83 - 2.67 (m, 1H), 1.53 - 1.37 (m, 2H), 1.31 - 1.11 (m, 17H), 0.89 - 0.80 (m, 3H).
Step 4: Decyl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)-L-alaninate Decyl(((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenyl) stirred under nitrogen methyl )amino )-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L- alaninate ( 1 g, 0. To a solution of 830 mmol) in DCM (10 mL) at room temperature was added TFA (1 mL, 12.98 mmol). The reaction mixture was stirred at room temperature for 1 hour. LCMS showed the reaction was complete. The reaction mixture was quenched with water and extracted with DCM (20 mL). The organic phase was washed with saturated sodium carbonate (25 mL), water (25 mL) and saturated brine (25 mL), dried over sodium sulfate and evaporated under vacuum to give the crude product as a white solid. The crude product was subjected to preparative SFC (column: CHIRALPAK IA, 2 x 25 cm, 5 μm; mobile phase A: Hex: DCM = 3:1 (0.1% FA)-HPLC, mobile phase B: EtOH-HPLC; flow rate: 15 mL/min; Gradient: 30B to 30B in 10 minutes; 220/254 nm; RT1: 5.582; RT2: 7.933; Injection volume: 1 mL; Number of runs: 6) and the first eluting isomer (Example 13A, RT1: 5.582, 100 mg) was obtained as a white solid (this solid was prepared using an achiral column (DAICEL DCpak P4VP, 20 x 250 cm, 5 μm; mobile phase A: CO 2 , mobile phase B: MeOH (8 mmol)). /L NH 3 /MeOH)-HPLC; flow rate: 50 mL/min; gradient: 20% B; 254 nm; injection volume: 1.5 mL; number of runs: 4) to repurify the first eluting isomer (run Example 13A, RT1: 6.63, 60.8 mg) was obtained as a white solid.): LCMS (ESI) m/z calcd for C 31 H 42 FN 6 O 7 P: 660; found: 661(M+H ). 1 H NMR (400 MHz, DMSO-d6) δ 8.25 (s, 1H), 7.85 (s, 2H), 7.35 - 7.26 (m, 2H), 7.18 - 7.09 (m, 3H), 6.28 (dd, J = 7.6, 4.8 Hz, 1H), 6.02 - 6.00 (m, 1H), 5.83 (d, J = 5.2 Hz, 1H), 4.66 - 4.64 (m, 1H), 4.21 (dd, J = 10.8, 5.6 Hz , 1H), 4.10 (dd, J = 11.2, 4.4 Hz, 1H), 3.98 - 3.89 (m, 2H), 3.72 - 3.64 (m, 2H), 2.83 - 2.74 (m, 1H), 1.49 - 1.44 (m , 2H), 1.28 - 1.08 (m, 17H), 0.89 - 0.81 (m, 3H), the second eluting isomer (Example 13B, RT: 7.933, 104.9 mg) was obtained as a white solid. :LCMS (ESI) m/z calcd for C 31 H 42 FN 6 O 7 P: 660; found: 661(M+H). 1 H NMR (300 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.85 (s, 2H), 7.38 - 7.26 (m, 2H), 7.22 - 7.08 (m, 3H), 6.28-6.24 (m, 1H), 6.03 - 6.00 (m, 1H), 5.86 - 5.73 (m, 1H) ), 4.66 - 4.56 (m, 1H), 4.24 (dd, J = 10.5, 5.7 Hz, 1H), 4.06 (dd, J = 11.1, 4.8 Hz, 1H), 3.99 - 3.71 (m, 3H), 3.64 ( s, 1H), 2.83 - 2.67 (m, 1H), 1.53 - 1.37 (m, 2H), 1.31 - 1.11 (m, 17H), 0.89 - 0.80 (m, 3H).

工程3:デシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
ドデシルL-アラニナート(3g、11.65mmol)、TEA(4.87mL、35.0mmol)及びフェニルホスホロジクロリデート(2.459g、11.65mmol)のDCM(30mL)溶液を、窒素下、室温で1時間撹拌した。次いで、((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メタノール(1.5g、1.790mmol)及びtert-ブチルマグネシウムクロリド/THF(16.32mL、16.32mmol)のTHF(15mL)/ピリジン(15mL)溶液を室温で30分間撹拌し、上記混合物に加えた。得られた反応混合物を室温で一晩撹拌した。反応混合物を水でクエンチし、ジクロロメタン(100mL)と水(100mL)とで分配した。有機相を水(100mL)及び飽和ブライン(100mL)で洗浄し、硫酸ナトリウムで乾燥させ、真空下でエバポレーションして、粗生成物を白色固体として得た。残留物をゲルシリカカラム(330g、石油エーテル:EtOAc=1:1)により精製して、ドデシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(1.8g、純度98%、収率12.27%)を白色固体として得た。LCMS (ESI) m/z calcd for C73H78FN6O9P: 1233; found:1234 (M+1). 1H NMR (300 MHz, Chloroform-d) δ 7.79 - 7.71 (m, 1H), 7.60 - 7.49 (m, 4H), 7.45 - 7.04 (m, 25H), 6.90 - 6.74 (m, 4H), 6.21 - 6.13 (m, 1H), 4.65 - 4.53 (m, 1H), 4.33 (t, J = 6.6 Hz, 2H), 4.26 - 4.17 (m, 1H), 4.15 - 4.00 (m, 3H), 3.84 - 3.71 (m, 6H), 3.59 - 3.42 (m, 1H), 2.05 - 1.97 (m, 1H), 1.75 (dd, J = 8.7, 6.3 Hz, 2H), 1.54 - 1.41 (m, 2H), 1.27 (br s, 19H), 0.93 - 0.86 (m, 3H).
Step 3: Decyl (((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl) -3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate Dodecyl L-alaninate (3 g, 11.65 mmol), TEA (4.87 mL, 35. A solution of phenylphosphorodichloridate (2.459 g, 11.65 mmol) in DCM (30 mL) was stirred at room temperature under nitrogen for 1 h. Then, ((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-( (4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methanol (1.5 g, 1.790 mmol) and tert-butylmagnesium chloride/THF (16.32 mL, 16.32 mmol) in THF (15 mL)/pyridine ( 15 mL) solution was stirred at room temperature for 30 minutes and added to the above mixture. The resulting reaction mixture was stirred at room temperature overnight. The reaction mixture was quenched with water and partitioned between dichloromethane (100 mL) and water (100 mL). The organic phase was washed with water (100 mL) and saturated brine (100 mL), dried over sodium sulfate, and evaporated under vacuum to give the crude product as a white solid. The residue was purified by gel silica column (330 g, petroleum ether:EtOAc=1:1) to give dodecyl (((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(( (4-methoxyphenyl)diphenylmethyl )amino )-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L- Alaninate (1.8 g, 98% purity, 12.27% yield) was obtained as a white solid. LCMS (ESI) m/z calcd for C 73 H 78 FN 6 O 9 P: 1233; found:1234 (M+1). 1 H NMR (300 MHz, Chloroform-d) δ 7.79 - 7.71 (m, 1H) , 7.60 - 7.49 (m, 4H), 7.45 - 7.04 (m, 25H), 6.90 - 6.74 (m, 4H), 6.21 - 6.13 (m, 1H), 4.65 - 4.53 (m, 1H), 4.33 (t, J = 6.6 Hz, 2H), 4.26 - 4.17 (m, 1H), 4.15 - 4.00 (m, 3H), 3.84 - 3.71 (m, 6H), 3.59 - 3.42 (m, 1H), 2.05 - 1.97 (m, 1H), 1.75 (dd, J = 8.7, 6.3 Hz, 2H), 1.54 - 1.41 (m, 2H), 1.27 (br s, 19H), 0.93 - 0.86 (m, 3H).

工程4:ドデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
窒素下、室温で撹拌されているドデシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(1.8g、1.459mmol)のDCM(18mL)溶液に、TFA(1.8mL、23.36mmol)を加えた。反応混合物を室温で1時間撹拌した。LCMSは反応の完了を示した。反応混合物を水でクエンチし、ジクロロメタン(20mL)で抽出した。有機相を飽和重炭酸ナトリウム溶液(20mL)、水(25mL)及び飽和ブライン(25mL)で洗浄し、硫酸ナトリウムで乾燥させ、真空下でエバポレーションして、粗生成物を白色固体として得た。粗生成物を分取SFC(カラム:CHIRALPAK IH、2×25cm、5μm;移動相A:CO、移動相B:MEOH(2mM NH-MEOH);流速:5mL/分;勾配:30%B;220nm;RT1:3.94;RT2:5.13;注射量:1.5mL;実行数:14)により精製して、最初に溶出する異性体(実施例14A、RT:3.94、300mg)を白色固体として得、これを分取アキラルカラム(カラム:DAICEL DCpak P4VP、20×250cm、5μm;移動相A:CO、移動相B:MeOH(8mmol/L NH.MeOH)-HPLC;流速:50mL/分;勾配:25%B;254nm;注射量:1mL;実行数:10)によってさらに精製して、最初に溶出する異性体(実施例14A、RT1:3.85、178.3mg)を得:LCMS (ESI) m/z calcd for C33H46FN6O7P: 688; found: 689 (M+H). 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.86 (br s, 2H), 7.32 (d, J = 7.6 Hz, 2H), 7.20 - 7.11 (m, 3H), 6.30 - 6.23 (m, 1H), 6.06 - 5.95 (m, 1H), 5.79 (d, J = 5.6 Hz, 1H), 4.66 - 4.57 (m, 1H), 4.28 - 4.20 (m, 1H), 4.10 - 4.02 (m, 1H), 3.99 - 3.90 (m, 1H), 3.89 - 3.74 (m, 2H), 3.65 (s, 1H), 3.34 (s, 2H), 2.79 - 2.71 (m, 1H), 1.49 - 1.39 (m, 2H), 1.28 - 1.15 (m, 19H), 0.89 - 0.81 (m, 3H)、2番目に溶出する異性体(実施例14B、RT:5.13、200mg)を白色固体として得、これを分取キラルカラム(カラム:CHIRALPAK IA、2×25cm、5μm;移動相A:Hex:DCM=3:1(0.1%FA)-HPLC、移動相B:IPA-HPLC;流速:20mL/分;勾配:8分で30Bから30B;220/254nm;RT1:4.103;RT2:6.726;注射量:1mL;実行数:4)によりさらに精製して、99.0mgの生成物(RT:4.103)を得た:LCMS (ESI) m/z calcd for C33H46FN6O7P: 688; found: 689 (M+H). 1H NMR (400 MHz, DMSO-d6) δ 8.25 (s, 1H), 7.88 (brs, 2H),7.35 - 7.26 (m, 2H), 7.18 - 7.09 (m, 3H), 6.32 - 6.24 (m, 1H), 6.05 - 5.94 (m, 1H), 5.82 (d, J = 5.6 Hz, 1H), 4.64 (t, J = 6.4 Hz, 1H), 4.26 - 4.17 (m, 1H), 4.14 - 4.06 (m, 1H), 3.94 (t, J = 5.6 Hz, 2H), 3.75 - 3.62 (m, 2H), 2.84 - 2.71 (m, 1H), 1.49 - 1.43 (m, 2H), 1.28 - 1.14 (m, 21H), 0.89 - 0.81 (m, 3H)。
Step 4: Dodecyl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)-L-alaninate Dodecyl (((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)) is stirred at room temperature under nitrogen. ) diphenylmethyl )amino )-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (1.8g , 1.459 mmol) in DCM (18 mL) was added TFA (1.8 mL, 23.36 mmol). The reaction mixture was stirred at room temperature for 1 hour. LCMS showed the reaction was complete. The reaction mixture was quenched with water and extracted with dichloromethane (20 mL). The organic phase was washed with saturated sodium bicarbonate solution (20 mL), water (25 mL) and saturated brine (25 mL), dried over sodium sulfate and evaporated under vacuum to give the crude product as a white solid. The crude product was subjected to preparative SFC (column: CHIRALPAK IH, 2 x 25 cm, 5 μm; mobile phase A: CO 2 , mobile phase B: MEOH (2mM NH 3 -MEOH); flow rate: 5 mL/min; gradient: 30% B ; 220 nm; RT1: 3.94; RT2: 5.13; Injection volume: 1.5 mL; Number of runs: 14) to obtain the first eluting isomer (Example 14A, RT: 3.94, 300 mg ) was obtained as a white solid, which was purified using a preparative achiral column (column: DAICEL DCpak P4VP, 20 x 250 cm, 5 μm; mobile phase A: CO 2 , mobile phase B: MeOH (8 mmol/L NH 3 .MeOH)-HPLC; Flow rate: 50 mL/min; gradient: 25% B; 254 nm; injection volume: 1 mL; number of runs: 10) to further purify the first eluting isomer (Example 14A, RT1: 3.85, 178.3 mg ) obtained: LCMS (ESI) m/z calcd for C 33 H 46 FN 6 O 7 P: 688; found: 689 (M+H). 1 H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.86 (br s, 2H), 7.32 (d, J = 7.6 Hz, 2H), 7.20 - 7.11 (m, 3H), 6.30 - 6.23 (m, 1H), 6.06 - 5.95 (m, 1H), 5.79 (d, J = 5.6 Hz, 1H), 4.66 - 4.57 (m, 1H), 4.28 - 4.20 (m, 1H), 4.10 - 4.02 (m, 1H), 3.99 - 3.90 (m, 1H), 3.89 - 3.74 (m, 2H), 3.65 (s, 1H), 3.34 (s, 2H), 2.79 - 2.71 (m, 1H), 1.49 - 1.39 (m, 2H), 1.28 - 1.15 (m, 19H), 0.89 - 0.81 (m, 3H), the second eluting isomer (Example 14B, RT: 5.13, 200 mg) was obtained as a white solid, which was applied to a preparative chiral column (column: CHIRALPAK IA, 2 x 25 cm, 5 μm; Mobile phase A: Hex:DCM=3:1 (0.1% FA)-HPLC, mobile phase B: IPA-HPLC; flow rate: 20 mL/min; gradient: 30B to 30B in 8 minutes; 220/254 nm; RT1: Further purification by 4.103; RT2: 6.726; injection volume: 1 mL; number of runs: 4) yielded 99.0 mg of product (RT: 4.103): LCMS (ESI) m/z calcd for C 33 H 46 FN 6 O 7 P: 688; found: 689 (M+H). 1 H NMR (400 MHz, DMSO-d6) δ 8.25 (s, 1H), 7.88 (brs, 2H),7.35 - 7.26 (m, 2H), 7.18 - 7.09 (m, 3H), 6.32 - 6.24 (m, 1H), 6.05 - 5.94 (m, 1H), 5.82 (d, J = 5.6 Hz, 1H), 4.64 (t , J = 6.4 Hz, 1H), 4.26 - 4.17 (m, 1H), 4.14 - 4.06 (m, 1H), 3.94 (t, J = 5.6 Hz, 2H), 3.75 - 3.62 (m, 2H), 2.84 - 2.71 (m, 1H), 1.49 - 1.43 (m, 2H), 1.28 - 1.14 (m, 21H), 0.89 - 0.81 (m, 3H).

工程3:ヘキサデシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
窒素下、0℃で撹拌されているヘキサデシルL-アラニナート(2g、6.38mmol)及びTEA(1.937g、19.14mmol)のDCM(20mL)溶液に、フェニルホスホロジクロリデート(1.615g、7.65mmol)を少しずつ加えた。反応混合物を室温で1時間撹拌した。
窒素下、室温で撹拌されている((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メタノール(2.67g、3.19mmol)のピリジン(10.0mL)/THF(10.0mL)溶液に、tert-ブチルマグネシウムクロリド/THF(8.93mL、8.93mmol)溶液を滴下した。反応混合物を25℃で0.5時間撹拌した。次いで、上記溶液をこの反応混合物に室温で添加した。得られた混合物を25℃で16時間撹拌した。LCMSは、反応の完了を示した。反応混合物を真空中でエバポレーションして、粗生成物を赤色の油状物として得た。0%~60%EtOAc/石油エーテル溶媒勾配を使用するシリカカラム(120g)により、この油状物を精製して、ヘキサデシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(800mg、純度80%、収率7.78%)を淡黄色の半固体として得た。LCMS (ESI) m/z calcd for C83H98FN6O9P: 1288; found: 1289 (M+1).
Step 3: Hexadecyl (((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl) -3-((4-Methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate Hexadecyl L-alaninate (2 g, 6.38 mmol) being stirred at 0° C. under nitrogen. ) and TEA (1.937 g, 19.14 mmol) in DCM (20 mL) was added phenylphosphorodichloridate (1.615 g, 7.65 mmol) in portions. The reaction mixture was stirred at room temperature for 1 hour.
((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purine-9 is stirred at room temperature under nitrogen. -yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methanol (2.67 g, 3.19 mmol) in pyridine (10.0 mL)/THF (10.0 mL), tert -Butylmagnesium chloride/THF (8.93 mL, 8.93 mmol) solution was added dropwise. The reaction mixture was stirred at 25°C for 0.5 hour. The above solution was then added to the reaction mixture at room temperature. The resulting mixture was stirred at 25°C for 16 hours. LCMS showed the reaction was complete. The reaction mixture was evaporated in vacuo to give the crude product as a red oil. This oil was purified by a silica column (120 g) using a 0% to 60% EtOAc/petroleum ether solvent gradient to give hexadecyl (((2R,3S,5R)-2-ethynyl-5-(2- Fluoro-6-(((4-methoxyphenyl)diphenylmethyl )amino )-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy ) Phosphoryl)-L-alaninate (800 mg, purity 80%, yield 7.78%) was obtained as a pale yellow semi-solid. LCMS (ESI) m/z calcd for C 83 H 98 FN 6 O 9 P: 1288; found: 1289 (M+1).

工程3:ドコシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
窒素下、0℃で撹拌されているドコシルL-アラニナート(2g、5.03mmol)及びTEA(1.527g、17.09mmol)のDCM(20mL)溶液に、フェニルホスホロジクロリデート(1.273g、6.03mmol)を少しずつ加えた。反応混合物を室温で1時間撹拌した。
窒素下、室温で撹拌されている((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メタノール(2.107g、2.51mmol)のピリジン(10.0mL)/THF(10.0mL)溶液に、tert-ブチルマグネシウムクロリド/THF(7.04mL、7.04mmol)を少しずつ加えた。反応混合物を25℃で0.5時間撹拌した。次いで、この反応混合物に上記溶液を室温で加えた。得られた混合物を25℃で16時間撹拌した。LCMS及びTLCは、反応の完了を示した。反応混合物を真空下でエバポレーションして、粗生成物を赤色の油状物として得た。0%~60%EtOAc/石油エーテル溶媒勾配を使用するシリカカラム(120g)により、この油状物を精製して、ドコシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(1.8g、純度80%、収率20.84%)を淡黄色の半固体として得た。LCMS (ESI) m/z calcd for C83H98FN6O9P: 1372; found: 1373 (M+1). 1H NMR (400 MHz, Chloroform-d) δ 7.94 (s, 1H), 7.59 - 7.45 ( m, 4H), 7.37 - 7.00 ( m, 26H), 6.85 - 6.73 ( m, 4H), 6.15 - 6.10 (m, 1H), 4.51 - 3.94 (m, 4H), 3.84 - 3.66 (m, 10H), 2.89 - 2.64 (m, 2H), 2.07 - 1.91 (m, 2H), 1.42 - 1.17 ( m, 41H), 0.90 - 0.84 (m, 3H).
Step 3: Docosyl((((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate To a solution of docosyl L-alaninate (2 g, 5.03 mmol) and TEA (1.527 g, 17.09 mmol) in DCM (20 mL) stirred under nitrogen at 0° C. was added phenyl phosphorodichloridate (1.273 g, 6.03 mmol) in portions. The reaction mixture was stirred at room temperature for 1 h.
To a solution of ((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methanol (2.107 g, 2.51 mmol) in pyridine (10.0 mL)/THF (10.0 mL) stirred at room temperature under nitrogen was added tert-butylmagnesium chloride/THF (7.04 mL, 7.04 mmol) in portions. The reaction mixture was stirred at 25° C. for 0.5 h. To this reaction mixture was then added the above solution at room temperature. The resulting mixture was stirred at 25° C. for 16 h. LCMS and TLC showed the reaction was complete. The reaction mixture was evaporated in vacuo to give the crude product as a red oil. The oil was purified by silica column (120 g) using a 0% to 60% EtOAc/petroleum ether solvent gradient to give docosyl((((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl )amino )-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (1.8 g, 80% purity, 20.84% yield) as a pale yellow semi-solid. LCMS (ESI) m/z calcd for C83H98FN6O9P : 1372; found: 1373 ( M + 1 ). 1H NMR (400 MHz, Chloroform-d) δ 7.94 (s, 1H), 7.59 - 7.45 (m, 4H), 7.37 - 7.00 (m, 26H), 6.85 - 6.73 (m, 4H), 6.15 - 6.10 (m, 1H), 4.51 - 3.94 (m, 4H), 3.84 - 3.66 (m, 10H), 2.89 - 2.64 (m, 2H), 2.07 - 1.91 (m, 2H), 1.42 - 1.17 (m, 41H), 0.90 - 0.84 (m, 3H).

工程4:ドコシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
室温で撹拌されているドコシル((((2R,3S,5R)-2-エチニル-5-(2-フルオロ-6-(((4-メトキシフェニル)ジフェニルメチル)アミノ)-9H-プリン-9-イル)-3-((4-メトキシフェニル)ジフェニルメトキシ)テトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(2.1g、1.529mol)のDCM(15mL)溶液に、TFA(2mL、26.0mmol)を滴下し、30分間撹拌した。LCMSは反応の完了を示した。反応混合物をNaHCO(100mL)でクエンチし、DCM(60mL×2)で抽出した。有機相を合わせ、ブライン(15mL)で洗浄し、NaSOで乾燥させ、真空下で濃縮した。残留物をシリカゲルカラム(120g、石油エーテル:EtOAc=1:1)により精製して、所望の生成物を無色の半固体として得た。異性体を以下の条件で分取SFCによって分離した(カラム:CHIRALPAK IG、3×25cm、5μm;移動相A:CO、移動相B:IPA;流速:80mL/分;勾配:50%B;220nm;RT1:6.41;RT2:18.31;注入量:4.5mL;実行数:5)。最初に溶出する異性体である実施例16A(RT1:6.41)を回収して、329.7mg(純度97.6%、収率25.5%)を白色固体として得た。1H NMR (400 MHz, Chloroform-d) δ 8.03 (s, 1H), 7.36 - 7.10 ( m, 5H), 6.63 - 6.01 (m, 3H), 4.71 (t, J = 7.6 Hz, 1H), 4.44 - 4.34 (m, 2H), 4.13 - 3.97 (m, 3H), 3.81 (t, J = 10.4 Hz, 1H), 2.77 (s, 1H), 2.76 - 2.62 (m, 2H), 1.63 - 1.54 (m, 2H), 1.39 - 1.17 ( m, 41H), 0.90 - 0.84 (m, 3H).2番目の異性体である実施例16B(RT2:18.31)を回収して、188.1mg(純度98.06%、収率14.5%)を白色固体として得た。LCMS (ESI) m/z calcd for C43H66FN6O7P: 828; found: 829 (M+1). 1H NMR (400 MHz, Chloroform-d)δ 8.05 (s, 1H), 7.34 - 7.12 ( m, 5H), 6.33 (dd, J = 4.0, 7.2 Hz, 1H), 6.15 - 5.76 (m, 2H), 4.85 (t, J = 6.4 Hz, 1H), 4.43 - 4.28 (m, 2H), 4.18 - 3.97 (m, 3H), 3.77 (t, J = 10.4 Hz, 1H), 3.52 (br, s, 1H), 2.84 - 2.67 (m, 3H), 1.63 - 1.54 (m, 2H), 1.39 (d, J = 6.8 Hz, 3H), 1.34 - 1.17 ( m, 38H), 0.90 - 0.84 (m, 3H).
Step 4: Docosyl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)-L-alaninate Docosyl(((2R,3S,5R)-2-ethynyl-5-(2-fluoro-6-(((4-methoxyphenyl)diphenylmethyl) stirred at room temperature )-amino )-9H-purin-9-yl)-3-((4-methoxyphenyl)diphenylmethoxy)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (2.1 g, 1. To a solution of 529 mol) in DCM (15 mL) was added TFA (2 mL, 26.0 mmol) dropwise and stirred for 30 minutes. LCMS showed the reaction was complete. The reaction mixture was quenched with NaHCO 3 (100 mL) and extracted with DCM (60 mL x 2). The organic phases were combined, washed with brine (15 mL), dried over Na 2 SO 4 and concentrated under vacuum. The residue was purified by silica gel column (120 g, petroleum ether:EtOAc=1:1) to give the desired product as a colorless semi-solid. The isomers were separated by preparative SFC under the following conditions (column: CHIRALPAK IG, 3 x 25 cm, 5 μm; mobile phase A: CO 2 , mobile phase B: IPA; flow rate: 80 mL/min; gradient: 50% B; 220 nm; RT1: 6.41; RT2: 18.31; Injection volume: 4.5 mL; Number of runs: 5). The first eluting isomer, Example 16A (RT1: 6.41), was collected to yield 329.7 mg (97.6% purity, 25.5% yield) as a white solid. 1 H NMR (400 MHz, Chloroform-d) δ 8.03 (s, 1H), 7.36 - 7.10 (m, 5H), 6.63 - 6.01 (m, 3H), 4.71 (t, J = 7.6 Hz, 1H), 4.44 - 4.34 (m, 2H), 4.13 - 3.97 (m, 3H), 3.81 (t, J = 10.4 Hz, 1H), 2.77 (s, 1H), 2.76 - 2.62 (m, 2H), 1.63 - 1.54 (m , 2H), 1.39 - 1.17 (m, 41H), 0.90 - 0.84 (m, 3H).The second isomer, Example 16B (RT2: 18.31), was recovered to yield 188.1 mg (purity 98 .06%, yield 14.5%) was obtained as a white solid. LCMS (ESI) m/z calcd for C 43 H 66 FN 6 O 7 P: 828; found: 829 (M+1). 1 H NMR (400 MHz, Chloroform-d)δ 8.05 (s, 1H), 7.34 - 7.12 (m, 5H), 6.33 (dd, J = 4.0, 7.2 Hz, 1H), 6.15 - 5.76 (m, 2H), 4.85 (t, J = 6.4 Hz, 1H), 4.43 - 4.28 (m, 2H) ), 4.18 - 3.97 (m, 3H), 3.77 (t, J = 10.4 Hz, 1H), 3.52 (br, s, 1H), 2.84 - 2.67 (m, 3H), 1.63 - 1.54 (m, 2H), 1.39 (d, J = 6.8 Hz, 3H), 1.34 - 1.17 (m, 38H), 0.90 - 0.84 (m, 3H).

工程1:テトラデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート
(tert-ブトキシカルボニル)-L-フェニルアラニン(15g、56.5mmol)、2-(3H-[1,2,3]トリアゾロ[4,5-b]ピリジン-3-イル)-1,1,3,3-テトラメチルイソウロニウムヘキサフルオロホスフェート(V)(32.2g、85mmol)及びテトラデカン-1-オール(14.55g、67.8mmol)のDCM(200mL)溶液に、1H-イミダゾール(11.55g、170mmol)及びN-エチル-N-イソプロピルプロパン-2-アミン(21.92g、170mmol)を加えた。得られた混合物を25℃で一晩撹拌した。TLCは反応の完了を示した。反応物を水(200mL)及びDCM(100mL)で希釈した。有機層を分離し、水層をDCM(2×200mL)で抽出した。次いで、合わせた有機層をブライン(200mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮して、粗生成物を得た。残留物をcombiflash(シリカゲルカラム330g、ヘキサン:酢酸エチル=20:1)で精製した。所望の生成物を含む適切な画分を合わせ、真空中で溶媒を除去して、テトラデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(20g、41.2mmol、収率72.8%)を黄色の固体として得た。LCMS(M+Na)=485.0;保持時間(0.1% TFA)=3.56分。
Step 1: Tetradecyl(tert-butoxycarbonyl)-L-phenylalaninate (tert-butoxycarbonyl)-L-phenylalanine (15 g, 56.5 mmol), 2-(3H-[1,2,3]triazolo[4, 5-b]pyridin-3-yl)-1,1,3,3-tetramethylisouronium hexafluorophosphate (V) (32.2 g, 85 mmol) and tetradecane-1-ol (14.55 g, 67. 8 mmol) in DCM (200 mL) were added 1H-imidazole (11.55 g, 170 mmol) and N-ethyl-N-isopropylpropan-2-amine (21.92 g, 170 mmol). The resulting mixture was stirred at 25°C overnight. TLC showed the reaction was complete. The reaction was diluted with water (200 mL) and DCM (100 mL). The organic layer was separated and the aqueous layer was extracted with DCM (2 x 200 mL). The combined organic layers were then washed with brine (200 mL), dried over Na 2 SO 4 , filtered, and concentrated to give the crude product. The residue was purified by combiflash (silica gel column 330 g, hexane:ethyl acetate=20:1). The appropriate fractions containing the desired product were combined and the solvent was removed in vacuo to yield tetradecyl(tert-butoxycarbonyl)-L-phenylalaninate (20 g, 41.2 mmol, 72.8% yield). Obtained as a yellow solid. LCMS (M+Na) = 485.0; retention time (0.1% TFA) = 3.56 minutes.

工程1:オクタデシル(tert-ブトキシカルボニル)フェニルアラニナート
オクタデカン-1-オール(32.5g、120mmol)、(tert-ブトキシカルボニル)-L-フェニルアラニン(29g、109mmol)及びHATU(62.3g、164mmol)のDCM(100mL)溶液に、1H-イミダゾール(22.32g、328mmol)及びDIPEA(57.3mL、328mmol)を加えた。得られた混合物を25℃で一晩撹拌した。TLC(石油エーテル:EtOAc=10:1、Rf=0.5)は反応の完了を示した。反応を水(200mL)及びDCM(100mL)でクエンチした。次いで、有機層を分離し、水層をDCM(2×50mL)で抽出した。合わせた有機層をブライン(200mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮して粗生成物を得た。残留物をcombiflash(シリカゲルカラム330g、ヘキサン:酢酸エチル=20:1)で精製した。所望の生成物を含む適切な画分を合わせ、真空で濃縮して、オクタデシル(tert-ブトキシカルボニル)フェニルアラニナート(32g、61.8mmol、収率56.5%)を黄色の固体として得た。
Step 1: Octadecyl(tert-butoxycarbonyl)phenylalaninate octadecane -1-ol (32.5g, 120mmol), (tert-butoxycarbonyl)-L-phenylalanine (29g, 109mmol) and HATU (62.3g, 164mmol) To a solution of DCM (100 mL) was added 1H-imidazole (22.32 g, 328 mmol) and DIPEA (57.3 mL, 328 mmol). The resulting mixture was stirred at 25°C overnight. TLC (petroleum ether:EtOAc=10:1, Rf=0.5) showed completion of the reaction. The reaction was quenched with water (200 mL) and DCM (100 mL). The organic layer was then separated and the aqueous layer was extracted with DCM (2 x 50 mL). The combined organic layers were washed with brine (200 mL), dried over Na 2 SO 4 , filtered, and concentrated to give the crude product. The residue was purified by combiflash (silica gel column 330 g, hexane:ethyl acetate=20:1). Appropriate fractions containing the desired product were combined and concentrated in vacuo to give octadecyl(tert-butoxycarbonyl)phenylalaninate (32 g, 61.8 mmol, 56.5% yield) as a yellow solid. .

工程3:ヘプタデカン-9-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
ヘプタデカン-9-イルL-フェニルアラニナート(2.75g、6.82mmol)、トリエチルアミン(0.951mL、6.82mmol)のDCM(60mL)溶液に、フェニルホスホロジクロリデート(1.019mL、6.82mmol)のDCM(1mL)溶液を窒素雰囲気下、約5℃で滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(1g、3.41mmol)のTHF(20mL)/ピリジン(10mL)溶液に、tert-ブチルマグネシウムクロリド(8.52mL、8.52mmol)を窒素雰囲気下、約5℃で滴下し、次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温でゆっくりと加え、2時間撹拌した。LCMSは反応の完了を示した。混合物を濾過し、濃縮して、黄色の固体を得た。次いで、固体をEtOAc(40mL)に溶解させ、HCl(0.05N、20mL)で分配した。層を分離し、水層をEtOAc(30×2mL)で抽出した。合わせた有機層をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮して、粗生成物を得た。残留物を逆相クロマトグラフィー(SepaFlash(登録商標)C18、0~100% CHCN/10mM NHHCOO)により精製して、ヘプタデカン-9-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(600mg、0.660mmol、収率19.36%)を淡黄色の固体として得た。LCMS(M+H)=835.4;保持時間(0.1% TFA)=2.474及び2.506分。ジアステレオマーを分取SFC(装置:SFC-150(Waters)、カラム:OX 20×250mm、10μm(Daicel)、カラム温度:35℃;移動相:CO/EtOH(0.5% アンモニア/メタノール)=65/35;流速:100g/分、背圧:100バール;検出波長:214nm、サイクル時間:5分、サンプル溶液:700mgを60mLメタノールに溶解させた、注入量:3mL)により分離して、最初に溶出する異性体(実施例23A、RT1:1.13分、109mg、0.125mmol、収率17.43%)を得;LCMS(M+H)=835.4;保持時間(0.1% TFA)=2.468分;HPLC:保持時間(0.1% NHHCO)=9.409分; 1 H NMR (400 MHz, CDCl3) δ 7.92 (s, 1H), 7.25-7.17 (m, 5H), 7.14 (d, J = 7.3 Hz, 1H), 7.12-7.08 (m, 4H), 6.31 (dd, J = 7.3, 4.3 Hz, 1H), 6.10 (s, 2H), 4.71 (t, J = 7.6 Hz, 1H), 4.26 (dd, J = 11.2, 7.7 Hz, 2H), 4.20 (dd, J = 11.3, 8.8 Hz, 1H), 4.03 (t, J = 6.7 Hz, 2H), 3.88 (s, 1H), 2.99 (d, J = 6.2 Hz, 2H), 2.76-2.63 (m, 3H), 1.86 (s, 2H), 1.24 (d, J = 9.0 Hz, 30H), 0.88 (t, J = 6.8 Hz, 3H)、2番目に溶出する異性体(実施例23B、RT2:2.12分、145mg、0.167mmol、収率23.29%)を白色固体として;LCMS(M+H)=835.3;保持時間(0.1% TFA)=2.505分;HPLC:保持時間(0.1% NHHCO)=9.584分;1H NMR (400 MHz, CDCl3) δ7.78 (s, 1H), 7.30-7.26 (m, 2H), 7.23 (dd, J = 8.4, 4.6 Hz, 3H), 7.15 (d, J = 7.8 Hz, 3H), 7.06 (dd, J = 7.5, 1.7 Hz, 2H), 6.32 (dd, J = 7.4, 4.2 Hz, 1H), 6.24 (s, 2H), 4.64 (t, J = 7.6 Hz, 1H), 4.23-4.15 (m, 2H), 4.02 (t, J = 6.7 Hz, 2H), 3.97 (dd, J = 11.5, 8.4 Hz, 1H), 3.73 (t, J = 10.8 Hz, 1H), 3.04-2.92 (m, 2H), 2.70 (s, 1H), 2.66 (dt, J = 13.7, 7.8 Hz, 1H), 2.57 (ddd, J = 13.6, 7.1, 4.2 Hz, 1H), 1.89 (s, 2H), 1.24 (d, J = 4.9 Hz, 30H), 0.87 (t, J = 6.8 Hz, 3H).
Step 3: Heptadecan-9-yl(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2- yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate heptadecan- 9-yl L-phenylalaninate (2.75 g, 6.82 mmol), triethylamine (0.951 mL, 6.82 mmol) in DCM (60 mL) To the solution was added a solution of phenylphosphorodichloridate (1.019 mL, 6.82 mmol) in DCM (1 mL) under nitrogen atmosphere at about 5° C., and then the reaction mixture was stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (1 g, 3.41 mmol) To a THF (20 mL)/pyridine (10 mL) solution of tert-butylmagnesium chloride (8.52 mL, 8.52 mmol) was added dropwise at about 5° C. under a nitrogen atmosphere, and the mixture was then stirred at room temperature for 30 minutes. The first prepared mixture was slowly added to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. The mixture was filtered and concentrated to give a yellow solid. The solid was then dissolved in EtOAc (40 mL) and partitioned with HCl (0.05N, 20 mL). The layers were separated and the aqueous layer was extracted with EtOAc (30 x 2 mL). The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered, and concentrated to give the crude product. The residue was purified by reverse phase chromatography (SepaFlash® C18, 0-100% CH 3 CN/10 mM NH 4 HCO 3 H 2 O) to give heptadecan-9-yl ((((2R,3S, 5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate ( 600 mg, 0.660 mmol, yield 19.36%) was obtained as a pale yellow solid. LCMS (M+H) = 835.4; retention time (0.1% TFA) = 2.474 and 2.506 minutes. Diastereomers were separated by preparative SFC (equipment: SFC-150 (Waters), column: OX 20 x 250 mm, 10 μm (Daicel), column temperature: 35°C; mobile phase: CO 2 /EtOH (0.5% ammonia / methanol). )=65/35; flow rate: 100 g/min, back pressure: 100 bar; detection wavelength: 214 nm, cycle time: 5 minutes, sample solution: 700 mg dissolved in 60 mL methanol, injection volume: 3 mL). , the first eluting isomer (Example 23A, RT1: 1.13 min, 109 mg, 0.125 mmol, yield 17.43%) was obtained; LCMS (M+H) = 835.4; retention time (0.1 % TFA) = 2.468 min; HPLC: Retention time (0.1% NH4HCO3 ) = 9.409 min; 1H NMR (400 MHz, CDCl3 ) δ 7.92 ( s, 1H), 7.25-7.17 (m, 5H), 7.14 (d, J = 7.3 Hz, 1H), 7.12-7.08 (m, 4H), 6.31 (dd, J = 7.3, 4.3 Hz, 1H), 6.10 (s, 2H), 4.71 ( t, J = 7.6 Hz, 1H), 4.26 (dd, J = 11.2, 7.7 Hz, 2H), 4.20 (dd, J = 11.3, 8.8 Hz, 1H), 4.03 (t, J = 6.7 Hz, 2H), 3.88 (s, 1H), 2.99 (d, J = 6.2 Hz, 2H), 2.76-2.63 (m, 3H), 1.86 (s, 2H), 1.24 (d, J = 9.0 Hz, 30H), 0.88 (t , J = 6.8 Hz, 3H), the second eluting isomer (Example 23B, RT2: 2.12 min, 145 mg, 0.167 mmol, 23.29% yield) as a white solid; LCMS (M+H) = 835.3; Retention time (0.1% TFA) = 2.505 minutes; HPLC: Retention time (0.1% NH 4 HCO 3 ) = 9.584 minutes; 1 H NMR (400 MHz, CDCl 3 ) δ7.78 (s, 1H), 7.30-7.26 (m, 2H), 7.23 (dd, J = 8.4, 4.6 Hz, 3H), 7.15 (d, J = 7.8 Hz, 3H), 7.06 (dd, J = 7.5, 1.7 Hz, 2H), 6.32 (dd, J = 7.4, 4.2 Hz, 1H), 6.24 (s, 2H), 4.64 (t, J = 7.6 Hz, 1H), 4.23-4.15 (m, 2H), 4.02 (t, J = 6.7 Hz, 2H), 3.97 (dd, J = 11.5, 8.4 Hz, 1H), 3.73 (t, J = 10.8 Hz, 1H), 3.04-2.92 (m, 2H), 2.70 (s , 1H), 2.66 (dt, J = 13.7, 7.8 Hz, 1H), 2.57 (ddd, J = 13.6, 7.1, 4.2 Hz, 1H), 1.89 (s, 2H), 1.24 (d, J = 4.9 Hz, 30H), 0.87 (t, J = 6.8 Hz, 3H).

工程4:ノナデカン-10-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
ノナデカン-10-イルL-フェニルアラニナート(1,840mg、4.26mmol)、トリエチルアミン(0.594mL、4.26mmol)のDCM(30mL)冷(氷水浴)溶液に、フェニルホスホロジクロリデート(0.510mL、3.41mmol)のDCM(1mL)溶液を窒素雰囲気下で滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(500mg、1.705mmol)のTHF(20mL)/ピリジン(10mL)冷(氷水浴)溶液に、tert-ブチルマグネシウムクロリド(4.26mL、4.26mmol)を窒素雰囲気下で滴下し、次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を、2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは反応の完了を示した。減圧下で溶媒を除去し、残留物をEtOAc(200mL)及び水(50mL)で希釈した。有機相を分離し、水層をEtOAc(20mL×2)で抽出した。合わせた有機相を水(50mL×2)で洗浄し、NaSOで乾燥させ、濃縮した。残留物をゲルシリカクロマトグラフィー(80g、MeOH:DCM=1:15)により精製して、ノナデカン-10-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(650mg、0.742mmol、収率43.5%)を固体として得た。LCMS(M+H)=863.2;保持時間(0.1% TA)=2.77、2.83分。ジアステレオマーを分取SFC(装置:SFC-80(Thar,Waters);カラム:OZ 20×250mm、10μm(Daicel);カラム温度:40℃;移動相:CO/MeOH(0.2%アンモニア/メタノール)=45/55;流速:80g/分;背圧:100バール;検出波長:260nm;サイクル時間:7.5分;サンプル溶液:356mgを10mLのメタノールに溶解させた;注入量:1.5mL)により分離して、最初に溶出する異性体(実施例24A、RT1:1.71分、184.6mg、0.217mmol、99.36%、収率26.8%)をオフホワイトの固体として得;LCMS(M+H)=863.2;保持時間(0.1% TFA)=3.39分;1H NMR (400 MHz, DMSO) δ 8.22 (s, 1H), 7.85 (brs, 2H), 7.27-7.19 (m, 4H), 7.18-7.08 (m, 4H), 7.04 (d, J = 8.4 Hz, 2H), 6.23 (dd, J = 7.6, 4.9 Hz, 1H), 6.09 (dd, J = 11.9, 10.9 Hz, 1H), 5.73 (d, J = 5.6 Hz, 1H), 4.68-4.60 (m, 1H), 4.51 (dd, J = 12.8, 7.0 Hz, 1H), 4.03-3.92 (m, 2H), 3.75 (dd, J = 10.9, 4.4 Hz, 1H), 3.61 (s, 1H), 2.98-2.89 (m, 1H), 2.78 (dd, J = 13.5, 8.3 Hz, 1H), 2.74-2.66 (m, 1H), 2.46-2.39 (m, 1H), 1.31-1.00 (m, 32H), 0.83 (td, J = 6.9, 3.1 Hz, 6H)、2番目に溶出する異性体(実施例24B、RT2:2.41分、133.7mg、0.155mmol、98.94%、収率:19.1%)をオフホワイトの固体として得た。LCMS(M+H)=863.5;保持時間(0.1% TFA)=3.34分;1H NMR (400 MHz, DMSO) δ 8.17 (s, 1H), 7.85 (s, 2H), 7.25-7.16 (m, 5H), 7.15-7.07 (m, 3H), 6.99 (d, J = 8.4 Hz, 2H), 6.26 (dd, J = 7.3, 5.4 Hz, 1H), 6.13 (dd, J = 13.1, 10.6 Hz, 1H), 5.76 (d, J = 5.6 Hz, 1H), 4.66 (p, J = 6.0 Hz, 1H), 4.50 (dd, J = 12.5, 6.7 Hz, 1H), 3.99 (dd, J = 10.7, 5.2 Hz, 1H), 3.95-3.85 (m, 2H), 3.64 (s, 1H), 2.95-2.87 (m, 1H), 2.80 (dd, J = 13.5, 8.0 Hz, 1H), 2.70-2.62 (m, 1H), 2.46-2.37 (m, 1H), 1.30-0.98 (m, 32H), 0.83 (td, J = 6.9, 4.7 Hz, 6H).
Step 4: Nonadecan-10-yl(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2- yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate nonadecan-10-yl L-phenylalaninate (1,840 mg, 4.26 mmol), triethylamine (0.594 mL, 4.26 mmol) in DCM (30 mL) To the cold (ice-water bath) solution was added a solution of phenylphosphorodichloridate (0.510 mL, 3.41 mmol) in DCM (1 mL) dropwise under nitrogen atmosphere, and then the reaction mixture was stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (500mg, 1.705mmol) To a cold (ice-water bath) solution of THF (20 mL)/pyridine (10 mL) was added tert-butylmagnesium chloride (4.26 mL, 4.26 mmol) dropwise under nitrogen atmosphere, and the mixture was then stirred at room temperature for 30 min. . The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. The solvent was removed under reduced pressure and the residue was diluted with EtOAc (200 mL) and water (50 mL). The organic phase was separated and the aqueous layer was extracted with EtOAc (20 mL x 2). The combined organic phases were washed with water (50 mL x 2), dried over Na 2 SO 4 and concentrated. The residue was purified by gel silica chromatography (80 g, MeOH:DCM=1:15) to give nonadecan-10-yl (((2R,3S,5R)-5-(6-amino-2-fluoro- 9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate (650 mg, 0.742 mmol, yield 43.5%) Obtained as a solid. LCMS (M+H) = 863.2; retention time (0.1% TF A) = 2.77, 2.83 min. Diastereomers were separated by preparative SFC (equipment: SFC-80 (Thar, Waters); column: OZ 20 x 250 mm, 10 μm (Daicel); column temperature: 40°C; mobile phase: CO 2 /MeOH (0.2% ammonia /methanol) = 45/55; flow rate: 80 g/min; back pressure: 100 bar; detection wavelength: 260 nm; cycle time: 7.5 min; sample solution: 356 mg dissolved in 10 mL of methanol; injection volume: 1 .5 mL) and the first eluting isomer (Example 24A, RT 1: 1.71 min, 184.6 mg, 0.217 mmol, 99.36%, 26.8% yield) was separated by off-white Obtained as a solid; LCMS (M+H) = 863.2; retention time (0.1% TFA) = 3.39 min; 1 H NMR (400 MHz, DMSO) δ 8.22 (s, 1H), 7.85 (brs, 2H) ), 7.27-7.19 (m, 4H), 7.18-7.08 (m, 4H), 7.04 (d, J = 8.4 Hz, 2H), 6.23 (dd, J = 7.6, 4.9 Hz, 1H), 6.09 (dd, J = 11.9, 10.9 Hz, 1H), 5.73 (d, J = 5.6 Hz, 1H), 4.68-4.60 (m, 1H), 4.51 (dd, J = 12.8, 7.0 Hz, 1H), 4.03-3.92 (m , 2H), 3.75 (dd, J = 10.9, 4.4 Hz, 1H), 3.61 (s, 1H), 2.98-2.89 (m, 1H), 2.78 (dd, J = 13.5, 8.3 Hz, 1H), 2.74- 2.66 (m, 1H), 2.46-2.39 (m, 1H), 1.31-1.00 (m, 32H), 0.83 (td, J = 6.9, 3.1 Hz, 6H), the second eluting isomer (Example 24B , RT2: 2.41 min, 133.7 mg, 0.155 mmol, 98.94%, yield: 19.1%) as an off-white solid. LCMS (M+H) = 863.5; retention time (0.1% TFA) = 3.34 min; 1 H NMR (400 MHz, DMSO) δ 8.17 (s, 1H), 7.85 (s, 2H), 7.25- 7.16 (m, 5H), 7.15-7.07 (m, 3H), 6.99 (d, J = 8.4 Hz, 2H), 6.26 (dd, J = 7.3, 5.4 Hz, 1H), 6.13 (dd, J = 13.1, 10.6 Hz, 1H), 5.76 (d, J = 5.6 Hz, 1H), 4.66 (p, J = 6.0 Hz, 1H), 4.50 (dd, J = 12.5, 6.7 Hz, 1H), 3.99 (dd, J = 10.7, 5.2 Hz, 1H), 3.95-3.85 (m, 2H), 3.64 (s, 1H), 2.95-2.87 (m, 1H), 2.80 (dd, J = 13.5, 8.0 Hz, 1H), 2.70-2.62 (m, 1H), 2.46-2.37 (m, 1H), 1.30-0.98 (m, 32H), 0.83 (td, J = 6.9, 4.7 Hz, 6H).

工程3:ヘンイコサン-11-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
ヘンイコサン-11-イルL-フェニルアラニナート(1.254g、2.73mmol)、トリエチルアミン(0.380mL、2.73mmol)のDCM(20mL)溶液に、フェニルホスホロジクロリデート(0.408mL、2.73mmol)のDCM(1mL)溶液を窒素雰囲気下、約5℃で滴下した。次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(0.4g、1.364mmol)のTHF(20mL)/ピリジン(10mL)溶液に、tert-ブチルマグネシウムクロリド(3.41mL、3.41mmol)を窒素雰囲気下、0℃で滴下した。次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは反応の完了を示した。混合物を濾過し、濃縮して、黄色の固体を得た。次いで、固体をEtOAc(40mL)に溶解させ、HCl(0.05N、20mL)で分配した。層を分離し、水層をEtOAc(30mL×2)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮して、粗生成物を得た。残留物を逆相クロマトグラフィー(SepaFlash(登録商標)C18、0~100% CHCN/10mM NHHCOO)により精製して、ヘンイコサン-11-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(240mg、0.256mmol、収率18.77%)を得た。LCMS:no mass;保持時間(0.1% TFA)=4.004、4.097分。ジアステレオマーを2回の連続する分取SFC精製:1回目の精製(装置:SFC-150(Waters)、カラム:OX 20×250mm、10μm(Daicel)、カラム温度:35℃;移動相:CO/MeOH(0.2% アンモニア/メタノール)=55/45;流速:100g/分、背圧:100バール;検出波長:214nm、サイクル時間:4.5分、サンプル溶液:280mgを40mLメタノールに溶解させた;注入量:2mL)及び2回目の精製(装置:SFC-150(Waters)、カラム:ID 20×250mm、10μm(Daicel)、カラム温度:35℃;移動相:CO/MeOH(0.2% アンモニア/メタノール)=55/45;流速:120g/分、背圧:100バール;検出波長:214nm、サイクル時間:5分、サンプル溶液:220mgを40mLメタノールに溶解させた;注入量:2mL)により精製して、最初に溶出する異性体(実施例25A、RT1:1.08分、133mg、0.145mmol、収率32.3%)を得;LCMS:保持時間(0.1% TFA)=3.697分;HPLC:保持時間(0.1% NHHCO)=12.652分;1H NMR (400 MHz, CDCl3) δ 7.64 (s, 1H), 7.29 (dd, J = 11.0, 6.9 Hz, 3H), 7.25-7.20 (m, 2H), 7.18-7.13 (m, 5H), 6.29 (dd, J = 7.6, 4.1 Hz, 1H), 5.86 (s, 2H), 4.90-4.82 (m, 1H), 4.51 (t, J = 7.7 Hz, 1H), 4.19-4.11 (m, 1H), 4.70 (dd, J = 11.8, 10.0 Hz 1H), 3.72 (dd, J = 11.7, 9.3 Hz, 1H), 3.63-3.38 (m, 2H), 3.07 (d, J = 10.8 Hz, 1H), 2.89 (dd, J = 13.6, 7.7 Hz, 1H), 2.69 (s, 1H), 2.67-2.58 (m, 1H), 2.51-2.43 (m, 1H), 1.66 (s, 6H), 1.25-1.15 (m, 30H), 0.87 (dd, J = 6.9, 5.8 Hz, 6H)、及び2番目に溶出する異性体(実施例25B、RT2:1.69分、100mg、0.107mmol、収率23.77%)を得た;LCMS:保持時間(0.1% TFA)=3.785分;HPLC:保持時間(0.1% NHHCO)=13.150分;1H NMR (400 MHz, CDCl3) δ 7.90 (s, 1H), 7.25-7.17 (m, 5H), 7.13 (t, J = 6.8 Hz, 3H), 7.07 (d, J = 8.0 Hz, 2H), 6.30 (t, J = 5.7 Hz, 1H), 6.21 (s, 2H), 4.85-4.78 (m, 1H), 4.67 (dd, J = 12.8, 7.8 Hz, 1H), 4.32-4.25 (m, 1H), 4.25-4.13 (m, 2H), 3.90 (t, J = 10.7 Hz, 1H), 3.80 (d, J = 4.2 Hz, 1H), 3.06 (dd, J = 12.8, 5.6 Hz, 1H), 2.94 (dd, J = 13.9, 7.2 Hz, 1H), 2.71-2.65 (m, 3H), 1.92 (s, 4H), 1.25-1.15 (m, 32H), 0.87 (t, J = 7.2 Hz, 6H).
Step 3: Henicosan-11-yl(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2- yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninatehenicosan -11-yl L-phenylalaninate (1.254 g, 2.73 mmol), triethylamine (0.380 mL, 2.73 mmol) in DCM (20 mL) To the solution was added a solution of phenylphosphorodichloridate (0.408 mL, 2.73 mmol) in DCM (1 mL) dropwise at about 5° C. under nitrogen atmosphere. The reaction mixture was then stirred at room temperature for 1 hour. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (0.4 g, 1. To a solution of 364 mmol) in THF (20 mL)/pyridine (10 mL), tert-butylmagnesium chloride (3.41 mL, 3.41 mmol) was added dropwise at 0° C. under a nitrogen atmosphere. The mixture was then stirred at room temperature for 30 minutes. The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. The mixture was filtered and concentrated to give a yellow solid. The solid was then dissolved in EtOAc (40 mL) and partitioned with HCl (0.05N, 20 mL). The layers were separated and the aqueous layer was extracted with EtOAc (30 mL x 2). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The residue was purified by reverse phase chromatography (SepaFlash® C18, 0-100% CH 3 CN/10 mM NH 4 HCO 3 H 2 O) to give heniicosan-11-yl (((2R,3S, 5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate ( 240 mg, 0.256 mmol, yield 18.77%) was obtained. LCMS: no mass; retention time (0.1% TFA) = 4.004, 4.097 min. Two consecutive preparative SFC purifications of diastereomers: 1st purification (equipment: SFC-150 (Waters), column: OX 20 x 250 mm, 10 μm (Daicel), column temperature: 35 °C; mobile phase: CO 2 /MeOH (0.2% ammonia/methanol) = 55/45; flow rate: 100 g/min, back pressure: 100 bar; detection wavelength: 214 nm, cycle time: 4.5 min, sample solution: 280 mg in 40 mL methanol Injection volume: 2 mL) and second purification (equipment: SFC-150 (Waters), column: ID 20 x 250 mm, 10 μm (Daicel), column temperature: 35 °C; mobile phase: CO 2 /MeOH ( 0.2% ammonia/methanol) = 55/45; flow rate: 120 g/min, back pressure: 100 bar; detection wavelength: 214 nm, cycle time: 5 min, sample solution: 220 mg dissolved in 40 mL methanol; injection volume : 2 mL) to obtain the first eluting isomer (Example 25A, RT 1: 1.08 min, 133 mg, 0.145 mmol, yield 32.3%); LCMS: retention time (0.1 % TFA) = 3.697 min; HPLC: Retention time (0.1% NH 4 HCO 3 ) = 12.652 min; 1 H NMR (400 MHz, CDCl 3 ) δ 7.64 (s, 1H), 7.29 (dd , J = 11.0, 6.9 Hz, 3H), 7.25-7.20 (m, 2H), 7.18-7.13 (m, 5H), 6.29 (dd, J = 7.6, 4.1 Hz, 1H), 5.86 (s, 2H), 4.90-4.82 (m, 1H), 4.51 (t, J = 7.7 Hz, 1H), 4.19-4.11 (m, 1H), 4.70 (dd, J = 11.8, 10.0 Hz 1H), 3.72 (dd, J = 11.7 , 9.3 Hz, 1H), 3.63-3.38 (m, 2H), 3.07 (d, J = 10.8 Hz, 1H), 2.89 (dd, J = 13.6, 7.7 Hz, 1H), 2.69 (s, 1H), 2.67 -2.58 (m, 1H), 2.51-2.43 (m, 1H), 1.66 (s, 6H), 1.25-1.15 (m, 30H), 0.87 (dd, J = 6.9, 5.8 Hz, 6H), and second An isomer (Example 25B, RT2: 1.69 min, 100 mg, 0.107 mmol, yield 23.77%) was obtained; LCMS: Retention time (0.1% TFA) = 3.785 min. ; HPLC: Retention time (0.1% NH 4 HCO 3 ) = 13.150 minutes; 1 H NMR (400 MHz, CDCl 3 ) δ 7.90 (s, 1H), 7.25-7.17 (m, 5H), 7.13 ( t, J = 6.8 Hz, 3H), 7.07 (d, J = 8.0 Hz, 2H), 6.30 (t, J = 5.7 Hz, 1H), 6.21 (s, 2H), 4.85-4.78 (m, 1H), 4.67 (dd, J = 12.8, 7.8 Hz, 1H), 4.32-4.25 (m, 1H), 4.25-4.13 (m, 2H), 3.90 (t, J = 10.7 Hz, 1H), 3.80 (d, J = 4.2 Hz, 1H), 3.06 (dd, J = 12.8, 5.6 Hz, 1H), 2.94 (dd, J = 13.9, 7.2 Hz, 1H), 2.71-2.65 (m, 3H), 1.92 (s, 4H), 1.25-1.15 (m, 32H), 0.87 (t, J = 7.2 Hz, 6H).

工程3:テトラデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
テトラデシルL-アラニナート(1217mg、4.26mmol)、トリエチルアミン(0.594mL、4.26mmol)のDCM(30mL)冷(氷水浴)溶液に、フェニルホスホロジクロリデート(899mg、4.26mmol)のDCM(1mL)溶液を窒素雰囲気下で滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(500mg、1.705mmol)のTHF(20mL)/ピリジン(10mL)冷(氷水浴)溶液に、tert-ブチルマグネシウムクロリド(4.26mL、4.26mmol)を窒素雰囲気下で滴下し、次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは反応の完了を示した。反応混合物を水でクエンチし、ジクロロメタン(100mL)と水(100mL)とに分配した。有機相を水(100mL)、飽和ブライン(100mL)で洗浄し、硫酸ナトリウムで乾燥させ、真空中でエバポレーションして粗生成物を得た。残留物をシリカゲルカラム(25g、MeOH:DCM=10:1)により精製し、テトラデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(457mg、0.552mmol、収率32.4%)を得た。LCMS(M+H)=717.1;保持時間(0.1% TFA)=2.82分。ジアステレオマーを分取SFC(装置:SFC-80(Thar,Waters);カラム:AD 20×250mm、10μm(Daicel);カラム温度:40℃;移動相:CO/ETOH(1.0%アンモニア/メタノール)=45/55;流速:80g/分;背圧:100バール;検出波長:214nm;サイクル時間:7.7分;サンプル溶液:457mgを35mLのメタノールに溶解させた;注入量:3mL)により分離して、最初に溶出する異性体(実施例28A、RT1:1.69分、148.5mg、0.224mmol、100%、収率32.5%)をオフホワイトの固体として得;LCMS(M+H)=717.1;保持時間(0.1% TFA)=2.81分;1H NMR (400 MHz, DMSO) δ 8.24 (s, 1H), 7.84 (s, 2H), 7.32-7.27 (m, 2H), 7.13 (t, J = 7.4 Hz, 3H), 6.28 (dd, J = 7.6, 4.8 Hz, 1H), 5.98 (dd, J = 13.4, 10.1 Hz, 1H), 5.81 (d, J = 5.5 Hz, 1H), 4.65 (dd, J = 12.7, 7.1 Hz, 1H), 4.22 (dd, J = 10.8, 5.5 Hz, 1H), 4.10 (dd, J = 10.9, 4.5 Hz, 1H), 3.97-3.89 (m, 2H), 3.73-3.65 (m, 2H), 2.81-2.73 (m, 1H), 2.48-2.42 (m, 1H), 1.50-1.43 (m, 2H), 1.20 (d, J = 15.3 Hz, 22H), 1.13 (d, J = 7.0 Hz, 3H), 0.85 (t, J = 6.8 Hz, 3H)、2番目に溶出する異性体(実施例28B、RT2:3.4分、154.8mg、0.231mmol、95.26%、収率32.3%)をオフホワイトの固体として得た;LCMS(M+H)=717.1;保持時間(0.1% TFA)=2.82分;1H NMR (400 MHz, DMSO) δ 8.26 (s, 1H), 7.85 (s, 2H), 7.34-7.28 (m, 2H), 7.15 (dd, J = 14.3, 7.5 Hz, 3H), 6.26 (dd, J = 7.6, 4.9 Hz, 1H), 5.99 (dd, J = 13.1, 10.0 Hz, 1H), 5.78 (d, J = 5.4 Hz, 1H), 4.61 (dd, J = 12.5, 7.2 Hz, 1H), 4.24 (dd, J = 10.7, 5.9 Hz, 1H), 4.06 (dd, J = 10.8, 4.7 Hz, 1H), 3.97-3.90 (m, 1H), 3.87-3.76 (m, 2H), 3.63 (s, 1H), 2.79-2.70 (m, 1H), 2.47-2.42 (m, 1H), 1.48-1.41 (m, 2H), 1.24-1.19 (m, 23H), 1.17 (s, 2H), 0.85 (t, J = 6.8 Hz, 3H).
Step 3: Tetradecyl ((((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate To a cold (ice-water bath) solution of tetradecyl L-alaninate (1217 mg, 4.26 mmol), triethylamine (0.594 mL, 4.26 mmol) in DCM (30 mL) was added dropwise a solution of phenyl phosphorodichloridate (899 mg, 4.26 mmol) in DCM (1 mL) under nitrogen atmosphere, then the reaction mixture was stirred at room temperature for 1 h. To a cold (ice-water bath) solution of (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (500 mg, 1.705 mmol) in THF (20 mL)/pyridine (10 mL) was added tert-butylmagnesium chloride (4.26 mL, 4.26 mmol) dropwise under nitrogen atmosphere, and the mixture was then stirred at room temperature for 30 minutes. The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. The reaction mixture was quenched with water and partitioned between dichloromethane (100 mL) and water (100 mL). The organic phase was washed with water (100 mL), saturated brine (100 mL), dried over sodium sulfate, and evaporated in vacuo to give the crude product. The residue was purified by silica gel column (25 g, MeOH:DCM=10:1) to give tetradecyl((((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (457 mg, 0.552 mmol, 32.4% yield) . LCMS (M+H)=717.1; retention time (0.1% TFA)=2.82 min. The diastereomers were separated by preparative SFC (instrument: SFC-80 (Thar, Waters); column: AD 20×250 mm, 10 μm (Daicel); column temperature: 40° C.; mobile phase: CO 2 /ETOH (1.0% ammonia/methanol)=45/55; flow rate: 80 g/min; back pressure: 100 bar; detection wavelength: 214 nm; cycle time: 7.7 min; sample solution: 457 mg dissolved in 35 mL of methanol; injection volume: 3 mL) to give the first eluting isomer (Example 28A, RT1: 1.69 min, 148.5 mg, 0.224 mmol, 100%, 32.5% yield) as an off-white solid; LCMS (M+H)=717.1; retention time (0.1% TFA)=2.81 min; 1 H NMR (400 MHz, DMSO) δ 8.24 (s, 1H), 7.84 (s, 2H), 7.32-7.27 (m, 2H), 7.13 (t, J = 7.4 Hz, 3H), 6.28 (dd, J = 7.6, 4.8 Hz, 1H), 5.98 (dd, J = 13.4, 10.1 Hz, 1H), 5.81 (d, J = 5.5 Hz, 1H), 4.65 (dd, J = 12.7, 7.1 Hz, 1H), 4.22 (dd, J = 10.8, 5.5 Hz, 1H), 4.10 (dd, J = 10.9, 4.5 Hz, 1H), 3.97-3.89 (m, 2H), 3.73-3.65 (m, 2H), 2.81-2.73 (m, 1H), 2.48-2.42 (m, 1H), 1.50-1.43 (m, 2H), 1.20 (d, J = 15.3 Hz, 22H), 1.13 (d, J = 7.0 Hz, 3H), 0.85 (t, J = 6.8 Hz, 3H), the second eluting isomer (Example 28B, RT2: 3.4 min, 154.8 mg, 0.231 mmol, 95.26%, 32.3% yield) was obtained as an off-white solid; LCMS (M+H) = 717.1; retention time (0.1% TFA) = 2.82 min; 1H NMR (400 MHz, DMSO) δ 8.26 (s, 1H), 7.85. (s, 2H), 7.34-7.28 (m, 2H), 7.15 (dd, J = 14.3, 7.5 Hz, 3H), 6.26 (dd, J = 7.6, 4.9 Hz, 1H), 5.99 (dd, J = 13.1, 10.0 Hz, 1H), 5.78 (d, J = 5.4 Hz, 1H), 4.61 (dd, J = 12.5, 7.2 Hz, 1H), 4.24 (dd, J = 10.7, 5.9 Hz, 1H), 4.06 (dd, J = 10.8, 4.7 Hz, 1H), 3.97-3.90 (m, 1H), 3.87-3.76 (m, 2H), 3.63 (s, 1H), 2.79-2.70 (m, 1H), 2.47-2.42 (m, 1H), 1.48-1.41 (m, 2H), 1.24-1.19 (m, 23H), 1.17 (s, 2H), 0.85 (t, J = 6.8 Hz, 3H).

工程2:オクタデシルL-アラニナート
オクタデシル(tert-ブトキシカルボニル)-L-アラニナート(34.47g、78mmol)のTFA(30mL、389mmol)及びDCM(150mL)混合液を25℃で一晩撹拌した。LCMSは新たな生成物の存在を示した。反応物を濃縮し、残留物のpHをNaOH(1N)で8~9に調整した。混合物をDCM(100mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮した。残留物をシリカゲルクロマトグラフィー(DCM:MeOH=10:1)で精製して、オクタデシルL-アラニナート(26g、76mmol、収率98%)を白色固体として得た。LCMS(M+H)=342.2;保持時間(0.1% TFA)=2.245分;1H NMR (400 MHz, CDCl3) δ: 4.12-4.08 (m, 2H), 3.55-3.54 (m, 1H), 1.68-1.61 (m, 4H), 1.34-1.33 (m, 5H), 1.33-1.22 (m, 28H), 0.89-0.86 (m, 3H).
Step 2: Octadecyl L-Alaninate A mixture of octadecyl (tert-butoxycarbonyl)-L-alaninate (34.47 g, 78 mmol) in TFA (30 mL, 389 mmol) and DCM (150 mL) was stirred at 25° C. overnight. LCMS showed the presence of new product. The reaction was concentrated and the pH of the residue was adjusted to 8-9 with NaOH (1N). The mixture was extracted with DCM (100 mL x 3). The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. The residue was purified by silica gel chromatography (DCM:MeOH=10:1) to give octadecyl L -alaninate (26 g, 76 mmol, 98% yield) as a white solid. LCMS (M+H) = 342.2; retention time (0.1% TFA) = 2.245 min; 1 H NMR (400 MHz, CDCl 3 ) δ: 4.12-4.08 (m, 2H), 3.55-3.54 (m , 1H), 1.68-1.61 (m, 4H), 1.34-1.33 (m, 5H), 1.33-1.22 (m, 28H), 0.89-0.86 (m, 3H).

実施例33:トリデカン-7-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)アラニナートExample 33: Tridecane-7-yl(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2 -yl)methoxy)(phenoxy)phosphoryl)alaninate

工程2:トリデカン-7-イルL-アラニナート
トリデカン-7-イル(tert-ブトキシカルボニル)-L-アラニナート(14.4g、38.8mmol)及びTFA(25mL、324mmol)のDCM(125mL)溶液を25℃で一晩撹拌した。TLCは、出発物質が消費され、新たな化合物が検出されたことを示した。反応混合物を濃縮し、残留物のpHを1N NaOHで8に調整し、得られた混合物をDCM(100mL×3)で抽出した。合わせた有機相をブラインで洗浄し、硫酸ナトリウムで乾燥させ、濃縮して残留物を得た。残留物をシリカゲルクロマトグラフィー(石油エーテル:EtOAc=20:1-DCM:MeOH=20:1)で精製して、トリデカン-7-イルL-アラニナート(10.3g、37.9mmol、収率98%)を黄色の油状物として得た。1H NMR: (400MHz, d6-DMSO): 4.93-4.87 (m, 1 H), 3.84-3.79 (m, 1 H), 1.55-1.53 (m, 4 H), 1.50 (d, J = 7.2 Hz, 3 H), 1.22-1.26 (m, 16 H), 0.88 (t, J = 6.8 Hz, 6 H).
Step 2: Tridecan-7-yl L-alaninate A solution of tridecan-7-yl(tert-butoxycarbonyl)-L-alaninate (14.4 g, 38.8 mmol) and TFA (25 mL, 324 mmol) in DCM (125 mL) was stirred at 25° C. overnight. TLC showed that the starting material was consumed and a new compound was detected. The reaction mixture was concentrated, the pH of the residue was adjusted to 8 with 1N NaOH, and the resulting mixture was extracted with DCM (100 mL×3). The combined organic phase was washed with brine, dried over sodium sulfate, and concentrated to give a residue. The residue was purified by silica gel chromatography (petroleum ether: EtOAc = 20: 1-DCM: MeOH = 20: 1) to give tridecan-7-yl L-alaninate (10.3 g, 37.9 mmol, 98% yield) as a yellow oil . 1H NMR: (400MHz, d6-DMSO): 4.93-4.87 (m, 1H), 3.84-3.79 (m, 1H), 1.55-1.53 (m, 4H), 1.50 (d, J = 7.2Hz, 3H), 1.22-1.26 (m, 16H), 0.88 (t, J = 6.8Hz, 6H).

工程3:トリデカン-7-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
トリデカン-7-イルL-アラニナート(2314mg、8.52mmol)、トリエチルアミン(1.188mL、8.52mmol)のDCM(40mL)冷(氷水浴)溶液に、フェニルホスホロジクロリデート(1.274mL、8.52mmol)のDCM(40mL)溶液を窒素雰囲気下で滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(1000mg、3.41mmol)のTHF(30mL)/ピリジン(15mL)冷(氷水浴)溶液に、tert-ブチルマグネシウムクロリド(8.52mL、8.52mmol)を窒素雰囲気下で滴下し、次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは反応の完了を示した。HO(20mL)及びEtOAc(30mL)を加えた。有機相を分離し、水層をEtOAc(20mL×2)で抽出した。有機相を合わせ、水(20mL×2)で洗浄し、NaSOで乾燥させ、濃縮した。粗生成物をシリカゲルクロマトグラフィー(DCM:MeOH=10:1)で精製して、トリデカン-7-イル(((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(320mg、0.450mmol、収率13.18%)を得た。LCMS(M+H)=703.3;保持時間(0.1% TA)=2.04分。ジアステレオマーを分取SFC(装置:SFC-150(Waters);カラム:OX 20×250mm、10μm(Daicel);カラム温度:35℃;移動相:CO/MeOH(0.2%アンモニア/メタノール)=70/30;流速:100g/分;背圧:100バール;検出波長:214nm;サイクル時間:7分;サンプル溶液:700mgを40mLのメタノールに溶解させた;注入量:2mL)により分離して、最初に溶出する異性体(実施例33A、RT1:2.12分、100%)をオフホワイトの固体として得;LCMS(M+H)=703.3;保持時間(0.1% TFA)=2.59分;1H NMR (400 MHz, DMSO) δ 8.23 (s, 1H), 7.82 (brs, 2H), 7.29 (t, J = 7.9 Hz, 2H), 7.13 (t, J = 8.8 Hz, 3H), 6.28 (dd, J = 7.6, 4.8 Hz, 1H), 5.94 (dd, J = 13.4, 10.3 Hz, 1H), 5.80 (d, J = 5.5 Hz, 1H), 4.75-4.60 (m, 2H), 4.21 (dd, J = 10.8, 5.6 Hz, 1H), 4.08 (dd, J = 10.9, 4.4 Hz, 1H), 3.73-3.63 (m, 2H), 2.80-2.72 (m, 1H), 2.48-2.41 (m, 1H), 1.47-1.37 (m, 4H), 1.22-1.07 (m, 19H), 0.80 (dt, J = 17.3, 6.9 Hz, 6H)、2番目に溶出する異性体(実施例33B、RT2: 2.43 分、98.25%)をオフホワイトの固体として得;LCMS(M+H)=703.3;保持時間(0.1% TFA)=2.60分;1H NMR (400 MHz, DMSO) δ 8.19 (s, 1H), 7.84 (brs, 2H), 7.33-7.27 (m, 2H), 7.20-7.12 (m, 3H), 6.26 (dd, J = 7.4, 5.1 Hz, 1H), 5.98 (dd, J = 12.9, 10.3 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.75-4.68 (m, 1H), 4.59 (dd, J = 12.4, 6.8 Hz, 1H), 4.18 (dd, J = 10.7, 5.1 Hz, 1H), 4.10 (dd, J = 10.7, 5.1 Hz, 1H), 3.77-3.69 (m, 1H), 3.65 (s, 1H), 2.77-2.68 (m, 1H), 2.47-2.40 (m, 1H), 1.46-1.37 (m, 4H), 1.24-1.13 (m, 19H), 0.82 (td, J = 6.8, 1.7 Hz, 6H)、3番目に溶出する異性体(実施例33C、RT3:2.89分、97.55%)をオフホワイトの固体として得;LCMS(M+H)=703.3;保持時間(0.1% TFA)=2.61分;1H NMR (400 MHz, DMSO) δ 8.19 (s, 1H), 7.84 (brs, 2H), 7.33-7.27 (m, 2H), 7.20-7.12 (m, 3H), 6.26 (dd, J = 7.4, 5.1 Hz, 1H), 5.98 (dd, J = 12.9, 10.3 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.75-4.68 (m, 1H), 4.59 (dd, J = 12.4, 6.8 Hz, 1H), 4.18 (dd, J = 10.7, 5.1 Hz, 1H), 4.10 (dd, J = 10.7, 5.1 Hz, 1H), 3.77-3.69 (m, 1H), 3.65 (s, 1H), 2.77-2.68 (m, 1H), 2.47-2.40 (m, 1H), 1.46-1.37 (m, 4H), 1.24-1.13 (m, 19H), 0.82 (td, J = 6.8, 1.7 Hz, 6H)、4番目に溶出する異性体(実施例33D、RT4:3.95分、99.54%)をオフホワイトの固体として得た;LCMS(M+H)=703.3;保持時間(0.1% TFA)=2.62分;1H NMR (400 MHz, DMSO) δ 8.19 (s, 1H), 7.84 (brs, 2H), 7.33-7.27 (m, 2H), 7.20-7.12 (m, 3H), 6.26 (dd, J = 7.4, 5.1 Hz, 1H), 5.98 (dd, J = 12.9, 10.3 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.75-4.68 (m, 1H), 4.59 (dd, J = 12.4, 6.8 Hz, 1H), 4.18 (dd, J = 10.7, 5.1 Hz, 1H), 4.10 (dd, J = 10.7, 5.1 Hz, 1H), 3.77-3.69 (m, 1H), 3.65 (s, 1H), 2.77-2.68 (m, 1H), 2.47-2.40 (m, 1H), 1.46-1.37 (m, 4H), 1.24-1.13 (m, 19H), 0.82 (td, J = 6.8, 1.7 Hz, 6H)。
Step 3: Tridecane-7-yl(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2- yl)methoxy)(phenoxy)phosphoryl)-L-alaninate tridecane -7-yl L-alaninate (2314 mg, 8.52 mmol), triethylamine (1.188 mL, 8.52 mmol) in DCM (40 mL) in a cold (ice water bath) solution. A solution of phenylphosphorodichloridate (1.274 mL, 8.52 mmol) in DCM (40 mL) was added dropwise under nitrogen atmosphere, and then the reaction mixture was stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (1000mg, 3.41mmol) To a cold (ice-water bath) solution of THF (30 mL)/pyridine (15 mL) was added tert-butylmagnesium chloride (8.52 mL, 8.52 mmol) dropwise under nitrogen atmosphere, and the mixture was then stirred at room temperature for 30 min. . The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. H 2 O (20 mL) and EtOAc (30 mL) were added. The organic phase was separated and the aqueous layer was extracted with EtOAc (20 mL x 2). The organic phases were combined, washed with water (20 mL x 2), dried over Na 2 SO 4 and concentrated. The crude product was purified by silica gel chromatography (DCM:MeOH=10:1) to give tridecane-7-yl ( ((2R,3S,5R)-5-(6-amino-2-fluoro-9H- Purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (320 mg, 0.450 mmol, yield 13.18%) was obtained . LCMS (M+H) = 703.3; retention time (0.1% TF A) = 2.04 min. Diastereomers were separated by preparative SFC (apparatus: SFC-150 (Waters); column: OX 20 x 250 mm, 10 μm (Daicel); column temperature: 35°C; mobile phase: CO 2 /MeOH (0.2% ammonia/methanol). )=70/30; flow rate: 100 g/min; back pressure: 100 bar; detection wavelength: 214 nm; cycle time: 7 minutes; sample solution: 700 mg dissolved in 40 mL of methanol; injection volume: 2 mL). The first eluting isomer (Example 33A, RT1: 2.12 min, 100%) was obtained as an off-white solid; LCMS (M+H) = 703.3; Retention time (0.1% TFA) = 2.59 min; 1 H NMR (400 MHz, DMSO) δ 8.23 (s, 1H), 7.82 (brs, 2H), 7.29 (t, J = 7.9 Hz, 2H), 7.13 (t, J = 8.8 Hz, 3H), 6.28 (dd, J = 7.6, 4.8 Hz, 1H), 5.94 (dd, J = 13.4, 10.3 Hz, 1H), 5.80 (d, J = 5.5 Hz, 1H), 4.75-4.60 (m, 2H) ), 4.21 (dd, J = 10.8, 5.6 Hz, 1H), 4.08 (dd, J = 10.9, 4.4 Hz, 1H), 3.73-3.63 (m, 2H), 2.80-2.72 (m, 1H), 2.48- 2.41 (m, 1H), 1.47-1.37 (m, 4H), 1.22-1.07 (m, 19H), 0.80 (dt, J = 17.3, 6.9 Hz, 6H), the second eluting isomer (Example 33B , RT2: 2.43 min, 98.25%) as an off-white solid; LCMS (M+H) = 703.3; retention time (0.1% TFA) = 2.60 min; 1 H NMR (400 MHz, DMSO) δ 8.19 (s, 1H), 7.84 (brs, 2H), 7.33-7.27 (m, 2H), 7.20-7.12 (m, 3H), 6.26 (dd, J = 7.4, 5.1 Hz, 1H) , 5.98 (dd, J = 12.9, 10.3 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.75-4.68 (m, 1H), 4.59 (dd, J = 12.4, 6.8 Hz, 1H), 4.18 (dd, J = 10.7, 5.1 Hz, 1H), 4.10 (dd, J = 10.7, 5.1 Hz, 1H), 3.77-3.69 (m, 1H), 3.65 (s, 1H), 2.77-2.68 (m, 1H), 2.47-2.40 (m, 1H), 1.46-1.37 (m, 4H), 1.24-1.13 (m, 19H), 0.82 (td, J = 6.8, 1.7 Hz, 6H), the third eluting isomer LCMS (M+H) = 703.3; Retention time (0.1% TFA) = 2.61 min; 1 H NMR (400 MHz, DMSO) δ 8.19 (s, 1H), 7.84 (brs, 2H), 7.33-7.27 (m, 2H), 7.20-7.12 (m, 3H), 6.26 (dd, J = 7.4, 5.1 Hz, 1H), 5.98 (dd, J = 12.9, 10.3 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.75-4.68 (m, 1H), 4.59 (dd, J = 12.4, 6.8 Hz, 1H), 4.18 (dd, J = 10.7, 5.1 Hz, 1H), 4.10 (dd, J = 10.7, 5.1 Hz, 1H), 3.77-3.69 (m, 1H), 3.65 (s, 1H), 2.77 -2.68 (m, 1H), 2.47-2.40 (m, 1H), 1.46-1.37 (m, 4H), 1.24-1.13 (m, 19H), 0.82 (td, J = 6.8, 1.7 Hz, 6H), 4 The first eluting isomer (Example 33D, RT4: 3.95 min, 99.54%) was obtained as an off-white solid; LCMS (M+H) = 703.3; retention time (0.1% TFA) = 2.62 min; 1 H NMR (400 MHz, DMSO) δ 8.19 (s, 1H), 7.84 (brs, 2H), 7.33-7.27 (m, 2H), 7.20-7.12 (m, 3H), 6.26 ( dd, J = 7.4, 5.1 Hz, 1H), 5.98 (dd, J = 12.9, 10.3 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.75-4.68 (m, 1H), 4.59 (dd , J = 12.4, 6.8 Hz, 1H), 4.18 (dd, J = 10.7, 5.1 Hz, 1H), 4.10 (dd, J = 10.7, 5.1 Hz, 1H), 3.77-3.69 (m, 1H), 3.65 ( s, 1H), 2.77-2.68 (m, 1H), 2.47-2.40 (m, 1H), 1.46-1.37 (m, 4H), 1.24-1.13 (m, 19H), 0.82 (td, J = 6.8, 1.7 Hz, 6H).

工程4:ペンタデカン-8-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
ペンタデカン-8-イルL-アラニナート(4.09g、13.64mmol)、トリエチルアミン(1.901mL、13.64mmol)のDCM(6mL)冷(氷水浴)溶液に、フェニルホスホロジクロリデート(2.88g、13.64mmol)のDCM(1mL)溶液を窒素雰囲気下で滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(2g、6.82mmol)のTHF(4mL)/ピリジン(2mL)冷(氷水浴)溶液に、tert-ブチルマグネシウムクロリド(17.05mL、17.05mmol)を窒素雰囲気下で滴下し、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、-20℃で60時間撹拌した。LCMSは、新たな生成物の存在を示した。冷(氷水浴)反応混合物を飽和NHCl(20mL)でクエンチし、濾過し、濃縮した。濾液をEtOAc(30mL×2)で抽出した。合わせた有機相を飽和NaCl(20mL)で洗浄し、NaSOで乾燥させ、濃縮した。残留物を逆相カラムクロマトグラフィー(120g、CHCN/10mM NHHCOO=1:3)により精製した。適切な画分を合わせ、溶媒を真空中で除去して、ペンタデカン-8-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(350mg、0.464mmol、収率6.80%)を白色固体として得た。LCMS:no mass、保持時間(0.1% TFA)=2.77分。ジアステレオマーを分取SFC(装置:SFC-150(Waters);カラム:OX 20×250mm、10μm(Daicel);カラム温度:35℃;移動相:CO/MeOH(0.2%アンモニア/メタノール)=60/40;流速:100g/分;背圧:100バール;検出波長:214nm;サイクル時間:5分;サンプル溶液:580mgを60mLのメタノールに溶解させた;注入量:2mL)により分離して、最初に溶出する異性体(実施例34A、RT1:1.40分、180mg、0.242mmol、収率30.4%)を白色固体として得;保持時間(0.1% TFA)=2.164分、m/z=731.2(M+H);HPLC:保持時間(0.1% NHHCO)=12.438分;1H NMR (400 MHz, CDCl3) δ 7.83 (s, 1H), 7.28 (d, J = 8.3 Hz, 1H), 7.25-7.22 (m, 1H), 7.19 (d, J = 8.0 Hz, 2H), 7.12 (t, J = 7.2 Hz, 1H), 6.45 (s, 2H), 6.34 (dd, J = 7.2, 4.2 Hz, 1H), 4.85 (p, J = 6.2 Hz, 1H), 4.73 (t, J = 7.6 Hz, 1H), 4.39 (d, J = 8.2 Hz, 2H), 4.22-3.89 (m, 3H), 2.74 (s, 1H), 2.73-2.59 (m, 2H), 1.49 (d, J = 4.5 Hz, 4H), 1.35 (d, J = 6.7 Hz, 3H), 1.21 (d, J = 6.4 Hz, 20H), 0.88-0.82 (m, 6H)、2番目に溶出する異性体(実施例34B、RT2:2.42分、156mg、0.207mmol、収率26.0%)を白色固体として得た;保持時間(0.1% TFA)=2.189分、m/z=731.3(M+H);HPLC:保持時間(0.1% NHHCO)=12.549分;1H NMR (400 MHz, CDCl3) δ 7.98 (s, 1H), 7.24 (s, 1H), 7.17 (d, J = 8.3 Hz, 2H), 7.11 (t, J = 7.3 Hz, 1H), 6.82 (s, 2H), 6.33 (t, J = 5.7 Hz, 1H), 4.88-4.79 (m, 2H), 4.46-4.24 (m, 4H), 4.06-3.95 (m, 1H), 2.76-2.66 (m, 3H), 1.46 (d, J = 6.1 Hz, 4H), 1.36 (d, J = 7.0 Hz, 3H), 1.20 (t, J = 15.3 Hz, 20H), 0.83 (td, J = 6.8, 3.3 Hz, 6H).
Step 4: Pentadecane-8-yl(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2- yl)methoxy)(phenoxy)phosphoryl)-L-alaninatepentadecane -8-yl L-alaninate (4.09 g, 13.64 mmol), triethylamine (1.901 mL, 13.64 mmol) in DCM ( 6 mL) in cold (ice water) To the solution was added dropwise a solution of phenylphosphorodichloridate (2.88 g, 13.64 mmol) in DCM (1 mL) under nitrogen atmosphere, and then the reaction mixture was stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (2g, 6.82mmol) To a cold (ice-water bath) solution of THF (4 mL)/pyridine (2 mL) was added tert-butylmagnesium chloride (17.05 mL, 17.05 mmol) dropwise under a nitrogen atmosphere, and the mixture was stirred at room temperature for 30 minutes. The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred at -20°C for 60 hours. LCMS showed the presence of new product. The cold (ice-water bath) reaction mixture was quenched with saturated NH 4 Cl (20 mL), filtered, and concentrated. The filtrate was extracted with EtOAc (30 mL x 2). The combined organic phases were washed with saturated NaCl (20 mL), dried over Na 2 SO 4 and concentrated. The residue was purified by reverse phase column chromatography (120 g, CH3CN / 10mM NH4HCO3H2O =1:3). The appropriate fractions were combined and the solvent removed in vacuo to give pentadecane-8-yl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl). )-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (350 mg, 0.464 mmol, yield 6.80%) was obtained as a white solid. LCMS: no mass, retention time (0.1% TFA) = 2.77 minutes. Diastereomers were separated by preparative SFC (apparatus: SFC-150 (Waters); column: OX 20 x 250 mm, 10 μm (Daicel); column temperature: 35°C; mobile phase: CO 2 /MeOH (0.2% ammonia/methanol). )=60/40; flow rate: 100 g/min; back pressure: 100 bar; detection wavelength: 214 nm; cycle time: 5 minutes; sample solution: 580 mg dissolved in 60 mL of methanol; injection volume: 2 mL). The first eluting isomer (Example 34A, RT1: 1.40 min, 180 mg, 0.242 mmol, 30.4% yield) was obtained as a white solid; retention time (0.1% TFA) = 2 .164 min, m/z = 731.2 (M+H); HPLC: retention time (0.1% NH 4 HCO 3 ) = 12.438 min; 1 H NMR (400 MHz, CDCl 3 ) δ 7.83 (s, 1H), 7.28 (d, J = 8.3 Hz, 1H), 7.25-7.22 (m, 1H), 7.19 (d, J = 8.0 Hz, 2H), 7.12 (t, J = 7.2 Hz, 1H), 6.45 ( s, 2H), 6.34 (dd, J = 7.2, 4.2 Hz, 1H), 4.85 (p, J = 6.2 Hz, 1H), 4.73 (t, J = 7.6 Hz, 1H), 4.39 (d, J = 8.2 Hz, 2H), 4.22-3.89 (m, 3H), 2.74 (s, 1H), 2.73-2.59 (m, 2H), 1.49 (d, J = 4.5 Hz, 4H), 1.35 (d, J = 6.7 Hz) , 3H), 1.21 (d, J = 6.4 Hz, 20H), 0.88-0.82 (m, 6H), second eluting isomer (Example 34B, RT2: 2.42 min, 156 mg, 0.207 mmol, Yield 26.0%) was obtained as a white solid; Retention time (0.1% TFA) = 2.189 min, m/z = 731.3 (M+H); HPLC: Retention time (0.1% NH) 4 HCO 3 ) = 12.549 min; 1 H NMR (400 MHz, CDCl 3 ) δ 7.98 (s, 1H), 7.24 (s, 1H), 7.17 (d, J = 8.3 Hz, 2H), 7.11 (t , J = 7.3 Hz, 1H), 6.82 (s, 2H), 6.33 (t, J = 5.7 Hz, 1H), 4.88-4.79 (m, 2H), 4.46-4.24 (m, 4H), 4.06-3.95 ( m, 1H), 2.76-2.66 (m, 3H), 1.46 (d, J = 6.1 Hz, 4H), 1.36 (d, J = 7.0 Hz, 3H), 1.20 (t, J = 15.3 Hz, 20H), 0.83 (td, J = 6.8, 3.3 Hz, 6H).

工程3:トリコサン-12-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート
トリコサン-12-イルL-アラニナート(3.37g、8.18mmol)、トリエチルアミン(1.141mL、8.18mmol)のDCM(50mL)冷溶液に、フェニルホスホロジクロリデート(1.223mL、8.18mmol)のDCM(1mL)溶液を窒素雰囲気下、約5℃で滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(1.2g、4.09mmol)のTHF(20mL)/ピリジン(10mL)冷溶液に、tert-ブチルマグネシウムクロリド(10.23mL、10.23mmol)を窒素雰囲気下、0℃で滴下した。次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは生成物の存在を示した。混合物を濾過し、濃縮して、黄色の固体を得た。次いで、固体をEtOAcに溶解させ、濾過し、濃縮して、粗生成物を得た。残留物を逆相クロマトグラフィー(SepaFlash(登録商標)C18カラム、0~100% CHCN/10mM NHHCOO)により精製して、トリコサン-12-イル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-アラニナート(850mg、0.972mmol、収率23.7%)を黄色の固体として得た。LCMS:保持時間(0.1% TFA)=4.004、4.097分。ジアステレオマーを分取SFC(装置:SFC-80(Thar、Waters);カラム:OX 20×250mm、10μm(Daicel);カラム温度:35℃;移動相:CO/MeOH(0.2% アンモニア/メタノール)=55/45;流速:100g/分;背圧:100バール;検出波長:214nm;サイクル時間:4分;サンプル溶液:880mgを30mLのメタノール及びDCMに溶解させた)により分離して、最初に溶出する異性体(実施例38A、RT1:1.2分、296mg、0.338mmol、収率40.7%)を白色固体として得;LCMS:保持時間(0.1% TFA)=3.907分;HPLC:保持時間(0.1% TFA)=13.606分;1H NMR (400 MHz, CDCl3) δ 7.79 (s, 1H), 7.31 (t, J = 7.9 Hz, 2H), 7.21 (d, J = 7.7 Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 6.35 (dd, J = 7.0, 4.7 Hz, 1H), 6.05 (s, 2H), 4.87 (d, J = 6.2 Hz, 1H), 4.72 (t, J = 7.5 Hz, 1H), 4.38 (d, J = 8.9 Hz, 2H), 4.00 (dd, J = 15.8, 8.1 Hz, 1H), 3.86-3.62 (m, 2H), 2.75 (s, 1H), 2.72-2.62 (m, 2H), 1.76 (s, 4H), 1.36 (d, J = 7.0 Hz, 3H), 1.26-1.20 (m, 36H), 0.87 (t, J = 6.8 Hz, 6H)、2番目に溶出する異性体(実施例38B、RT2:2.56分、168mg、0.197mmol、23.73%収率)を白色固体として得た;LCMS(M+H)=843.4;保持時間(0.1% TFA)=3.983分;HPLC:保持時間(0.1% TFA)=13.942分;1H NMR (400 MHz, CDCl3) δ 7.95 (s, 1H), 7.31-7.27 (m, 2H), 7.18 (d, J = 8.6 Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 6.33 (dd, J = 7.4, 4.2 Hz, 1H), 6.00 (s, 2H), 4.86 (dd, J = 11.7, 5.8 Hz, 2H), 4.36 (ddd, J = 20.6, 11.3, 8.7 Hz, 2H), 4.03 (dd, J = 16.1, 9.0 Hz, 1H), 3.91-3.84 (m, 1H), 3.71 (s, 1H), 2.81-2.67 (m, 3H), 1.77 (s, 4H), 1.40 (d, J = 7.0 Hz, 3H), 1.26-1.18 (d, J = 14.5 Hz, 36H), 0.87 (t, J = 6.9 Hz, 6H).
Step 3: Tricosan-12-yl(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2- yl)methoxy)(phenoxy)phosphoryl)-L-alaninatetricosan -12-yl L-alaninate (3.37 g, 8.18 mmol), triethylamine (1.141 mL, 8.18 mmol) in a cold solution of DCM (50 mL). A solution of phenylphosphorodichloridate (1.223 mL, 8.18 mmol) in DCM (1 mL) was added dropwise at approximately 5° C. under a nitrogen atmosphere, and the reaction mixture was then stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (1.2 g, 4. To a cold solution of 0.09 mmol) in THF (20 mL)/pyridine (10 mL) was added tert-butylmagnesium chloride (10.23 mL, 10.23 mmol) dropwise at 0° C. under nitrogen atmosphere. The mixture was then stirred at room temperature for 30 minutes. The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the presence of product. The mixture was filtered and concentrated to give a yellow solid. The solid was then dissolved in EtOAc, filtered, and concentrated to give the crude product. The residue was purified by reverse phase chromatography (SepaFlash® C18 column, 0-100% CH 3 CN/10 mM NH 4 HCO 3 H 2 O) to give tricosan-12-yl (((2R,3S ,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate (850 mg , 0.972 mmol, yield 23.76 %) as a yellow solid. LCMS: Retention time (0.1% TFA) = 4.004, 4.097 minutes. Diastereomers were separated by preparative SFC (apparatus: SFC-80 (Thar, Waters); column: OX 20 x 250 mm, 10 μm (Daicel); column temperature: 35°C; mobile phase: CO 2 /MeOH (0.2% ammonia). /methanol) = 55/45; flow rate: 100 g/min; back pressure: 100 bar; detection wavelength: 214 nm; cycle time: 4 min; sample solution: 880 mg dissolved in 30 mL of methanol and DCM). , the first eluting isomer (Example 38A, RT1: 1.2 min, 296 mg, 0.338 mmol, 40.7% yield) was obtained as a white solid; LCMS: Retention time (0.1% TFA) = 3.907 minutes; HPLC: retention time (0.1% TFA) = 13.606 minutes; 1 H NMR (400 MHz, CDCl 3 ) δ 7.79 (s, 1H), 7.31 (t, J = 7.9 Hz, 2H ), 7.21 (d, J = 7.7 Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 6.35 (dd, J = 7.0, 4.7 Hz, 1H), 6.05 (s, 2H), 4.87 (d , J = 6.2 Hz, 1H), 4.72 (t, J = 7.5 Hz, 1H), 4.38 (d, J = 8.9 Hz, 2H), 4.00 (dd, J = 15.8, 8.1 Hz, 1H), 3.86-3.62 (m, 2H), 2.75 (s, 1H), 2.72-2.62 (m, 2H), 1.76 (s, 4H), 1.36 (d, J = 7.0 Hz, 3H), 1.26-1.20 (m, 36H), 0.87 (t, J = 6.8 Hz, 6H), the second eluting isomer (Example 38B, RT2: 2.56 min, 168 mg, 0.197 mmol, 23.73% yield) was obtained as a white solid. ; LCMS (M+H) = 843.4; Retention time (0.1% TFA) = 3.983 min; HPLC: Retention time (0.1% TFA) = 13.942 min; 1 H NMR (400 MHz, CDCl 3 ) δ 7.95 (s, 1H), 7.31-7.27 (m, 2H), 7.18 (d, J = 8.6 Hz, 2H), 7.15 (t, J = 7.3 Hz, 1H), 6.33 (dd, J = 7.4 , 4.2 Hz, 1H), 6.00 (s, 2H), 4.86 (dd, J = 11.7, 5.8 Hz, 2H), 4.36 (ddd, J = 20.6, 11.3, 8.7 Hz, 2H), 4.03 (dd, J = 16.1, 9.0 Hz, 1H), 3.91-3.84 (m, 1H), 3.71 (s, 1H), 2.81-2.67 (m, 3H), 1.77 (s, 4H), 1.40 (d, J = 7.0 Hz, 3H ), 1.26-1.18 (d, J = 14.5 Hz, 36H), 0.87 (t, J = 6.9 Hz, 6H).

工程1:ヘキサデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
ヘキサデカン-1-オール(8.85g、36.5mmol)、(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(10g、33.2mmol)及びHATU(18.93g、49.8mmol)のDCM(100mL)溶液に、イミダゾール(6.78g、100mmol)及びDIPEA(17.39mL、100mmol)を加えた。得られた混合物を25℃で一晩撹拌した。TLC(石油エーテル:EtOAc=10:1、Rf=0.5)は反応の完了を示した。反応を水(100mL)及びDCM(50mL)でクエンチし、有機層を分離した。水層をDCM(2×50mL)で抽出した。合わせた有機層をブライン(200mL)で洗浄し、NaSOで乾燥させ、濃縮して粗生成物を得た。残留物をcombiflash(シリカゲルカラム330g、ヘキサン:酢酸エチル=20:1)で精製した。生成物を含む適切な画分を合わせ、溶媒を真空で除去して、ヘキサデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(8.5g、16.17mmol、収率48.7%)を黄色の固体として得た。1H NMR (400 MHz, MeOD) δ 6.87 (d, J = 6.6 Hz, 2H), 6.82 (dd, J = 14.9, 5.6 Hz, 1H), 4.37 (dd, J = 9.2, 5.8 Hz, 1H), 4.13 (t, J = 6.5 Hz, 2H), 3.15 (dd, J = 13.8, 5.7 Hz, 1H), 2.94 (dd, J = 13.7, 9.4 Hz, 1H), 1.67-1.57 (m, 2H), 1.41 (s, 9H), 1.37 (d, J = 12.3 Hz, 2H), 1.31 (s, 24H), 0.92 (t, J = 6.8 Hz, 3H).
Step 1: Hexadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate hexadecane -1-ol (8.85 g, 36.5 mmol), (S)- A solution of 2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoic acid (10 g, 33.2 mmol) and HATU (18.93 g, 49.8 mmol) in DCM (100 mL) Imidazole (6.78 g, 100 mmol) and DIPEA (17.39 mL, 100 mmol) were added. The resulting mixture was stirred at 25°C overnight. TLC (petroleum ether:EtOAc=10:1, Rf=0.5) showed completion of the reaction. The reaction was quenched with water (100 mL) and DCM (50 mL) and the organic layer was separated. The aqueous layer was extracted with DCM (2 x 50 mL). The combined organic layers were washed with brine (200 mL), dried over Na 2 SO 4 and concentrated to give the crude product. The residue was purified by combiflash (silica gel column 330 g, hexane:ethyl acetate=20:1). Appropriate fractions containing the product are combined and the solvent is removed in vacuo to give hexadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate (8. 5 g, 16.17 mmol, yield 48.7%) was obtained as a yellow solid. 1 H NMR (400 MHz, MeOD) δ 6.87 (d, J = 6.6 Hz, 2H), 6.82 (dd, J = 14.9, 5.6 Hz, 1H), 4.37 (dd, J = 9.2, 5.8 Hz, 1H), 4.13 (t, J = 6.5 Hz, 2H), 3.15 (dd, J = 13.8, 5.7 Hz, 1H), 2.94 (dd, J = 13.7, 9.4 Hz, 1H), 1.67-1.57 (m, 2H), 1.41 (s, 9H), 1.37 (d, J = 12.3 Hz, 2H), 1.31 (s, 24H), 0.92 (t, J = 6.8 Hz, 3H).

工程2:ヘキサデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
ヘキサデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(8.5g、16.17mmol)のDCM(100mL)溶液に、TFA(7.47mL、97mmol)を加えた。得られた混合物を25℃で2時間撹拌した。TLC(石油エーテル:EtOAc=10:1、Rf=0.05)は、反応の完了を示した。反応物を水(200mL)及びDCM(100mL)で希釈した。有機層を分離し、水層をDCM(2×100mL)で抽出した。合わせた有機層をブライン(50mL)で洗浄し、NaSOで乾燥させ、濃縮して、粗ヘキサデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(6.3g、14.80mmol、収率92%)を得て、これを精製することなく次の工程で使用した。
Step 2: Hexadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate To a solution of hexadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate (8.5 g, 16.17 mmol) in DCM (100 mL) was added TFA (7.47 mL, 97 mmol). The resulting mixture was stirred at 25° C. for 2 h. TLC (petroleum ether: EtOAc = 10:1, Rf = 0.05) showed the reaction was complete. The reaction was diluted with water (200 mL) and DCM (100 mL). The organic layer was separated and the aqueous layer was extracted with DCM (2×100 mL). The combined organic layers were washed with brine (50 mL), dried over Na 2 SO 4 and concentrated to give crude hexadecyl (S)-2-amino-3-(3,5- difluorophenyl )propanoate (6.3 g, 14.80 mmol, 92% yield), which was used in the next step without purification.

工程3:ヘキサデシル(2S)-2-(((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
ヘキサデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(3.99g、9.38mmol)及びトリエチルアミン(1.307mL、9.38mmol)のDCM(60mL)冷(氷水浴)溶液に、窒素雰囲気下で、フェニルホスホロジクロリデート(1.978g、9.38mmol)のDCM(10mL)溶液を滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(1.1g、3.75mmol)のTHF(30mL)/ピリジン(15mL)冷(氷水浴)溶液に、tert-ブチルマグネシウムクロリド(9.38mL、9.38mmol)を窒素雰囲気下で滴下し、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは反応の完了を示した。混合物を濾過し、濃縮して、黄色の固体を得た。次いで、固体をEtOAc(40mL)に溶解させ、HCl(0.05N、20mL)で分配した。層を分離し、水層をEtOAc(40mL)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮して、粗生成物を得た。残留物をcombiflash(シリカゲルカラム20g、DCM:MeOH=24:1)により精製した。生成物を含む適切な画分を合わせ、溶媒を真空中で除去して、ヘキサデシル(2S)-2-(((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(500mg、0.583mmol、収率15.56%)を黄色の固体として得た。LCMS(M+H)=857.1;保持時間(0.1% TFA)=2.52分。ジアステレオマーをSFC(装置:SFC-80(Thar、Waters)、カラム:OZ 20×250mm、10μm(Daicel)、カラム温度:40℃、移動相:CO/ETOH(1.0%アンモニア/メタノール)=60/40;流速:80g/分;背圧:100バール;検出波長:259nm;サイクル時間:9分)により分離して、最初に溶出する異性体(実施例39A、RT1:1.67分、200mg、0.233mmol、収率40.0%)を白色固体として得;LCMS(M+H)=857.3;保持時間(0.1% TFA)=2.512分;HPLC:保持時間(0.1% TFA)=13.439分;1H NMR (400 MHz, DMSO) δ 8.18 (s, 1H), 7.84 (s, 2H), 7.22 (t, J = 7.9 Hz, 2H), 7.09 (t, J = 7.4 Hz, 1H), 6.97 (s, 1H), 6.95 (s, 1H), 6.88 (d, J = 6.3 Hz, 2H), 6.26 (dd, J = 7.4, 5.1 Hz, 1H), 6.15 (dd, J = 12.3, 10.5 Hz, 1H), 5.78 (d, J = 5.5 Hz, 1H), 4.55 (dd, J = 12.6, 6.9 Hz, 1H), 4.02 (dd, J = 9.8, 5.2 Hz, 2H), 3.93 (ddd, J = 13.8, 10.8, 4.2 Hz, 3H), 3.64 (s, 1H), 2.95 (d, J = 11.0 Hz, 1H), 2.80 (dd, J = 13.7, 9.0 Hz, 1H), 2.69 (dd, J = 12.0, 6.3 Hz, 1H), 2.43 (dd, J = 13.6, 7.2 Hz, 2H), 1.43 (s, 2H), 1.19 (d, J = 23.9 Hz, 26H), 0.85 (t, J = 6.8 Hz, 3H)、2番目に溶出する異性体(実施例39B、RT2:2.82分、200mg、0.233mmol、収率40.0%)を白色固体として得た;LCMS(M+H)=857.3;保持時間(0.1% TA)=2.512分;HPLC:保持時間(0.1% NHHCO)=13.736分;LCMS(M+H)=857.3;保持時間(0.1% TFA)=2.52分;HPLC:保持時間(0.1% TA)=13.39分;1H NMR (400 MHz, DMSO) δ 8.22 (s, 1H), 7.83 (s, 2H), 7.25 (t, J = 7.9 Hz, 2H), 7.11 (t, J = 7.2 Hz, 1H), 7.01 (d, J = 8.5 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 6.23 (dd, J = 7.6, 4.8 Hz, 1H), 6.14 (dd, J = 12.7, 10.6 Hz, 1H), 5.74 (d, J = 5.6 Hz, 1H), 4.52 (dd, J = 12.9, 7.2 Hz, 1H), 4.06 (dd, J = 10.8, 6.4 Hz, 1H), 3.98 (dd, J = 9.4, 6.0 Hz, 1H), 3.89-3.83 (m, 1H), 3.82-3.75 (m, 1H), 3.60 (s, 1H), 3.36 (dd, J = 11.7, 6.5 Hz, 1H), 2.96 (dd, J = 12.1, 4.6 Hz, 1H), 2.80 (dd, J = 13.5, 9.1 Hz, 1H), 2.73-2.65 (m, 1H), 2.43 (dd, J = 13.5, 7.5 Hz, 2H), 1.40-1.35 (m, 2H), 1.23 (d, J = 4.9 Hz, 26H), 0.86-0.83 (m, 3H).
Step 3: Hexadecyl (2S)-2-((((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran -2-yl)methoxy)(phenoxy)phosphoryl)amino)-3-(3,5-difluorophenyl)propanoate hexadecyl (S)-2-amino-3-(3,5- difluorophenyl )propanoate (3. 99 g, 9.38 mmol) and triethylamine (1.307 mL, 9.38 mmol) in DCM (60 mL, ice water bath) under nitrogen atmosphere. A DCM (10 mL) solution was added dropwise and the reaction mixture was then stirred at room temperature for 1 hour. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (1.1 g, 3. To a cold (ice-water bath) solution of 75 mmol) in THF (30 mL)/pyridine (15 mL) was added dropwise tert-butylmagnesium chloride (9.38 mL, 9.38 mmol) under a nitrogen atmosphere, and the mixture was stirred at room temperature for 30 minutes. . The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. The mixture was filtered and concentrated to give a yellow solid. The solid was then dissolved in EtOAc (40 mL) and partitioned with HCl (0.05N, 20 mL). The layers were separated and the aqueous layer was extracted with EtOAc (40 mL). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated to give the crude product. The residue was purified by combiflash (silica gel column 20 g, DCM:MeOH=24:1). Appropriate fractions containing the product were combined and the solvent removed in vacuo to give hexadecyl(2S)-2-(((((2R,3S,5R)-5-(6-amino-2-fluoro- 9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)-3-(3,5-difluorophenyl)propanoate (500 mg, 0.583 mmol, Yield: 15.56%) was obtained as a yellow solid. LCMS (M+H) = 857.1; retention time (0.1% TFA) = 2.52 minutes. Diastereomers were separated by SFC (equipment: SFC-80 (Thar, Waters), column: OZ 20 x 250 mm, 10 μm (Daicel), column temperature: 40°C, mobile phase: CO 2 /ETOH (1.0% ammonia/methanol). ) = 60/40; flow rate: 80 g/min; back pressure: 100 bar; detection wavelength: 259 nm; cycle time: 9 min) to separate the first eluting isomer (Example 39A, RT1: 1.67 min, 200 mg, 0.233 mmol, yield 40.0%) as a white solid; LCMS (M+H) = 857.3; Retention time (0.1% TFA) = 2.512 min; HPLC: Retention time ( 0.1% TFA) = 13.439 min; 1 H NMR (400 MHz, DMSO) δ 8.18 (s, 1H), 7.84 (s, 2H), 7.22 (t, J = 7.9 Hz, 2H), 7.09 ( t, J = 7.4 Hz, 1H), 6.97 (s, 1H), 6.95 (s, 1H), 6.88 (d, J = 6.3 Hz, 2H), 6.26 (dd, J = 7.4, 5.1 Hz, 1H), 6.15 (dd, J = 12.3, 10.5 Hz, 1H), 5.78 (d, J = 5.5 Hz, 1H), 4.55 (dd, J = 12.6, 6.9 Hz, 1H), 4.02 (dd, J = 9.8, 5.2 Hz , 2H), 3.93 (ddd, J = 13.8, 10.8, 4.2 Hz, 3H), 3.64 (s, 1H), 2.95 (d, J = 11.0 Hz, 1H), 2.80 (dd, J = 13.7, 9.0 Hz, 1H), 2.69 (dd, J = 12.0, 6.3 Hz, 1H), 2.43 (dd, J = 13.6, 7.2 Hz, 2H), 1.43 (s, 2H), 1.19 (d, J = 23.9 Hz, 26H), 0.85 (t, J = 6.8 Hz, 3H), the second eluting isomer (Example 39B, RT2: 2.82 min, 200 mg, 0.233 mmol, yield 40.0%) was obtained as a white solid. ; LCMS (M+H) = 857.3; Retention time (0.1% TFA ) = 2.512 min; HPLC : Retention time (0.1% NH4HCO3 ) = 13.736 min; LCMS (M+H ) = 857.3; Retention time (0.1% TFA) = 2.52 minutes; HPLC: Retention time (0.1% TFA ) = 13.39 minutes; 1 H NMR (400 MHz, DMSO) δ 8.22 (s, 1H), 7.83 (s, 2H), 7.25 (t, J = 7.9 Hz, 2H), 7.11 (t, J = 7.2 Hz, 1H), 7.01 (d, J = 8.5 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 6.23 (dd, J = 7.6, 4.8 Hz, 1H), 6.14 (dd, J = 12.7, 10.6 Hz, 1H), 5.74 (d, J = 5.6 Hz, 1H ), 4.52 (dd, J = 12.9, 7.2 Hz, 1H), 4.06 (dd, J = 10.8, 6.4 Hz, 1H), 3.98 (dd, J = 9.4, 6.0 Hz, 1H), 3.89-3.83 (m, 1H), 3.82-3.75 (m, 1H), 3.60 (s, 1H), 3.36 (dd, J = 11.7, 6.5 Hz, 1H), 2.96 (dd, J = 12.1, 4.6 Hz, 1H), 2.80 (dd , J = 13.5, 9.1 Hz, 1H), 2.73-2.65 (m, 1H), 2.43 (dd, J = 13.5, 7.5 Hz, 2H), 1.40-1.35 (m, 2H), 1.23 (d, J = 4.9 Hz, 26H), 0.86-0.83 (m, 3H).

工程1:オクタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
オクタデカン-1-オール(8.98g、33.2mmol)、(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(10g、33.2mmol)、イミダゾール(6.78g、100mmol)、DIPEA(17.39mL、100mmol)及びHATU(18.93g、49.8mmol)のDCM(500mL)混合液を25℃で16時間撹拌した。TLCは新たな生成物の存在を示した。水(500mL)を加え、得られた混合物をDCM(250mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル:EtOAc=30:1)で精製して、オクタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(16g、28.9mmol、収率87%)を白色固体として得た。1H NMR (400 MHz, DMSO) δ 7.34-6.98 (m, 3H), 4.21-4.01 (m, 3H), 3.03-2.84 (m, 3H), 2.83 (qd, J = 13.5, 7.0 Hz, 2H), 1.49 (s, 3H), 1.39 (s, 9H), 1.23 (s, 30H), 0.84 (t, J = 6.8 Hz, 3H).
Step 1: Octadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate octadecane -1-ol (8.98 g, 33.2 mmol), (S)- 2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoic acid (10 g, 33.2 mmol), imidazole (6.78 g, 100 mmol), DIPEA (17.39 mL, 100 mmol) and A mixture of HATU (18.93 g, 49.8 mmol) in DCM (500 mL) was stirred at 25° C. for 16 hours. TLC showed the presence of new product. Water (500 mL) was added and the resulting mixture was extracted with DCM (250 mL x 3). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (petroleum ether:EtOAc=30:1) to give octadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl )propanoate. (16 g, 28.9 mmol, 87% yield) was obtained as a white solid. 1 H NMR (400 MHz, DMSO) δ 7.34-6.98 (m, 3H), 4.21-4.01 (m, 3H), 3.03-2.84 (m, 3H), 2.83 (qd, J = 13.5, 7.0 Hz, 2H) , 1.49 (s, 3H), 1.39 (s, 9H), 1.23 (s, 30H), 0.84 (t, J = 6.8 Hz, 3H).

工程2:オクタデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
オクタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(16g、28.9mmol)のDCM(100mL)溶液に、TFA(95mL、1228mmol)を25℃で加えた。反応混合物を
25℃で4時間撹拌した。TLCは、出発物質が完全に消費されたことを示した。反応物を濃縮乾固し、残留物のpHをNaCO溶液で5~6に調整し、次いで、DCM(200mL×3)で抽出した。合わせた有機層をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィーで精製して、オクタデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(8.0g、17.63mmol、収率61.0%)。1H NMR (400 MHz, DMSO) δ 7.14- 6.83 (m, 3H), 4.08-3.85 (m, 2H), 3.60 (t, J = 6.9 Hz, 1H), 2.83 (qd, J = 13.5, 7.0 Hz, 2H), 1.48 (d, J = 6.6 Hz, 2H), 1.23 (s, 30H), 0.85 (t, J = 6.8 Hz, 3H).
Step 2: Octadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Octadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl ) To a solution of propanoate (16 g, 28.9 mmol) in DCM (100 mL) was added TFA (95 mL, 1228 mmol) at 25°C. The reaction mixture was stirred at 25°C for 4 hours. TLC showed complete consumption of starting material. The reaction was concentrated to dryness, the pH of the residue was adjusted to 5-6 with Na 2 CO 3 solution, and then extracted with DCM (200 mL×3). The combined organic layers were washed with brine, dried over Na2SO4 , filtered, and concentrated. The residue was purified by silica gel chromatography to give octadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (8.0 g, 17.63 mmol, yield 61.0%). 1 H NMR (400 MHz, DMSO) δ 7.14- 6.83 (m, 3H), 4.08-3.85 (m, 2H), 3.60 (t, J = 6.9 Hz, 1H), 2.83 (qd, J = 13.5, 7.0 Hz , 2H), 1.48 (d, J = 6.6 Hz, 2H), 1.23 (s, 30H), 0.85 (t, J = 6.8 Hz, 3H).

工程1:イコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
イコサン-1-オール(9.91g、33.2mmol)、(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(10g、33.2mmol)、イミダゾール(6.78g、100mmol)、DIPEA(17.39mL、100mmol)及びHATU(18.93g、49.8mmol)のDCM(500mL)溶液を25℃で16時間撹拌した。TLCは、新たな生成物の存在を示した。水(500mL)を添加し、反応混合物をDCM(250mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル:EtOAc=30:1)で精製して、イコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(14g、24.0mmol、収率72.5%)を白色固体として得た。1H NMR (400 MHz, DMSO) δ 7.36-7.34 (m, 1H), 7.06-6.98 (m, 3H), 4.02-3.99 (m, 3H), 2.88 (m, 3H), 1.51-1.48 (m, 2H), 1.32 (s, 9H), 1.27 (S, 34H), 0.86-0.83 (m, 3H).
Step 1: Icosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate icosan- 1-ol (9.91 g, 33.2 mmol), (S)- 2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoic acid (10 g, 33.2 mmol), imidazole (6.78 g, 100 mmol), DIPEA (17.39 mL, 100 mmol) and A solution of HATU (18.93 g, 49.8 mmol) in DCM (500 mL) was stirred at 25° C. for 16 hours. TLC showed the presence of new product. Water (500 mL) was added and the reaction mixture was extracted with DCM (250 mL x 3). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (petroleum ether:EtOAc=30:1) to give icosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl )propanoate. (14 g, 24.0 6 mmol, yield 72.5%) was obtained as a white solid. 1 H NMR (400 MHz, DMSO) δ 7.36-7.34 (m, 1H), 7.06-6.98 (m, 3H), 4.02-3.99 (m, 3H), 2.88 (m, 3H), 1.51-1.48 (m, 2H), 1.32 (s, 9H), 1.27 (S, 34H), 0.86-0.83 (m, 3H).

工程2:イコシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
イコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(14g、24.06mmol)のDCM(50mL)溶液にTFA(50mL、649mmol)を25℃で加えた。反応混合物を25℃で4時間撹拌した。TLCは、反応が完了したことを示した。反応物を濃縮乾固した。残留物のpHをNaCO溶液で5~6に調整し、DCM(100mL×3)で抽出した。合わせた有機層をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィーで精製して、イコシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(8g、16.61mmol、収率69.0%)を得た。1H NMR (400 MHz, DMSO) δ 7.11- 6.84 (m, 3H), 3.98 (dd, J = 11.6, 5.9 Hz, 2H), 3.60 (t, J = 6.9 Hz, 1H), 2.94- 2.72 (m, 2H), 2.07 (s, 2H), 1.47 (s, 2H), 1.23 (s, 34H), 0.84 (d, J = 6.8 Hz, 3H).
Step 2: Icosyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate To a solution of Icosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl) propanoate (14 g, 24.06 mmol) in DCM (50 mL) was added TFA (50 mL, 649 mmol) at 25 °C. The reaction mixture was stirred at 25 °C for 4 h. TLC showed the reaction was complete. The reaction was concentrated to dryness. The pH of the residue was adjusted to 5-6 with Na 2 CO 3 solution and extracted with DCM (100 mL × 3). The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography to give icosyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (8 g, 16.61 mmol, 69.0% yield). 1H NMR (400 MHz, DMSO) δ 7.11- 6.84 (m, 3H), 3.98 (dd, J = 11.6, 5.9 Hz, 2H), 3.60 (t, J = 6.9 Hz, 1H), 2.94- 2.72 (m, 2H), 2.07 (s, 2H), 1.47 (s, 2H), 1.23 (s, 34H), 0.84 (d, J = 6.8 Hz, 3H).

工程1:ドコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
ドコサン-1-オール(10.84g、33.2mmol)、(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(10g、33.2mmol)、イミダゾール(6.78g、100mmol)、DIPEA(17.39mL、100mmol)及びHATU(18.93g、49.8mmol)のDCM(500mL)混合液を25℃で16時間撹拌した。TLCは、新たな生成物の存在を示した。水(500mL)を加え、反応混合物をDCM(250mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル:EtOAc=30:1)で精製して、ドコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(16g、26.2mmol、収率79%)を白色固体として得た。1H NMR (400 MHz, DMSO) δ 7.36-7.34 (m, 1H), 7.06-6.98 (m, 3H), 4.03-4.00 (m, 3H), 3.00-2.68 (m, 3H), 1.51-1.48 (m, 2H), 1.32 (s, 9H), 1.27 (S, 38H), 0.86-0.83 (m, 3H).
Step 1: docosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate docosan- 1-ol (10.84 g, 33.2 mmol), (S)- 2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoic acid (10 g, 33.2 mmol), imidazole (6.78 g, 100 mmol), DIPEA (17.39 mL, 100 mmol) and A mixture of HATU (18.93 g, 49.8 mmol) in DCM (500 mL) was stirred at 25° C. for 16 hours. TLC showed the presence of new product. Water (500 mL) was added and the reaction mixture was extracted with DCM (250 mL x 3). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (petroleum ether:EtOAc=30:1) to give docosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl )propanoate. (16 g, 26.2 mmol, 79% yield) was obtained as a white solid. 1 H NMR (400 MHz, DMSO) δ 7.36-7.34 (m, 1H), 7.06-6.98 (m, 3H), 4.03-4.00 (m, 3H), 3.00-2.68 (m, 3H), 1.51-1.48 ( m, 2H), 1.32 (s, 9H), 1.27 (S, 38H), 0.86-0.83 (m, 3H).

工程2:ドコシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
ドコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(10g、16.40mmol)のDCM(50mL)溶液に、TFA(1.263mL、16.40mmol)を0℃で加えた。次いで、混合物を室温に加温し、2時間撹拌した。TLCは、反応の完了を示した。反応混合物のpHを飽和NaCO溶液で7~8に調整し、DCM(100mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮して、残留物を得た。残留物をシリカゲルクロマトグラフィー(DCM:MeOH=20:1)で精製して、ドコシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(8g、14.91mmol、収率91%)を得た。1H NMR (400 MHz, DMSO) δ 7.00 (d, J = 34.2 Hz, 3H), 5.76 (s, 1H), 3.99 (s, 2H), 3.62 (s, 1H), 2.83 (s, 2H), 1.47 (s, 2H), 1.23 (s, 38H), 0.85 (s, 3H).
Step 2: Docosyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate docosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl ) To a solution of propanoate (10 g, 16.40 mmol) in DCM (50 mL) was added TFA (1.263 mL, 16.40 mmol) at 0<0>C. The mixture was then warmed to room temperature and stirred for 2 hours. TLC showed completion of the reaction. The pH of the reaction mixture was adjusted to 7-8 with saturated Na 2 CO 3 solution and extracted with DCM (100 mL×3). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated to give a residue. The residue was purified by silica gel chromatography (DCM:MeOH=20:1) to give docosyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (8 g, 14.91 mmol, yield 91 %) was obtained. 1 H NMR (400 MHz, DMSO) δ 7.00 (d, J = 34.2 Hz, 3H), 5.76 (s, 1H), 3.99 (s, 2H), 3.62 (s, 1H), 2.83 (s, 2H), 1.47 (s, 2H), 1.23 (s, 38H), 0.85 (s, 3H).

工程3:イコシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
イコシルL-フェニルアラニナート(7.60g、17.05mmol)及びトリエチルアミン(2.376mL、17.05mmol)のDCM(48mL)冷(氷水浴)溶液に、窒素雰囲気下、氷水中で、フェニルホスホロジクロリデート(3.60g、17.05mmol)のDCM(1mL)溶液を滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(2g、6.82mmol)のTHF(24mL)/ピリジン(12mL)溶液に、tert-ブチルマグネシウムクロリド(17.05mL、17.05mmol)を窒素雰囲気下、0℃で滴下し、次いで、混合物を室温に加温し、30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは、反応の完了を示した。反応混合物を濾過し、濃縮し、次いで、残留物をDCMで希釈した。混合物に水を加え、抽出した。次いで、有機層を0.5N HCl(3回)及びブラインで洗浄した。有機相をNaSOで乾燥させ、濾過し、濃縮した。残留物をフラッシュクロマトグラフィー(0~5% MeOH/DCM)により精製して、イコシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(800mg、0.867mmol、収率12.71%)を得た。LCMS(M+H)=877.7;保持時間(0.1% TFA)=3.82分。ジアステレオマーを分取SFC(装置:SFC-80(Thar、Waters)、カラム:OZ 20×250mm、10μm(Daicel)、カラム温度:60℃、移動相:CO/ETOH(1.0%アンモニア/メタノール)=60/40;流速:80g/分;背圧:100バール;検出波長:260nm;サイクル時間:9分)により分離して、最初に溶出する異性体(実施例43A、RT1:1.35分、125.8mg、0.1434mmol、100.0%、収率16.79%)をオフホワイトの固体として得;LCMS(M+H)=877.7、保持時間(0.1% TFA)=3.82分;HPLC:保持時間(0.1% NHHCO)=13.350分;1H NMR (400 MHz, MeOD) δ 8.14 (d, J = 18.6 Hz, 1H), 7.33-7.18 (m, 5H), 7.16- 6.99 (m, 5H), 6.42-6.28 (m, 1H), 4.76-4.65 (m, 1H), 4.17 (dt, J = 37.1, 18.6 Hz, 1H), 4.02 (ddd, J = 23.5, 12.5, 5.9 Hz, 4H), 2.98 (dt, J = 15.3, 7.5 Hz, 1H), 2.86 (dd, J = 11.8, 6.5 Hz, 1H), 2.80-2.59 (m, 2H), 1.47 (dd, J = 18.5, 12.9 Hz, 2H), 1.39 -1.08 (m, 36H), 0.91 (t, J = 6.4 Hz, 3H)、2番目に溶出する異性体(実施例43B、RT2:2.04分、207.5mg、0.2366mmol、99.56%、収率17.10%)をオフホワイトの固体として得た;LCMS(M+H)=877.7、保持時間(0.1% TFA)=3.84分;HPLC:保持時間(0.1% NHHCO)=12.581分;1H NMR (400 MHz, MeOD) δ 8.06-7.96 (m, 1H), 7.18- 6.89 (m, 10H), 6.24-6.12 (m, 1H), 4.58 (t, J = 7.5 Hz, 1H), 4.04-3.94 (m, 2H), 3.91-3.73 (m, 3H), 3.08- 3.03 (m, 1H), 2.91 (ddd, J = 13.5, 6.3, 2.2 Hz, 1H), 2.84-2.40 (m, 3H), 1.4-1.27 (m, 2H), 1.23-1.08 (m, 36H), 0.79 (t, J = 6.9 Hz, 3H)。
Step 3: Icosyl ((((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate To a cold (ice-water bath) solution of Icosyl L-phenylalaninate (7.60 g, 17.05 mmol) and triethylamine (2.376 mL, 17.05 mmol) in DCM (48 mL), a solution of phenyl phosphorodichloridate (3.60 g, 17.05 mmol) in DCM (1 mL) was added dropwise in ice water under a nitrogen atmosphere, and the reaction mixture was then stirred at room temperature for 1 hour. To a solution of (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (2 g, 6.82 mmol) in THF (24 mL)/pyridine (12 mL) was added tert-butylmagnesium chloride (17.05 mL, 17.05 mmol) dropwise under nitrogen at 0° C., then the mixture was warmed to room temperature and stirred for 30 minutes. The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. The reaction mixture was filtered and concentrated, then the residue was diluted with DCM. Water was added to the mixture and extracted. The organic layer was then washed with 0.5 N HCl (3 times) and brine. The organic phase was dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by flash chromatography (0-5% MeOH/DCM) to give icosyl ((((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate (800 mg, 0.867 mmol, 12.71% yield). LCMS (M+H) = 877.7 ; retention time (0.1% TFA) = 3.82 min. The diastereomers were separated by preparative SFC (instrument: SFC-80 (Thar, Waters), column: OZ 20×250 mm, 10 μm (Daicel), column temperature: 60° C., mobile phase: CO 2 /ETOH (1.0% ammonia/methanol)=60/40; flow rate: 80 g/min; back pressure: 100 bar; detection wavelength: 260 nm; cycle time: 9 min) to give the first eluting isomer (Example 43A, RT1: 1.35 min, 125.8 mg, 0.1434 mmol, 100.0%, 16.79% yield) as an off-white solid; LCMS (M+H)=877.7, retention time (0.1% TFA)=3.82 min; HPLC: retention time (0.1% NH 4 HCO 3 )=13.350 min; 1 H NMR (400 MHz, MeOD) δ 8.14 (d, J = 18.6 Hz, 1H), 7.33-7.18 (m, 5H), 7.16- 6.99 (m, 5H), 6.42-6.28 (m, 1H), 4.76-4.65 (m, 1H), 4.17 (dt, J = 37.1, 18.6 Hz, 1H), 4.02 (ddd, J = 23.5, 12.5, 5.9 Hz, 4H), 2.98 (dt, J = 15.3, 7.5 Hz, 1H), 2.86 (dd, J = 11.8, 6.5 Hz, 1H), 2.80-2.59 (m, 2H), 1.47 (dd, J = 18.5, 12.9 Hz, 2H), 1.39 -1.08 (m, 36H), 0.91 (t, J = 6.4 Hz, 3H), the second eluting isomer (Example 43B, RT2: 2.04 min, 207.5 mg, 0.2366 mmol, 99.56%, 17.10% yield) was obtained as an off-white solid; LCMS (M+H) = 877.7, retention time (0.1% TFA) = 3.84 min; HPLC: retention time (0.1% NH4HCO3 ) = 12.581 min; 1H NMR (400 MHz, MeOD) δ 8.06-7.96 (m, 1H), 7.18- 6.89 (m, 10H), 6.24-6.12 (m, 1H), 4.58 (t, J = 7.5 Hz, 1H), 4.04-3.94 (m, 2H), 3.91-3.73 (m, 3H), 3.08- 3.03 (m, 1H), 2.91 (ddd, J = 13.5, 6.3, 2.2 Hz, 1H), 2.84-2.40 (m, 3H), 1.4-1.27 (m, 2H), 1.23-1.08 (m, 36H), 0.79 (t, J = 6.9 Hz, 3H).

工程2:12,12,13,13,14,14,15,15,15-ノナフルオロペンタデカン-1-オール
亜鉛(28.5g、436mmol)のエタノール(50mL)スラリーに、AcOH(1.386mL、24.21mmol)を加えた。12,12,13,13,14,14,15,15,15-ノナフルオロ-10-ヨードペンタデカン-1-オール(50g、97mmol)のエタノール(10.0mL)溶液を、撹拌しながら1時間かけて滴下し、反応混合物を50℃で4時間加熱した。TLCは、新たな化合物の存在を示した。反応物を濃縮乾固した。残留物のpHをNaCO水溶液で5~6に調整し、EtOAc(50mL×3)で抽出した。合わせた有機層をブラインで洗浄し、N SOで乾燥させ、濾過し、濃縮した。粗生成物をシリカゲルクロマトグラフィーで精製して、12,12,13,13,14,14,15,15,15-ノナフルオロペンタデカン-1-オール(21g、53.8mmol、収率55.5%)を得た。1H NMR (400 MHz, CDCl3): δ 3.54 (t, J = 17.0, 6.8 Hz, 2H), 2.16-2.12 (m, 2H), 1.62-1.51 (m, 4H), 1.33 (s, 14H).
Step 2: AcOH (1.386 mL, 24.21 mmol) was added. A solution of 12,12,13,13,14,14,15,15,15-nonafluoro-10-iodopentadecane-1-ol (50 g, 97 mmol) in ethanol (10.0 mL) was stirred for 1 hour. was added dropwise and the reaction mixture was heated at 50° C. for 4 hours. TLC showed the presence of new compound. The reaction mixture was concentrated to dryness. The pH of the residue was adjusted to 5-6 with aqueous Na 2 CO 3 and extracted with E tOAc (50 mL×3). The combined organic layers were washed with brine, dried over Na2SO4 , filtered , and concentrated. The crude product was purified by silica gel chromatography to give 12,12,13,13,14,14,15,15,15-nonafluoropentadecane-1-ol (21 g, 53.8 mmol, 55.5% yield) ) was obtained. 1 H NMR (400 MHz, CDCl 3 ): δ 3.54 (t, J = 17.0, 6.8 Hz, 2H), 2.16-2.12 (m, 2H), 1.62-1.51 (m, 4H), 1.33 (s, 14H) .

工程5:12,12,13,13,14,14,15,15,15-ノナフルオロペンタデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
12,12,13,13,14,14,15,15,15-ノナフルオロペンタデシルL-フェニルアラニナート(7.33g、13.64mmol)及びトリエチルアミン(1.901mL、13.64mmol)のDCM(48mL)冷(氷水浴)溶液に、窒素雰囲気下でフェニルホスホロジクロリデート(2.88g、13.64mmol)のDCM(1mL)滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(2.0g、6.82mmol)のTHF(24mL)/ピリジン(12mL)溶液に、tert-ブチルマグネシウムクロリド(13.64mL、13.64mmol)を窒素雰囲気下で滴下し、次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、室温で2時間撹拌した。LCMSは、反応の完了を示した。反応混合物を濾過し、濾液を濃縮した。次いで、残留物をDCMで希釈し、水、0.5N HCl(3回)、ブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(0~5% MeOH/DCM)により精製して、12,12,13,13,14,14,15,15,15-ノナフルオロペンタデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(1g、1.032mmol、収率15.13%)を得た。LCMS(M+H)=969.7;保持時間(0.1% TFA)=2.15分。ジアステレオマーを分取SFC(装置:SFC-80(Thar、Waters)、カラム:AS 20×250mm、10μm(Daicel)、カラム温度:40℃、移動相:CO/MeOH(0.2%アンモニア/メタノール)=70/30;流速:70g/分;背圧:100バール;検出波長:260nm;サイクル時間:6.5分;サンプル溶液:510mgを12mLのメタノールに溶解させた;注入量:2mL)により分離して、最初に溶出する異性体(実施例44A、RT1:1.66分、100.5mg、0.127mmol、98.59%、収率16.79%)をオフホワイトの固体として得;LCMS(M+H)=969.7;保持時間(0.1% TFA)=2.76分;HPLC:保持時間(10mM NHHCO)=7.911分;1H NMR (400 MHz, DMSO) δ 8.24 (d, J = 8.9 Hz, 1H), 7.85 (s, 2H), 7.35-7.07 (m, 8H), 7.02 (d, J = 8.4 Hz, 2H), 6.23 (dd, J = 7.5, 4.9 Hz, 1H), 6.14-6.00 (m, 1H), 5.74 (d, J = 5.6 Hz, 1H), 4.52 (dd, J = 12.6, 7.2 Hz, 1H), 3.89 (dddd, J = 42.6, 35.9, 14.2, 9.5 Hz, 5H), 3.63 (d, J = 8.9 Hz, 1H), 2.99-2.85 (m, 1H), 2.84-2.63 (m, 2H), 2.18 (dd, J = 18.2, 10.0 Hz, 2H), 1.50 (dd, J = 15.5, 7.8 Hz, 2H), 1.38-1.28 (m, 4H), 1.18 (d, J = 15.8 Hz, 13H)、2番目に溶出する異性体(実施例44B、RT2:2.77分、85.5mg、0.107mmol、97.28%、収率:14.10%)をオフホワイトの固体として得た;LCMS(M+H)=969.7;保持時間(0.1% TFA)=2.75分;HPLC:保持時間(10mM NHHCO)=7.876分;1H NMR (400 MHz, DMSO) δ 8.20 (s, 1H), 7.85 (s, 2H), 7.29-7.16 (m, 5H), 7.11 (dd, J = 7.2, 3.2 Hz, 3H), 6.98 (d, J = 8.5 Hz, 2H), 6.28 (dd, J = 7.2, 5.2 Hz, 1H), 6.20-6.06 (m, 1H), 5.78 (d, J = 5.5 Hz, 1H), 4.54 (dd, J = 12.5, 6.8 Hz, 1H), 4.11-3.92 (m, 2H), 3.95-3.79 (m, 3H), 3.66 (s, 1H), 2.88 (d, J = 7.1 Hz, 1H), 2.80 (dd, J = 13.5, 7.9 Hz, 1H), 2.75-2.64 (m, 1H), 2.19 (s, 2H), 1.56-1.42 (m, 2H), 1.35 (d, J = 6.8 Hz, 4H), 1.27-1.07 (m, 13H).
Step 5: 12,12,13,13,14,14,15,15,15-nonafluoropentadecyl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purine) -9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate 12,12,13,13,14,14,15,15,15- Phenylphosphorodichloride was added to a cold (ice-water bath) solution of nonafluoropentadecyl L-phenylalaninate (7.33 g, 13.64 mmol) and triethylamine (1.901 mL, 13.64 mmol) in DCM (48 mL) under a nitrogen atmosphere. Date (2.88 g, 13.64 mmol) in DCM (1 mL) was added dropwise and the reaction mixture was then stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (2.0 g, 6. To a solution of 82 mmol) in THF (24 mL)/pyridine (12 mL) was added tert-butylmagnesium chloride (13.64 mL, 13.64 mmol) dropwise under nitrogen atmosphere, and the mixture was then stirred at room temperature for 30 minutes. The first prepared mixture was added dropwise to the second prepared mixture at room temperature, and the mixture was stirred at room temperature for 2 hours. LCMS showed the reaction was complete. The reaction mixture was filtered and the filtrate was concentrated. The residue was then diluted with DCM and washed with water, 0.5N HCl (3x), brine, dried over Na2SO4 , filtered, and concentrated . The residue was purified by silica gel chromatography (0-5% MeOH/DCM) to give 12,12,13,13,14,14,15,15,15-nonafluoropentadecyl (((2R,3S, 5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate ( 1 g, 1.032 mmol, yield 15.13%). LCMS (M+H) = 969.7; retention time (0.1% TFA) = 2.15 minutes. Diastereomers were separated by preparative SFC (equipment: SFC-80 (Thar, Waters), column: AS 20 x 250 mm, 10 μm (Daicel), column temperature: 40°C, mobile phase: CO 2 /MeOH (0.2% ammonia). /methanol) = 70/30; flow rate: 70 g/min; back pressure: 100 bar; detection wavelength: 260 nm; cycle time: 6.5 min; sample solution: 510 mg dissolved in 12 mL of methanol; injection volume: 2 mL ) to give the first eluting isomer (Example 44A, RT 1: 1.66 min, 100.5 mg, 0.127 mmol, 98.59%, 16.79% yield) as an off-white solid. Obtained; LCMS (M+H) = 969.7; Retention time (0.1% TFA) = 2.76 minutes; HPLC: Retention time (10mM NH 4 HCO 3 ) = 7.911 minutes; 1 H NMR (400 MHz, DMSO) δ 8.24 (d, J = 8.9 Hz, 1H), 7.85 (s, 2H), 7.35-7.07 (m, 8H), 7.02 (d, J = 8.4 Hz, 2H), 6.23 (dd, J = 7.5 , 4.9 Hz, 1H), 6.14-6.00 (m, 1H), 5.74 (d, J = 5.6 Hz, 1H), 4.52 (dd, J = 12.6, 7.2 Hz, 1H), 3.89 (dddd, J = 42.6, 35.9, 14.2, 9.5 Hz, 5H), 3.63 (d, J = 8.9 Hz, 1H), 2.99-2.85 (m, 1H), 2.84-2.63 (m, 2H), 2.18 (dd, J = 18.2, 10.0 Hz , 2H), 1.50 (dd, J = 15.5, 7.8 Hz, 2H), 1.38-1.28 (m, 4H), 1.18 (d, J = 15.8 Hz, 13H), the second eluting isomer (Example 44B , RT2: 2.77 min, 85.5 mg, 0.107 mmol, 97.28%, yield: 14.10%) was obtained as an off-white solid; LCMS (M+H) = 969.7; retention time ( 0.1% TFA) = 2.75 minutes; HPLC: retention time (10mM NH 4 HCO 3 ) = 7.876 minutes; 1 H NMR (400 MHz, DMSO) δ 8.20 (s, 1H), 7.85 (s, 2H), 7.29-7.16 (m, 5H), 7.11 (dd, J = 7.2, 3.2 Hz, 3H), 6.98 (d, J = 8.5 Hz, 2H), 6.28 (dd, J = 7.2, 5.2 Hz, 1H ), 6.20-6.06 (m, 1H), 5.78 (d, J = 5.5 Hz, 1H), 4.54 (dd, J = 12.5, 6.8 Hz, 1H), 4.11-3.92 (m, 2H), 3.95-3.79 ( m, 3H), 3.66 (s, 1H), 2.88 (d, J = 7.1 Hz, 1H), 2.80 (dd, J = 13.5, 7.9 Hz, 1H), 2.75-2.64 (m, 1H), 2.19 (s , 2H), 1.56-1.42 (m, 2H), 1.35 (d, J = 6.8 Hz, 4H), 1.27-1.07 (m, 13H).

工程5:7,7,8,8,9,9,10,10,11,11,12,12,12-トリデカフルオロドデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
7,7,8,8,9,9,10,10,11,11,12,12,12-トリデカフルオロドデシルL-フェニルアラニナート(5804mg、10.23mmol)及びトリエチルアミン(3.56mL、25.6mmol)のDCM(60mL)冷(氷水浴)溶液に、窒素雰囲気下でフェニルホスホロジクロリデート(5396mg、25.6mmol)のDCM(60mL)滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(3000mg、10.23mmol)のTHF(60mL)/ピリジン(30mL)冷(氷水浴)溶液に、tert-ブチルマグネシウムクロリド(25.6mL、25.6mmol)を窒素雰囲気下で滴下し、次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは、反応の完了を示した。NHCl溶液を残留物に加えてpHを7に調整し、有機層を分離し、水層をDCM(300mL)で抽出した。合わせた有機層を0.5N HCl(100mL、3回)及びブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(0~5% MeOH/DCM)によって精製して、7,7,8,8,9,9,10,10,11,11,12,12,12-トリデカフルオロドデシル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(462mg、0.463mmol、収率4.52%)を得た。LCMS(M+H)=999.0;保持時間(0.1% TFA)=2.03分。ジアステレオマーを分取SFC(装置:SFC-80(Thar、Waters)、カラム:IG 20×250mm、10μm(Daicel)、カラム温度:40℃、移動相:CO/IPA(0.2%アンモニア/メタノール)=55/45;流速:80g/分;背圧:100バール;検出波長:260nm;サイクル時間:6分)により分離して、最初に溶出する異性体(実施例45A、1.46分、134.2mg、0.134mmol、100%、収率16.79%)オフホワイトの固体として得;LCMS(M+H)=999.7;保持時間(0.1% TFA)=2.60分;HPLC:保持時間(0.05% TFA)=12.070分;1HNMR (400 MHz, DMSO) δ 8.20 (s, 1H), 8.00- 7.71 (m, 2H), 7.32- 6.84 (m, 10H), 6.35- 6.22 (m, 1H), 6.21- 6.05 (m, 1H), 5.87- 5.74 (m, 1H), 4.62- 4.43 (m, 1H), 4.08- 3.95 (m, 2H), 3.95- 3.78 (m, 3H), 3.66 (s, 1H), 2.95- 2.61 (m, 3H), 2.30- 2.00 (m, 2H), 1.50- 1.02 (m, 9H)、2番目に溶出する異性体(実施例45B、RT2:2.15分、155.1mg、0.155mmol、100%、収率14.10%)をオフホワイトの固体として得た;LCMS(M+H)=999.7;保持時間(0.1% TFA)=2.60分;HPLC:保持時間(0.05% TFA)=12.048分;1H NMR (400 MHz, DMSO) δ 8.20 (s, 1H), 8.00-7.74 (m, 2H), 7.32- 6.71 (m, 10H), 6.28 (dd, J = 7.4,5.1 Hz, 1H), 6.14 (dd, J = 13.0, 10.4 Hz, 1H), 5.79 (d,J = 5.5 Hz, 1H), 4.55 (d, J = 5.7 Hz, 1H), 4.09-3.96 (m, 2H), 3.92- 3.81 (m, 3H), 3.66 (s, 1H), 2.78 (ddd,J = 50.3, 17.6, 6.9 Hz, 3H), 2.15 (d, J = 8.1Hz,2H), 1.58- 1.02 (m, 9H)。
Step 5: 7,7,8,8,9,9,10,10,11,11,12,12,12-tridecafluorododecyl (((2R,3S,5R)-5-(6-amino -2-Fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate 7,7,8,8,9, 9,10,10,11,11,12,12,12-tridecafluorododecyl L-phenylalaninate (5804 mg, 10.23 mmol) and triethylamine (3.56 mL, 25.6 mmol) in cold DCM (60 mL) To the ice-water bath solution was added phenylphosphorodichloridate (5396 mg, 25.6 mmol) in DCM (60 mL) dropwise under nitrogen atmosphere, and then the reaction mixture was stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (3000mg, 10.23mmol) To a cold (ice-water bath) solution of THF (60 mL)/pyridine (30 mL) was added tert-butylmagnesium chloride (25.6 mL, 25.6 mmol) dropwise under a nitrogen atmosphere, and the mixture was then stirred at room temperature for 30 min. . The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. NH 4 Cl solution was added to the residue to adjust the pH to 7, the organic layer was separated and the aqueous layer was extracted with DCM (300 mL). The combined organic layers were washed with 0.5N HCl (100 mL, 3 times) and brine, dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (0-5% MeOH/DCM) to give 7,7,8,8,9,9,10,10,11,11,12,12,12-tridecafluorododecyl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl )-L-phenylalaninate (462 mg, 0.463 mmol, yield 4.52%) was obtained. LCMS (M+H) = 999.0; retention time (0.1% TFA) = 2.03 minutes. Diastereomers were separated by preparative SFC (equipment: SFC-80 (Thar, Waters), column: IG 20 x 250 mm, 10 μm (Daicel), column temperature: 40°C, mobile phase: CO 2 /IPA (0.2% ammonia). /methanol) = 55/45; flow rate: 80 g/min; back pressure: 100 bar; detection wavelength: 260 nm; cycle time: 6 min) to separate the first eluting isomer (Example 45A, 1.46 min, 134.2 mg, 0.134 mmol, 100%, yield 16.79%) obtained as an off-white solid; LCMS (M+H) = 999.7; retention time (0.1% TFA) = 2.60 min ; HPLC: Retention time (0.05% TFA) = 12.070 minutes; 1 HNMR (400 MHz, DMSO) δ 8.20 (s, 1H), 8.00- 7.71 (m, 2H), 7.32- 6.84 (m, 10H) ), 6.35- 6.22 (m, 1H), 6.21- 6.05 (m, 1H), 5.87- 5.74 (m, 1H), 4.62- 4.43 (m, 1H), 4.08- 3.95 (m, 2H), 3.95- 3.78 (m, 3H), 3.66 (s, 1H), 2.95- 2.61 (m, 3H), 2.30- 2.00 (m, 2H), 1.50- 1.02 (m, 9H), the second eluting isomer (Example 45B, RT2: 2.15 min, 155.1 mg, 0.155 mmol, 100%, yield 14.10%) was obtained as an off-white solid; LCMS (M+H) = 999.7; retention time (0. 1% TFA) = 2.60 min; HPLC: Retention time (0.05% TFA) = 12.048 min; 1 H NMR (400 MHz, DMSO) δ 8.20 (s, 1H), 8.00-7.74 (m, 2H), 7.32- 6.71 (m, 10H), 6.28 (dd, J = 7.4,5.1 Hz, 1H), 6.14 (dd, J = 13.0, 10.4 Hz, 1H), 5.79 (d,J = 5.5 Hz, 1H ), 4.55 (d, J = 5.7 Hz, 1H), 4.09-3.96 (m, 2H), 3.92- 3.81 (m, 3H), 3.66 (s, 1H), 2.78 (ddd,J = 50.3, 17.6, 6.9 Hz, 3H), 2.15 (d, J = 8.1Hz,2H), 1.58- 1.02 (m, 9H).

工程5:5,5,6,6,7,7,8,8,8-ノナフルオロオクチル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
5,5,6,6,7,7,8,8,8-ノナフルオロオクチルL-フェニルアラニナート(5.99g、13.63mmol)及びトリエチルアミン(1.900mL、13.63mmol)のDCM(60mL)冷(氷水浴)溶液に、窒素雰囲気下でフェニルホスホロジクロリデート(2.88g、13.63mmol)のDCM(60mL)に滴下し、次いで、反応混合物を室温で1時間撹拌した。(2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-2-(ヒドロキシメチル)テトラヒドロフラン-3-オール(1.997g、6.81mmol)のTHF(40mL)/ピリジン(20mL)冷(氷水浴)溶液に、tert-ブチルマグネシウムクロリド(13.63mL、13.63mmol)を窒素雰囲気下で滴下し、次いで、混合物を室温で30分間撹拌した。最初に調製した混合物を2番目に調製した混合物に室温で滴下し、2時間撹拌した。LCMSは、反応の完了を示した。反応混合物を濾過し、濾液を濃縮した。残留物をDCMで希釈し、水、0.5N HCl(3回)、ブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルカラム(0~5% MeOH/DCM)で精製して、5,5,6,6,7,7,8,8,8-ノナフルオロオクチル((((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(1.2g、1.378mmol、収率20.24%)を得た。LCMS(M+H)=871.7;保持時間(0.1% TFA)=1.85分。ジアステレオマーを分取SFC(装置:SFC-80(Thar、Waters)、カラム:OZ 20×250mm、10μm(Daicel)、カラム温度:40℃、移動相:CO/MEOH(0.2%アンモニア/メタノール)=70/30;流速:80g/分;背圧:100バール;検出波長:260nm;サイクル時間:6分)により分離して、最初に溶出する異性体(実施例46A、RT1:2.07分、100.0mg、0.114mmol、98.71%、収率16.79%)をオフホワイトの固体として得;LCMS(M+H)=871.7;保持時間(0.1% TFA)=1.85分;HPLC:保持時間(0.05% TFA)=10.761分;1H NMR (400 MHz, DMSO) δ 8.20 (s, 1H), 8.00-7.74 (m, 2H), 7.32- 6.71 (m, 10H), 6.28 (dd, J = 7.4, 5.1 Hz, 1H), 6.14 (dd, J = 13.0, 10.4 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.55 (d, J = 5.7 Hz, 1H), 4.09 - 3.96 (m, 2H), 3.92- 3.81 (m, 3H), 3.66 (s, 1H), 2.78 (ddd, J = 50.3, 17.6, 6.9 Hz, 3H), 2.15 (d, J = 8.1 Hz, 2H), 1.58 -1.02 (m, 9H)、二番目に溶出する異性体(実施例46B、RT2:2.96分、148.0mg、0.169mmol、98.1%、収率14.10%)をオフホワイトの固体として得た;LCMS(M+H)=871.7;保持時間(0.1% TFA)=2.35分;HPLC:保持時間(0.05% TFA)=10.79分;1H NMR (400 MHz, DMSO). HPLC: Retention time (0.05% TFA) = 10.769 min. δ 8.20 (s, 1H), 8.00- 7.74 (m, 2H), 7.32- 6.71 (m, 10H), 6.28 (dd, J = 7.4, 5.1 Hz, 1H), 6.14 (dd, J = 13.0, 10.4 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.55 (d, J = 5.7 Hz, 1H), 4.09- 3.96 (m, 2H), 3.92- 3.81 (m, 3H), 3.66 (s, 1H), 2.78 (ddd, J = 50.3, 17.6, 6.9 Hz, 3H), 2.15 (d, J = 8.1 Hz, 2H), 1.58- 1.02 (m, 9H)。
Step 5: 5,5,6,6,7,7,8,8,8-nonafluorooctyl (((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purine- 9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate 5,5,6,6,7,7,8,8,8-nona Phenylphosphorodichloridate ( 2.88 g, 13.63 mmol) was added dropwise to DCM (60 mL) and the reaction mixture was then stirred at room temperature for 1 h. (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol (1.997 g, 6. To a cold (ice-water bath) solution of 81 mmol) in THF (40 mL)/pyridine (20 mL) was added dropwise tert-butylmagnesium chloride (13.63 mL, 13.63 mmol) under a nitrogen atmosphere, and the mixture was then stirred at room temperature for 30 min. Stirred. The first prepared mixture was added dropwise to the second prepared mixture at room temperature and stirred for 2 hours. LCMS showed the reaction was complete. The reaction mixture was filtered and the filtrate was concentrated. The residue was diluted with DCM, washed with water, 0.5N HCl (3x), brine, dried over Na2SO4 , filtered, and concentrated . The residue was purified on a silica gel column (0-5% MeOH/DCM) to give 5,5,6,6,7,7,8,8,8-nonafluorooctyl (((2R,3S,5R) -5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-phenylalaninate (1. 2 g, 1.378 mmol, yield 20.24%). LCMS (M+H) = 871.7; retention time (0.1% TFA) = 1.85 min. Diastereomers were separated by preparative SFC (equipment: SFC-80 (Thar, Waters), column: OZ 20 x 250 mm, 10 μm (Daicel), column temperature: 40°C, mobile phase: CO 2 /MEOH (0.2% ammonia). /methanol) = 70/30; flow rate: 80 g/min; back pressure: 100 bar; detection wavelength: 260 nm; cycle time: 6 min) to separate the first eluting isomer (Example 46A, RT 1:2 .07 min, 100.0 mg, 0.114 mmol, 98.71%, 16.79% yield) was obtained as an off-white solid; LCMS (M+H) = 871.7; retention time (0.1% TFA) = 1.85 min; HPLC: retention time (0.05% TFA) = 10.761 min; 1 H NMR (400 MHz, DMSO) δ 8.20 (s, 1H), 8.00-7.74 (m, 2H), 7.32 - 6.71 (m, 10H), 6.28 (dd, J = 7.4, 5.1 Hz, 1H), 6.14 (dd, J = 13.0, 10.4 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H), 4.55 ( d, J = 5.7 Hz, 1H), 4.09 - 3.96 (m, 2H), 3.92- 3.81 (m, 3H), 3.66 (s, 1H), 2.78 (ddd, J = 50.3, 17.6, 6.9 Hz, 3H) , 2.15 (d, J = 8.1 Hz, 2H), 1.58 -1.02 (m, 9H), second eluting isomer (Example 46B, RT2: 2.96 min, 148.0 mg, 0.169 mmol, 98 .1%, yield 14.10%) as an off-white solid; LCMS (M+H) = 871.7; retention time (0.1% TFA) = 2.35 min; HPLC: retention time (0.1%, yield 14.10%) as an off-white solid; .05% TFA) = 10.7 6 9 minutes; 1 H NMR (400 MHz, DMSO). HPLC: Retention time (0.05% TFA) = 10.769 min. δ 8.20 (s, 1H), 8.00- 7.74 (m, 2H), 7.32- 6.71 (m, 10H), 6.28 (dd, J = 7.4, 5.1 Hz, 1H), 6.14 (dd, J = 13.0, 10.4 Hz, 1H), 5.79 (d, J = 5.5 Hz, 1H ), 4.55 (d, J = 5.7 Hz, 1H), 4.09- 3.96 (m, 2H), 3.92- 3.81 (m, 3H), 3.66 (s, 1H), 2.78 (ddd, J = 50.3, 17.6, 6.9 Hz, 3H), 2.15 (d, J = 8.1 Hz, 2H), 1.58- 1.02 (m, 9H).

工程1:ノナデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート
撹拌されている(tert-ブトキシカルボニル)-L-フェニルアラニン(26.6g、100mmol)及びEDC(24.96g、130mmol)のDCM(150mL)混合液に、DMAP(1.224g、10.02mmol)を0℃で加えた。30分後、ノナデカン-1-オール(28.5g、100mmol)を加え、得られた反応混合物を25℃で16時間撹拌した。TLCは、反応が完了したことを示した。反応混合物を水(80mL)で希釈し、DCM(100mL×2)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル:EtOAc=10:1)で精製して、ノナデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(42g、79mmol、収率79%)を黄色の油状物として得た。 1 H NMR (400 MHz, CDCl3) δ 7.30-7.23 (m, 3H), 7.14-7.12 (m, 2H), 4.99-4.97 (m, 1H), 4.57-4.55 (m, 1H), 4.09-4.05 (m, 2H), 3.09-3.06 (t, J = 6.8 Hz, 3H), 1.61-1.55 (t, J = 6.8 Hz, 3H), 1.41 (s, 9H), 1.29 (bs, 30H), 0.86 (t, J = 6.8 Hz, 3H).
Step 1: Nonadecyl(tert-butoxycarbonyl)-L-phenylalaninate Stirring (tert-butoxycarbonyl)-L-phenylalanine (26.6 g, 100 mmol) and EDC (24.96 g, 130 mmol) in DCM (150 mL) ) DMAP (1.224 g, 10.02 mmol) was added to the mixture at 0°C. After 30 minutes, nonadecan-1-ol (28.5 g, 100 mmol) was added and the resulting reaction mixture was stirred at 25° C. for 16 hours. TLC showed the reaction was complete. The reaction mixture was diluted with water (80 mL) and extracted with DCM (100 mL x 2). The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. The residue was purified by silica gel chromatography (petroleum ether:EtOAc=10:1) to give nonadecyl(tert-butoxycarbonyl)-L-phenylalaninate (42 g, 79 mmol, 79% yield) as a yellow oil. Obtained. 1 H NMR (400 MHz, CDCl3) δ 7.30-7.23 (m, 3H), 7.14-7.12 (m, 2H), 4.99-4.97 (m, 1H), 4.57-4.55 (m, 1H), 4.09-4.05 ( m, 2H), 3.09-3.06 (t, J = 6.8 Hz, 3H), 1.61-1.55 (t, J = 6.8 Hz, 3H), 1.41 (s, 9H), 1.29 (bs, 30H), 0.86 (t , J = 6.8 Hz, 3H).

工程3:ノナデシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
撹拌されているノナデシルL-フェニルアラニナート(31g、71.8mmol)の無水DCM(50mL)溶液に、トリエチルアミン(10.9mL、79mmol)を15分かけて-70℃で滴下した。この混合物に、フェニルホスホロジクロリデート(15.00g、71.1mmol)の無水DCM(30mL)溶液を1時間かけて加えた。反応混合物をこの温度で30分間撹拌し、次いで、2時間かけて0℃まで加温し、1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(13.09g、71.1mmol)及びトリエチルアミン(10.98mL、79mmol)のDCM(20mL)溶液を20分かけて加えた。粗混合物を0℃で4時間撹拌した。TLCは、反応が完了したことを示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(50mL)で洗浄した。濾液を減圧下で濃縮し、得られた残留物をTHF(250mL)でトリチュレーションし、固体(トリエチルアミン塩酸塩)を濾別した。ケーキをTHF(2×50mL)で洗浄し、合わせた濾液を減圧下で濃縮した。粗生成物をEtOAc(200mL)でトリチュレーションし、濾過によりノナデシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(20g、21.22mmol、収率29.6%)を白色固体として回収した(31PNMRにより測定して>98% de)。1H NMR (400 MHz, CDCl3) δ 7.41 - 7.27 (m, 2H), 7.25 - 7.15 (m, 5H), 7.15 - 6.98 (m, 3H), 4.43 (d, J = 5.8 Hz, 1H), 4.13 - 3.96 (m, 2H), 3.84 - 3.74 (m, 1H), 3.10 (ddd, J = 20.0, 13.7, 5.8 Hz, 2H), 1.54 (s, 2H), 1.36 - 1.08 (m, 32H), 0.88 (t, J = 6.8 Hz, 3H). 31PNMR (CDCl3, 162 MHz) δ -1.54.
Step 3: Nonadecyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate To a stirred solution of nonadecyl L-phenylalaninate (31 g, 71.8 mmol) in anhydrous DCM (50 mL), Triethylamine ( 10.98 mL, 79 mmol) was added dropwise over 15 minutes at -70°C. To this mixture was added a solution of phenylphosphorodichloridate (15.00 g, 71.1 mmol) in anhydrous DCM (30 mL) over 1 hour. The reaction mixture was stirred at this temperature for 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added a solution of 2,3,4,5,6-pentafluorophenol (13.09 g, 71.1 mmol) and triethylamine (10.98 mL, 79 mmol) in DCM (20 mL) over 20 minutes. The crude mixture was stirred at 0°C for 4 hours. TLC showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (50 mL). The filtrate was concentrated under reduced pressure, the resulting residue was triturated with THF (250 mL), and the solid (triethylamine hydrochloride) was filtered off. The cake was washed with THF (2 x 50 mL) and the combined filtrates were concentrated under reduced pressure. The crude product was triturated with EtOAc (200 mL) and filtered to give nonadecyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate (20 g, 21.22 mmol, 29.6% yield) ) was recovered as a white solid (>98% de as determined by 31 PNMR). 1 H NMR (400 MHz, CDCl3) δ 7.41 - 7.27 (m, 2H), 7.25 - 7.15 (m, 5H), 7.15 - 6.98 (m, 3H), 4.43 (d, J = 5.8 Hz, 1H), 4.13 - 3.96 (m, 2H), 3.84 - 3.74 (m, 1H), 3.10 (ddd, J = 20.0, 13.7, 5.8 Hz, 2H), 1.54 (s, 2H), 1.36 - 1.08 (m, 32H), 0.88 (t, J = 6.8 Hz, 3H). 31 PNMR (CDCl 3 , 162 MHz) δ -1.54.

工程1:ヘンイコシル(tert-ブトキシカルボニル)-L-フェニルアラニナート
撹拌されている(tert-ブトキシカルボニル)-L-フェニルアラニン(5g、18.85mmol)、HOBt(3.82g、28.3mmol)及びEDC(4.34g、22.62mmol)のDCM(150mL)混合液に、TEA(2.63mL、18.85mmol)を0℃で加えた。30分間撹拌した後、ヘンイコサン-1-オール(5.89g、18.85mmol)を加え、得られた反応混合物を25℃で16時間撹拌した。TLCは、反応が完了したことを示した。反応混合物を水(80mL)で希釈し、DCM(100mL×2)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル:EtOAc=10:1)で精製し、ヘンイコシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(6.1g、10.90mmol、収率57.8%)を黄色の油状物として得た。1H NMR (400 MHz, CDCl3) δ 7.30-7.22 (m, 3H), 7.14-7.12 (m, 2H), 4.99-4.97 (m, 1H), 4.57-4.55 (m, 1H), 4.09-4.05 (m, 2H), 3.09-3.06 (t, J = 6.8 Hz, 3H), 1.61-1.55 (t, J = 6.8 Hz, 3H), 1.41 (s, 9H), 1.25 (bs, 32H), 0.85 (t, J = 6.8 Hz, 3H).
Step 1: Henicosyl(tert-butoxycarbonyl)-L-phenylalaninate Stirred (tert-butoxycarbonyl)-L-phenylalanine (5 g, 18.85 mmol), HOBt (3.82 g, 28.3 mmol) and EDC To a mixture of (4.34 g, 22.62 mmol) in DCM (150 mL) was added TEA (2.63 mL, 18.85 mmol) at 0<0>C. After stirring for 30 minutes, henicosan-1-ol (5.89 g, 18.85 mmol) was added and the resulting reaction mixture was stirred at 25° C. for 16 hours. TLC showed the reaction was complete. The reaction mixture was diluted with water (80 mL) and extracted with DCM (100 mL x 2). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (petroleum ether: EtOAc = 10:1) to obtain henicosyl(tert-butoxycarbonyl)-L-phenylalaninate (6.1 g, 10.90 mmol, yield 57.8%). Obtained as a yellow oil. 1 H NMR (400 MHz, CDCl3) δ 7.30-7.22 (m, 3H), 7.14-7.12 (m, 2H), 4.99-4.97 (m, 1H), 4.57-4.55 (m, 1H), 4.09-4.05 ( m, 2H), 3.09-3.06 (t, J = 6.8 Hz, 3H), 1.61-1.55 (t, J = 6.8 Hz, 3H), 1.41 (s, 9H), 1.25 (bs, 32H), 0.85 (t , J = 6.8 Hz, 3H).

工程2:ヘンイコシルL-フェニルアラニナート
撹拌されているヘンイコシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(6.1g、10.90mmol)のDCM(50mL)溶液に、TFA(25mL、324mmol)を0℃で加えた。5分後、混合物を25℃に加温し、2時間撹拌した。TLCは、新たな生成物の存在を示した。反応混合物を濃縮し、残留物を水(50mL)で希釈し、pHを飽和NaCOで8~9に調整し、DCM(50mL×3)で抽出した。合わせた有機相をブライン(80mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(DCM:MeOH=100:0~20:1)により精製して、ヘンイコシルL-フェニルアラニナート(4.56g、9.92mmol、収率91%)を得た。 1 H NMR (400 MHz, CDCl 3 ) δ 7.34 - 7.27 (m, 2H), 7.26 - 7.16 (m, 3H), 4.09 (dd, J = 8.6, 4.8 Hz, 2H), 3.72 (dd, J = 7.8, 5.4 Hz, 1H), 3.08 (dd, J = 13.5, 5.4 Hz, 1H), 2.87 (dd, J = 13.5, 7.8 Hz, 1H), 1.58 (s, 2H), 1.25 (bs, 36H), 0.88 (t, J = 6.8 Hz, 3H).
Step 2: Henicosyl L-phenylalaninate To a stirred solution of henicosyl (tert-butoxycarbonyl)-L-phenylalaninate (6.1 g, 10.90 mmol) in DCM (50 mL) was added TFA (25 mL, 324 mmol) at 0° C. After 5 min, the mixture was warmed to 25° C. and stirred for 2 h. TLC showed the presence of a new product. The reaction mixture was concentrated, the residue was diluted with water (50 mL), the pH was adjusted to 8-9 with saturated Na 2 CO 3 , and extracted with DCM (50 mL×3). The combined organic phase was washed with brine (80 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (DCM:MeOH=100:0-20:1) to give henicosyl L-phenylalaninate (4.56 g, 9.92 mmol, 91% yield). 1H NMR (400 MHz, CDCl3 ) δ 7.34 - 7.27 (m, 2H), 7.26 - 7.16 (m, 3H), 4.09 (dd, J = 8.6, 4.8 Hz, 2H), 3.72 (dd, J = 7.8, 5.4 Hz, 1H), 3.08 (dd, J = 13.5, 5.4 Hz, 1H), 2.87 (dd, J = 13.5, 7.8 Hz, 1H), 1.58 (s, 2H), 1.25 (bs, 36H), 0.88 (t, J = 6.8 Hz, 3H).

工程3:ヘンイコシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
撹拌されているヘンイコシルL-フェニルアラニナート(4.5g、9.79mmol)の無水DCM(50mL)溶液に、トリエチルアミン(1.497mL、10.77mmol)を15分かけて-70℃で滴下した。反応混合物に、フェニルホスホロジクロリデート(2.044g、9.69mmol)の無水DCM(30mL)溶液を1時間かけて加えた。反応混合物を-70℃で30分間撹拌し、次いで、2時間かけて0℃まで加温し、1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(1.784g、9.69mmol)及びトリエチルアミン(1.497mL、10.77mmol)のDCM(20mL)溶液を20分かけて加えた。粗混合物を0℃で4時間撹拌した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(50mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(250mL)でトリチュレーションした。固体トリエチルアミン塩酸塩を濾別した。ケーキをtert-ブチルメチルエーテル(2×50mL)で洗浄し、合わせた濾液を減圧下で濃縮した。粗生成物を20% EtOAcのヘキサン溶液(200mL)でトリチュレーションし、固体を濾過により回収して、ヘンイコシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(2.2g、2.64mmol、収率27.0%)を白色固体として得た(31PNMRにより測定して>94% de)。 1 H NMR (400 MHz, CDCl 3 ) δ 7.35 (t, J = 7.9 Hz, 2H), 7.26 - 7.14 (m, 6H), 7.05 (dd, J = 7.0, 2.4 Hz, 2H), 4.50 - 4.36 (m, 1H), 4.04 (ddd, J = 10.7, 8.7, 4.0 Hz, 2H), 3.87 - 3.76 (m, 1H), 3.10 (ddd, J = 20.0, 13.7, 5.8 Hz, 2H), 1.54 (s, 2H), 1.25 (s, 36H), 0.88 (t, J = 6.8 Hz, 3H). 31 PNMR (CDCl 3 , 162 MHz) δ -1.54.
Step 3: Henicosyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate Stirred solution of henicosyl L-phenylalaninate (4.5 g, 9.79 mmol) in anhydrous DCM (50 mL) To the solution, triethylamine (1.497 mL, 10.77 mmol) was added dropwise at −70° C. over 15 minutes. To the reaction mixture was added a solution of phenylphosphorodichloridate (2.044 g, 9.69 mmol) in anhydrous DCM (30 mL) over 1 hour. The reaction mixture was stirred at -70°C for 30 minutes, then warmed to 0°C over 2 hours and stirred for 1 hour. To this mixture was added a solution of 2,3,4,5,6-pentafluorophenol (1.784 g, 9.69 mmol) and triethylamine (1.497 mL, 10.77 mmol) in DCM (20 mL) over 20 minutes. . The crude mixture was stirred at 0°C for 4 hours. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (50 mL). The filtrate was concentrated under reduced pressure and the residue was triturated with tert-butyl methyl ether (250 mL). Solid triethylamine hydrochloride was filtered off. The cake was washed with tert-butyl methyl ether (2 x 50 mL) and the combined filtrates were concentrated under reduced pressure. The crude product was triturated with 20% EtOAc in hexanes (200 mL) and the solid was collected by filtration to give henicosyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate (2 .2 g, 2.64 mmol, 27.0% yield) was obtained as a white solid (>94% de as determined by 31 PNMR). 1 H NMR (400 MHz, CDCl 3 ) δ 7.35 (t, J = 7.9 Hz, 2H), 7.26 - 7.14 (m, 6H), 7.05 (dd, J = 7.0, 2.4 Hz, 2H), 4.50 - 4.36 ( m, 1H), 4.04 (ddd, J = 10.7, 8.7, 4.0 Hz, 2H), 3.87 - 3.76 (m, 1H), 3.10 (ddd, J = 20.0, 13.7, 5.8 Hz, 2H), 1.54 (s, 2H), 1.25 (s, 36H), 0.88 (t, J = 6.8 Hz, 3H). 31 PNMR (CDCl 3 , 162 MHz) δ -1.54.

工程1:ペンタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(4g、13.28mmol)のDCM(50mL)溶液に、DMAP(0.162g、1.328mmol)及びEDC(3.31g、17.26mmol)を0℃で加えた。30分後、ペンタデカン-1-オール(3.94g、17.26mmol)を加え、得られた反応混合物を25℃で2時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を水(40mL)で希釈し、DCM(2×100mL)で抽出した。合わせた有機層をブライン(40mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮して、ペンタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5.8g、11.33mmol、収率85%)を黄色の油状物として得、これをさらに精製することなく次の工程で使用した。LCMS:(M+Na)=534.2;保持時間(0.1% TFA)=3.19分。
Step 1: Pentadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl)amino) To a solution of -3-(3,5-difluorophenyl)propanoic acid (4 g, 13.28 mmol) in DCM (50 mL) was added DMAP (0.162 g, 1.328 mmol) and EDC (3.31 g, 17.26 mmol). Added at 0°C. After 30 minutes, pentadecane-1-ol (3.94 g, 17.26 mmol) was added and the resulting reaction mixture was stirred at 25° C. for 2 hours. LCMS showed the reaction was complete. The reaction mixture was diluted with water (40 mL) and extracted with DCM (2x100 mL). The combined organic layers were washed with brine (40 mL), dried over Na SO , filtered, and concentrated to give pentadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3, 5- difluorophenyl )propanoate (5.8 g, 11.33 mmol, 85% yield) was obtained as a yellow oil, which was used in the next step without further purification. LCMS: (M+Na) = 534.2; retention time (0.1% TFA) = 3.19 minutes.

工程2:ペンタデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているペンタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5.8g、11.33mmol)のDCM(50mL)溶液に、TFA(15mL、195mmol)を0℃で加えた。得られた反応混合物を25℃で4時間撹拌した。LCMSは、反応が完了したことを示した。反応物を濃縮し、残留物をNaHCO(30mL)で希釈し、DCM(3×80mL)で抽出した。合わせた有機層をブライン(50mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=2/1)で精製して、ペンタデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4.5g、10.93mmol、収率96%)を淡黄色の油状物として得た。LCMS(M+H)=412.4;保持時間(0.05% TFA)=2.01分。
Step 2: Pentadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirred pentadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (5.8 g, 11.33 mmol) in DCM (50 mL) was added TFA (15 mL, 195 mmol) at 0°C. The resulting reaction mixture was stirred at 25°C for 4 hours. LCMS showed the reaction was complete. The reaction was concentrated and the residue was diluted with NaHCO 3 (30 mL) and extracted with DCM (3×80 mL). The combined organic layers were washed with brine (50 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 2/1) to obtain pentadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (4.5 g, 10.93 mmol). , yield 96%) as a pale yellow oil. LCMS (M+H) = 412.4; retention time (0.05% TFA) = 2.01 min.

工程1:ウンデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(5g、16.60mmol)のDCM(80mL)溶液に、DMAP(0.203g、1.660mmol)及びEDC(4.14g、21.57mmol)を0℃で加えた。30分後、ウンデカン-1-オール(3.72g、21.57mmol)を0℃で加え、得られた反応混合物を25℃で4時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を水(50mL)で希釈し、DCM(2×100mL)で抽出した。合わせた有機層をブライン(40mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮して、ウンデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(6.9g、15.15mmol、収率91%)を黄色の固体として得、これをさらに精製することなく次の工程で使用した。LCMS:(M+Na)=478.1;保持時間(0.1% TFA)=2.80分。
Step 1: Undecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl)amino) To a solution of -3-(3,5-difluorophenyl)propanoic acid (5 g, 16.60 mmol) in DCM (80 mL) was added DMAP (0.203 g, 1.660 mmol) and EDC (4.14 g, 21.57 mmol). Added at 0°C. After 30 minutes, undecane-1-ol (3.72 g, 21.57 mmol) was added at 0° C. and the resulting reaction mixture was stirred at 25° C. for 4 hours. LCMS showed the reaction was complete. The reaction mixture was diluted with water (50 mL) and extracted with DCM (2x100 mL). The combined organic layers were washed with brine (40 mL), dried over Na 2 SO 4 , filtered, and concentrated to give undecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3, 5- Difluorophenyl )propanoate (6.9 g, 15.15 mmol, 91% yield) was obtained as a yellow solid, which was used in the next step without further purification. LCMS: (M+Na) = 478.1; retention time (0.1% TFA) = 2.80 minutes.

工程2:ウンデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているウンデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(6.9g、15.15mmol)のDCM(60mL)溶液に、TFA(15mL、195mmol)を0℃で加えた。得られた反応混合物を25℃で4時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を減圧下で濃縮し、残留物をNaHCO(20mL)/水(50mL)で希釈し、DCM(3×100mL)で抽出した。合わせた有機層をブライン(60mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=2/1)で精製して、ウンデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(3.8g、10.52mmol、収率69.4%)を黄色の固体として得た。LCMS(M+H)=356.3;保持時間(0.05% TFA)=1.78分。
Step 2: Undecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate To a stirred solution of undecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl )propanoate (6.9 g, 15.15 mmol) in DCM (60 mL) was added TFA (15 mL, 195 mmol) at 0° C. The resulting reaction mixture was stirred at 25° C. for 4 h. LCMS showed the reaction was complete. The reaction mixture was concentrated under reduced pressure and the residue was diluted with NaHCO 3 (20 mL)/water (50 mL) and extracted with DCM (3×100 mL). The combined organic layers were washed with brine (60 mL), dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate=2/1) to give undecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (3.8 g, 10.52 mmol, 69.4% yield) as a yellow solid: LCMS (M+H)=356.3; retention time (0.05% TFA)=1.78 min.

工程1:トリデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(4g、13.28mmol)のDCM(60mL)溶液に、DMAP(0.162g、1.328mmol)及びEDC(3.31g、17.26mmol)を0℃で加えた。30分後、トリデカン-1-オール(3.46g、17.26mmol)を加え、得られた反応混合物を25℃で4時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を水(50mL)で希釈し、DCM(2×100mL)で抽出した。合わせた有機相をブライン(40mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮して、トリデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5.7g、11.79mmol、収率89%)を黄色の固体として得、これをさらに精製することなく次の工程で使用した。LCMS:(M+Na)=506.2;保持時間(0.1% TFA)=3.15分。
Step 1: Tridecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl)amino) To a solution of -3-(3,5-difluorophenyl)propanoic acid (4 g, 13.28 mmol) in DCM (60 mL) was added DMAP (0.162 g, 1.328 mmol) and EDC (3.31 g, 17.26 mmol). Added at 0°C. After 30 minutes, tridecane-1-ol (3.46 g, 17.26 mmol) was added and the resulting reaction mixture was stirred at 25° C. for 4 hours. LCMS showed the reaction was complete. The reaction mixture was diluted with water (50 mL) and extracted with DCM (2x100 mL). The combined organic phases were washed with brine (40 mL), dried over Na SO , filtered, concentrated to give tridecyl(S)-2-((tert-butoxycarbonyl)amino)-3-(3, 5- difluorophenyl )propanoate (5.7 g, 11.79 mmol, 89% yield) was obtained as a yellow solid, which was used in the next step without further purification. LCMS: (M+Na) = 506.2; retention time (0.1% TFA) = 3.15 minutes.

工程2:トリデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているトリデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5.7g、11.79mmol)のDCM(50mL)溶液に、TFA(12mL、156mmol)を0℃で滴下した。得られた反応混合物を25℃で4時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を減圧下で濃縮した。残留物をNaHCO(20mL)/水(50mL)で希釈し、DCM(3×100mL)で抽出した。合わせた有機層をブライン(60mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=2/1)で精製して、トリデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(2.6g、6.56mmol、収率55.7%)を淡黄色の固体として得た。LCMS(M+H)=384.4;保持時間(0.05% TFA)=1.88分。
Step 2: Tridecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirring tridecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (5.7 g, 11.79 mmol) in DCM (50 mL) was added TFA (12 mL, 156 mmol) dropwise at 0°C. The resulting reaction mixture was stirred at 25°C for 4 hours. LCMS showed the reaction was complete. The reaction mixture was concentrated under reduced pressure. The residue was diluted with NaHCO 3 (20 mL)/water (50 mL) and extracted with DCM (3×100 mL). The combined organic layers were washed with brine (60 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 2/1) to obtain tridecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (2.6 g, 6.56 mmol). , yield 55.7%) as a pale yellow solid. LCMS (M+H) = 384.4; retention time (0.05% TFA) = 1.88 min.

工程3:トリデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート
撹拌されているトリデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(2.6g、6.78mmol)のDCM(60mL)溶液に、トリエチルアミン(1.037mL、7.46mmol)を-70℃で滴下した。この混合物に、フェニルホスホロジクロリデート(1.416g、6.71mmol)の無水DCM(10mL)溶液を滴下した。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(1.248g、6.78mmol)及びトリエチルアミン(1.037mL、7.46mmol)のDCM(15mL)溶液を滴下した。得られた混合物を0℃で4時間撹拌した。LCMSは、反応が完了したことを示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(1×10mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(tert-butyl mether ether)(120mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(tert-butyl mether ether)(2×30mL)で洗浄し、濾液を減圧下で濃縮した。残留物を15% EtOAcのヘキサン溶液(50mL)でトリチュレーションし、固体を濾過により回収して、トリデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(1.1g、1.559mmol、収率22.99%)を白色固体として得た(31PNMRで測定して、>98% de)。LCMS(M+H)=706.3;保持時間(0.05% TFA)=3.40分。31P NMR (CDCl3, 162 MHz) δ -1.58.
Step 3: Tridecyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate Stirring tridecyl(S)-2- To a solution of amino-3-(3,5-difluorophenyl)propanoate (2.6 g, 6.78 mmol) in DCM (60 mL) was added triethylamine (1.037 mL, 7.46 mmol) dropwise at -70°C. To this mixture was added dropwise a solution of phenylphosphorodichloridate (1.416 g, 6.71 mmol) in anhydrous DCM (10 mL). The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added dropwise a solution of 2,3,4,5,6-pentafluorophenol (1.248 g, 6.78 mmol) and triethylamine (1.037 mL, 7.46 mmol) in DCM (15 mL). The resulting mixture was stirred at 0°C for 4 hours. LCMS showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (1 x 10 mL). The filtrate was concentrated under reduced pressure, the residue was triturated with tert-butyl methyl ether (120 mL) , and triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (2 x 30 mL) and the filtrate was concentrated under reduced pressure. The residue was triturated with 15% EtOAc in hexane (50 mL) and the solid was collected by filtration to give tridecyl(S)-3-(3,5-difluorophenyl)-2-(((S)- (Perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (1.1 g, 1.559 mmol, 22.99% yield) was obtained as a white solid (>98% de as determined by 31 PNMR). LCMS (M+H) = 706.3; retention time (0.05% TFA) = 3.40 minutes. 31P NMR (CDCl 3 , 162 MHz) δ -1.58.

工程1:ヘプタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(4g、13.28mmol)のDCM(80mL)溶液に、DMAP(0.162g、1.328mmol)及びEDC(3.31g、17.26mmol)を0℃で加えた。30分後、ヘプタデカン-1-オール(4.43g、17.26mmol)を加え、得られた反応混合物を25℃で16時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を水(50mL)で希釈し、DCM(2×100mL)で抽出した。合わせた有機層をブライン(50mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮して、ヘプタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(6.3g、11.67mmol、収率88%)を黄色の固体として得、これをさらに精製することなく次の工程で使用した。LCMS:(M+Na)=563.2;保持時間(0.1% TFA)=4.62分。
Step 1: Heptadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl)amino) To a solution of -3-(3,5-difluorophenyl)propanoic acid (4 g, 13.28 mmol) in DCM (80 mL) was added DMAP (0.162 g, 1.328 mmol) and EDC (3.31 g, 17.26 mmol). Added at 0°C. After 30 minutes, heptadecan-1-ol (4.43 g, 17.26 mmol) was added and the resulting reaction mixture was stirred at 25° C. for 16 hours. LCMS showed the reaction was complete. The reaction mixture was diluted with water (50 mL) and extracted with DCM (2 x 100 mL). The combined organic layers were washed with brine (50 mL), dried over Na SO , filtered , and concentrated to give heptadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3, 5- difluorophenyl )propanoate (6.3 g, 11.67 mmol, 88% yield) was obtained as a yellow solid, which was used in the next step without further purification. LCMS: (M+Na) + =563.2; retention time (0.1% TFA) = 4.62 minutes.

工程2:ヘプタデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているヘプタデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5.8g、10.75mmol)のDCM(100mL)溶液に、TFA(20mL、260mmol)を0℃で滴下した。得られた反応混合物を25℃で4時間撹拌した。LCMSは、反応が完了したことを示した。反応物を濃縮し、残留物をNaHCO(40mL)で中和し、DCM(3×100mL)で抽出した。合わせた有機層をブライン(50mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=1/1)で精製して、ヘプタデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4.4g、10.01mmol、収率93%)を淡黄色の固体として得た。LCMS(M+H)=440.2;保持時間(0.1% TFA)=2.31分。
Step 2: Heptadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirred heptadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (5.8 g, 10.75 mmol) in DCM (100 mL) was added TFA (20 mL, 260 mmol) dropwise at 0°C. The resulting reaction mixture was stirred at 25°C for 4 hours. LCMS showed the reaction was complete. The reaction was concentrated and the residue was neutralized with NaHCO 3 (40 mL) and extracted with DCM (3×100 mL). The combined organic layers were washed with brine (50 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 1/1) to obtain heptadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (4.4 g, 10.01 mmol). , yield 93%) as a pale yellow solid. LCMS (M+H) = 440.2; retention time (0.1% TFA) = 2.31 min.

工程3:ヘプタデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート
撹拌されているヘプタデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4.4g、10.01mmol)のDCM(100mL)溶液に、トリエチルアミン(1.530mL、11.01mmol)を-70℃で滴下した。この混合物に、フェニルホスホロジクロリデート(2.090g、9.91mmol)の無水DCM(10mL)溶液を滴下した。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(1.842g、10.01mmol)及びトリエチルアミン(1.530mL、11.01mmol)のDCM(20mL)溶液を滴下した。粗混合物を0℃で16時間撹拌した。LCMSは、反応が完了したことを示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(1×30mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(tert-butyl mether ether)(200mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(tert-butyl mether ether)(2×20mL)で洗浄し、濾液を減圧下で濃縮した。残留物を15% EtOAcのヘキサン溶液(80mL)でトリチュレーションし、固体を濾過により回収して、ヘプタデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(1.6g、2.100mmol、収率20.99%)を白色固体として得た(31P NMRで測定して、>98% de)。LCMS(M+H)=762.1;保持時間(0.1% TFA)=4.70分。31PNMR (CDCl3, 162 MHz) δ -1.60.
Step 3: Heptadecyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate Stirred heptadecyl (S)-2- To a solution of amino-3-(3,5-difluorophenyl)propanoate (4.4 g, 10.01 mmol) in DCM (100 mL) was added triethylamine (1.530 mL, 11.01 mmol) dropwise at -70°C. To this mixture was added dropwise a solution of phenylphosphorodichloridate (2.090 g, 9.91 mmol) in anhydrous DCM (10 mL). The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added dropwise a solution of 2,3,4,5,6-pentafluorophenol (1.842 g, 10.01 mmol) and triethylamine (1.530 mL, 11.01 mmol) in DCM (20 mL). The crude mixture was stirred at 0°C for 16 hours. LCMS showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (1 x 30 mL). The filtrate was concentrated under reduced pressure, the residue was triturated with tert-butyl methyl ether (200 mL) , and triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (2 x 20 mL) and the filtrate was concentrated under reduced pressure. The residue was triturated with 15% EtOAc in hexane (80 mL) and the solid was collected by filtration to give heptadecyl (S)-3-(3,5-difluorophenyl)-2-(((S)- (Perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (1.6 g, 2.100 mmol, 20.99% yield) was obtained as a white solid (>98% de as determined by 31 P NMR). LCMS (M+H) = 762.1; retention time (0.1% TFA) = 4.70 minutes. 31 PNMR (CDCl 3 , 162 MHz) δ -1.60.

工程1:ドデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(5g、16.60mmol)、ドデカン-1-オール(3.09g、16.60mmol)及びEDC(4.14g、21.57mmol)のDCM(50mL)溶液に、N,N-ジメチルピリジン-4-アミン(2.027g、16.60mmol)を0℃で加えた。得られた反応混合物を25℃で16時間撹拌した。LCMSは、反応が完了したことを示した。混合物を水(80mL)で希釈し、DCM(100mL)で2回抽出した。合わせた有機相をブライン(100mL)で2回洗浄し、NaSOで乾燥させ、濃縮して、ドデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5.6g、11.92mmol、収率71.9%)を白色固体として得、これをさらに精製することなく次の工程で使用した。LCMS(M+Na)=492.1;保持時間(0.1% TFA)=2.954。
Step 1: Dodecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate stirred (S)-2-((tert-butoxycarbonyl)amino) -3-(3,5-difluorophenyl)propanoic acid (5 g, 16.60 mmol), dodecan-1-ol (3.09 g, 16.60 mmol) and EDC (4.14 g, 21.57 mmol) in DCM (50 mL) ) To the solution was added N,N-dimethylpyridin-4-amine (2.027 g, 16.60 mmol) at 0°C. The resulting reaction mixture was stirred at 25°C for 16 hours. LCMS showed the reaction was complete. The mixture was diluted with water (80 mL) and extracted twice with DCM (100 mL). The combined organic phases were washed twice with brine (100 mL), dried over Na SO and concentrated to give dodecyl(S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (5.6 g, 11.92 mmol, 71.9% yield) was obtained as a white solid, which was used in the next step without further purification. LCMS (M+Na) = 492.1; retention time (0.1% TFA) = 2.954.

工程2:ドデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているドデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5.6g、11.92mmol)のDCM(50mL)溶液に、TFA(10mL)を0℃で加えた。混合物を室温で16時間撹拌した。LCMSは、反応が完了したことを示した。混合物を真空下で濃縮して、DCM及びTFAの大部分を除去した。氷水(20mL)を加え、pHをNaHCO水溶液で7に調整し、EtOAc(50mL×2)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮した。粗生成物をフラッシュクロマトグラフィー(シリカゲル、80g、石油エーテル:EtOAc=3:1)により精製して、ドデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4g、7.01mmol、収率58.8%)を白色固体として得た。LCMS(M+H)=370.1;保持時間(0.1% TFA)=1.965。
Step 2: Dodecyl (S)-2-amino-3-(3,5-difluorophenyl) propanoate Dodecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (5.6 g, 11.92 mmol) in DCM (50 mL) was added TFA (10 mL) at 0°C. The mixture was stirred at room temperature for 16 hours. LCMS showed the reaction was complete. The mixture was concentrated under vacuum to remove most of the DCM and TFA. Ice water (20 mL) was added, pH was adjusted to 7 with aqueous NaHCO3 , and extracted with EtOAc (50 mL x 2). The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. The crude product was purified by flash chromatography (silica gel, 80 g, petroleum ether:EtOAc=3:1) to give dodecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (4 g, 7 .01 mmol, yield 58.8%) was obtained as a white solid. LCMS (M+H) = 370.1; Retention time (0.1% TFA) = 1.965.

工程3:ドデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート
撹拌されているドデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4g、10.83mmol)のDCM(50mL)溶液に、トリエチルアミン(1.580mL、11.37mmol)を-70℃で15分かけて滴下した。この混合物に、フェニルホスホロジクロリデート(2.261g、10.72mmol)の無水DCM(35mL)溶液を30分かけて滴下した。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(1.973g、10.72mmol)及びトリエチルアミン(1.655mL、11.91mmol)のDCM(30mL)溶液を20分かけて加えた。LCMSは反応の完了を示した。粗混合物を0℃で4時間撹拌し、白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(250mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(tert-butyl mether ether)(150mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(tert-butyl mether ether)(100mL)で洗浄し、濾液を濃縮した。固体を石油エーテル:EtOAc=5:1(20:4mL)でトリチュレーションし、濾過して、石油エーテル:EtOAc=5:1(40:8mL)で洗浄して、ドデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(700mg、1.012mmol、収率9.35%)を白色固体として得た(31PNMRで測定して、>98% de)。LCMS(M+H)=691.0;保持時間(10mM NHHCO)=3.010分。1H NMR (400 MHz, DMSO) δ 7.31 (t, J = 7.9 Hz, 2H), 7.18 (t, J = 7.3 Hz, 1H), 7.03-6.99 (m, 3H), 6.94 (t, J = 6.4 Hz, 2H), 4.15 (qd, J = 10.3, 5.5 Hz, 1H), 4.00 (t, J = 6.4 Hz, 2H), 3.09-3.00 (m, 1H), 2.85 (dd, J = 13.7, 9.7 Hz, 1H), 1.47 (d, J = 7.0 Hz, 2H), 1.21 (t, J = 12.7 Hz, 18H), 0.83 (t, J = 6.8 Hz, 3H). 31PNMR (DMSO-d6, 162 MHz) δ 0.21.
Step 3: Dodecyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate Stirred dodecyl(S)-2- To a solution of amino-3-(3,5-difluorophenyl)propanoate (4 g, 10.83 mmol) in DCM (50 mL) was added triethylamine (1.580 mL, 11.37 mmol) dropwise at −70° C. over 15 minutes. To this mixture was added a solution of phenylphosphorodichloridate (2.261 g, 10.72 mmol) in anhydrous DCM (35 mL) dropwise over 30 minutes. The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added a solution of 2,3,4,5,6-pentafluorophenol (1.973 g, 10.72 mmol) and triethylamine (1.655 mL, 11.91 mmol) in DCM (30 mL) over 20 minutes. . LCMS showed the reaction was complete. The crude mixture was stirred at 0° C. for 4 hours and the white solid (triethylamine hydrochloride) was filtered off and washed with DCM (250 mL). The filtrate was concentrated under reduced pressure, the residue was triturated with tert-butyl methyl ether (150 mL) , and triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (100 mL) and the filtrate was concentrated. The solid was triturated with petroleum ether:EtOAc=5:1 (20:4 mL), filtered, and washed with petroleum ether:EtOAc=5:1 (40:8 mL) to give dodecyl(S)-3- (3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (700 mg, 1.012 mmol, yield 9.35%) was obtained as a white solid ( >98% de) as determined by 31 PNMR. LCMS (M+H) = 691.0; retention time ( 10mM NH4HCO3 ) = 3.010 minutes. 1 H NMR (400 MHz, DMSO) δ 7.31 (t, J = 7.9 Hz, 2H), 7.18 (t, J = 7.3 Hz, 1H), 7.03-6.99 (m, 3H), 6.94 (t, J = 6.4 Hz, 2H), 4.15 (qd, J = 10.3, 5.5 Hz, 1H), 4.00 (t, J = 6.4 Hz, 2H), 3.09-3.00 (m, 1H), 2.85 (dd, J = 13.7, 9.7 Hz , 1H), 1.47 (d, J = 7.0 Hz, 2H), 1.21 (t, J = 12.7 Hz, 18H), 0.83 (t, J = 6.8 Hz, 3H). 31 PNMR (DMSO-d6, 162 MHz) δ 0.21.

工程1:ノナデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(5g、16.60mmol)、ノナデカン-1-オール(4.72g、16.60mmol)のDCM(50mL)溶液に、EDC(4.14g、21.57mmol)及びN,N-ジメチルピリジン-4-アミン(2.027g、16.60mmol)を0℃で加えた。得られた反応混合物を25℃で16時間撹拌した。TLCは、反応が完了したことを示した。混合物を真空下で濃縮し、残留物をEtOAc(50mL)に入れ、水(30mL)で洗浄した。水層をEtOAc(30mL×2)で逆抽出し、合わせた有機相をブライン(80mL)で2回洗浄し、NaSOで乾燥させ、濃縮して、ノナデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5g、8.81mmol、収率53.1%)を白色固体として得、これをさらに精製することなく次の工程で使用した。LCMS(M+Na)=none;保持時間(0.1% TFA)=none。
Step 1: Nonadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl)amino) To a solution of -3-(3,5-difluorophenyl)propanoic acid (5 g, 16.60 mmol) and nonadecan-1-ol (4.72 g, 16.60 mmol) in DCM (50 mL) was added EDC (4.14 g, 21 .57 mmol) and N,N-dimethylpyridin-4-amine (2.027 g, 16.60 mmol) were added at 0°C. The resulting reaction mixture was stirred at 25°C for 16 hours. TLC showed the reaction was complete. The mixture was concentrated under vacuum and the residue was taken up in EtOAc (50 mL) and washed with water (30 mL). The aqueous layer was back-extracted with EtOAc (30 mL x 2) and the combined organic phases were washed twice with brine (80 mL), dried over Na 2 SO 4 and concentrated to obtain nonadecyl (S)-2-(( tert-Butoxycarbonyl)amino)-3-(3,5- difluorophenyl )propanoate (5 g, 8.81 mmol, 53.1% yield) was obtained as a white solid, which was carried on to the next step without further purification. It was used in LCMS (M+Na) = none; retention time (0.1% TFA) = none.

工程2:ノナデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているノナデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(5g、8.81mmol)のDCM(50mL)溶液に、TFA(10mL)を0℃で加えた。混合物を25℃で16時間撹拌した。LCMSは、反応が完了したことを示した。混合物を真空下で濃縮して、DCM及びTFAの大部分を除去した。残留物を氷水(20mL)で希釈し、pHをNaHCO水溶液で7に調整し、EtOAc(50mL×2)で抽出した。合わせた有機相をブライン(50mL)で洗浄し、NaSOで乾燥させ、濃縮した。粗生成物をフラッシュクロマトグラフィー(シリカゲル、80g、石油エーテル:EtOAc=3:1)により精製して、ノナデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(3.6g、7.70mmol、収率87%)を白色固体として得た。LCMS(M+H)=468.1;保持時間(0.1% TFA)=2.387。
Step 2: Nonadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirred nonadecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (5 g, 8.81 mmol) in DCM (50 mL) was added TFA (10 mL) at 0°C. The mixture was stirred at 25°C for 16 hours. LCMS showed the reaction was complete. The mixture was concentrated under vacuum to remove most of the DCM and TFA. The residue was diluted with ice water (20 mL), the pH was adjusted to 7 with aqueous NaHCO3 , and extracted with EtOAc (50 mL x 2). The combined organic phases were washed with brine (50 mL), dried over Na 2 SO 4 and concentrated. The crude product was purified by flash chromatography (silica gel, 80 g, petroleum ether:EtOAc=3:1) to give nonadecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (3.6 g , 7.70 mmol, yield 87%) was obtained as a white solid. LCMS (M+H) = 468.1; Retention time (0.1% TFA) = 2.387.

工程3:ノナデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート
撹拌されているノナデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(3g、6.41mmol)のDCM(50mL)溶液に、トリエチルアミン(0.936mL、6.74mmol)を-70℃で15分かけて滴下した。この混合物に、フェニルホスホロジクロリデート(1.340g、6.35mmol)の無水DCM(35mL)溶液を30分かけて滴下した。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(1.169g、6.35mmol)及びトリエチルアミン(0.981mL、7.06mmol)のDCM(30mL)溶液を20分かけて加え、0℃で4時間撹拌した。LCMSは反応の完了を示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(250mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(tert-butyl mether ether)(150mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(tert-butyl mether ether)(100mL)で洗浄した。固体を石油エーテル:EtOAc=5:1(25:5mL)でトリチュレーションし、濾過して、石油エーテル:EtOAc=5:1(40:8mL)で洗浄して、ノナデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(1.1g、1.393mmol、収率21.71%)を白色固体として得た(31PNMRで測定して、>98% de)。1H NMR (400 MHz, DMSO) δ 7.24 (d, J = 53.4 Hz, 3H), 6.97 (d, J = 27.4 Hz, 5H), 3.99 (s, 2H), 3.07 (s, 2H), 2.86 (s, 1H), 1.48 (s, 2H), 1.21 (s, 32H), 0.84 (s, 3H). 31PNMR (DMSO-d6, 162 MHz) δ 0.16.
Step 3: Nonadecyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate Stirred nonadecyl (S)-2- To a solution of amino-3-(3,5-difluorophenyl)propanoate (3 g, 6.41 mmol) in DCM (50 mL) was added triethylamine (0.936 mL, 6.74 mmol) dropwise at −70° C. over 15 minutes. To this mixture was added a solution of phenylphosphorodichloridate (1.340 g, 6.35 mmol) in anhydrous DCM (35 mL) dropwise over 30 minutes. The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added a solution of 2,3,4,5,6-pentafluorophenol (1.169 g, 6.35 mmol) and triethylamine (0.981 mL, 7.06 mmol) in DCM (30 mL) over 20 min. Stirred at 0°C for 4 hours. LCMS showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (250 mL). The filtrate was concentrated under reduced pressure, the residue was triturated with tert-butyl methyl ether (150 mL) , and triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (100 mL). The solid was triturated with petroleum ether:EtOAc=5:1 (25:5 mL), filtered and washed with petroleum ether:EtOAc=5:1 (40:8 mL) to obtain nonadecyl(S)-3- (3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (1.1 g, 1.393 mmol, yield 21.71%) was obtained as a white solid. (>98% de as determined by 31 PNMR). 1 H NMR (400 MHz, DMSO) δ 7.24 (d, J = 53.4 Hz, 3H), 6.97 (d, J = 27.4 Hz, 5H), 3.99 (s, 2H), 3.07 (s, 2H), 2.86 ( 31 PNMR (DMSO-d6, 162 MHz) δ 0.16.

工程1:テトラデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(5g、16.60mmol)のDCM(10mL)混合液に、DMAP(0.203g、1.660mmol)、テトラデカン-1-オール(4.63g、21.60mmol)及びEDC(4.14g、21.61mmol)のDCM(40mL)溶液を0℃で加えた。混合物を室温で2時間撹拌した。LCMSは新たな生成物の存在を示した。反応混合物を水(30mL)で希釈し、DCM(15mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮した。粗生成物をシリカゲルクロマトグラフィー(120g、石油エーテル:EtOAc=30:1)により精製して、テトラデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(7.2g、14.02mmol、収率85%)を白色固体として得た。LCMS(M+Na)=386.1;保持時間(10mM NHHCO)=2.319分。
Step 1: Tetradecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate stirred (S)-2-((tert-butoxycarbonyl)amino) In a mixture of -3-(3,5-difluorophenyl)propanoic acid (5 g, 16.60 mmol) in DCM (10 mL), DMAP (0.203 g, 1.660 mmol), tetradecane-1-ol (4.63 g, 21.60 mmol) and EDC (4.14 g, 21.61 mmol) in DCM (40 mL) were added at 0<0>C. The mixture was stirred at room temperature for 2 hours. LCMS showed the presence of new product. The reaction mixture was diluted with water (30 mL) and extracted with DCM (15 mL x 3). The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated. The crude product was purified by silica gel chromatography (120 g, petroleum ether:EtOAc=30:1) to give tetradecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl). ) Propanoate (7.2 g, 14.02 mmol, 85% yield) was obtained as a white solid. LCMS (M+Na) = 386.1; retention time ( 10mM NH4HCO3 ) = 2.319 minutes.

工程2:テトラデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているテトラデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(7.2g、14.47mmol)のDCM(50mL)溶液に、TFA(11.15mL、145mmol)を加えた。得られた混合物を5℃で3時間撹拌した。LCMSは、反応が完了したことを示した。1M NaOH(1mol/L)でpHを約8に調整し、有機相を分離した。水層をDCM(20mL×2)で抽出した。合わせた有機相を水(30mL×2)、ブライン(30mL×2)で洗浄し、NaSOで乾燥させ、濃縮した。粗生成物をシリカゲルクロマトグラフィー(120g、Santai、DCM:MeOH=10:1)で精製して、テトラデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(3.7g、7.86mmol、収率54.3%)を白色固体として得た。LCMS(M+H)=398.4;保持時間(0.1% TFA)=2.59分。
Step 2: Tetradecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirred tetradecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (7.2 g, 14.47 mmol) in DCM (50 mL) was added TFA (11.15 mL, 145 mmol). The resulting mixture was stirred at 5°C for 3 hours. LCMS showed the reaction was complete. The pH was adjusted to about 8 with 1M NaOH (1 mol/L) and the organic phase was separated. The aqueous layer was extracted with DCM (20 mL x 2). The combined organic phases were washed with water (30 mL x 2), brine (30 mL x 2), dried over Na 2 SO 4 and concentrated. The crude product was purified by silica gel chromatography (120 g, Santai, DCM:MeOH=10:1) to give tetradecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (3.7 g, 7.86 mmol, yield 54.3%) was obtained as a white solid. LCMS (M+H) = 398.4; retention time (0.1% TFA) = 2.59 minutes.

工程3:テトラデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート 撹拌されているテトラデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(3.7g、9.31mmol)の無水DCM(35mL)溶液に、EtN(1.362mL、9.77mmol)を-70℃で15分かけて滴下した。この混合物に、フェニルホスホロジクロリデート(1.944g、9.21mmol)の無水DCM(35mL)溶液を1時間かけて滴下した。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、1時間撹拌した。この混合物に、EtN(1.427mL、10.24mmol)及び2,3,4,5,6-ペンタフルオロフェノール(1.696g、9.21mmol)のDCM(30mL)溶液を20分かけて加えた。反応混合物をこの温度で45分間撹拌した。LCMSは反応が完了したことを示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(1×25mL)で洗浄した。濾液を減圧下で濃縮した。残留物をtert-ブチルメチルエーテル(tert-butyl mether ether)(25mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(tert-butyl mether ether)(25mL)で洗浄し、合わせた濾液を減圧下で濃縮した。粗固体を石油エーテル:EtOAc=5:1(30:6mL)でトリチュレーションし、濾過して、石油エーテル:EtOAc=5:1(40:8mL)で洗浄して、テトラデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(1.2g、1.667mmol、収率17.92%)を白色固体として得た(31PNMRにより測定して>98% de)。LCMS(M+H)=719.1;保持時間(0.1% TFA)=3.57分。31PNMR (CDCl3, 162 MHz) δ -1.60. Step 3: Tetradecyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate Stirring Tetradecyl(S)-2- To a solution of amino-3-(3,5-difluorophenyl)propanoate (3.7 g, 9.31 mmol) in anhydrous DCM (35 mL) was added Et 3 N (1.362 mL, 9.77 mmol) at -70 °C for 15 min. It dripped. To this mixture was added a solution of phenylphosphorodichloridate (1.944 g, 9.21 mmol) in anhydrous DCM (35 mL) dropwise over 1 hour. The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added a solution of Et 3 N (1.427 mL, 10.24 mmol) and 2,3,4,5,6-pentafluorophenol (1.696 g, 9.21 mmol) in DCM (30 mL) over 20 min. added. The reaction mixture was stirred at this temperature for 45 minutes. LCMS showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (1 x 25 mL). The filtrate was concentrated under reduced pressure. The residue was triturated with tert-butyl methyl ether (25 mL) and triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (25 mL) and the combined filtrates were concentrated under reduced pressure. The crude solid was triturated with petroleum ether:EtOAc=5:1 (30:6 mL), filtered, and washed with petroleum ether:EtOAc=5:1 (40:8 mL) to obtain tetradecyl(S)-3. -(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (1.2 g, 1.667 mmol, yield 17.92%) as a white solid. (>98% de as determined by 31 PNMR). LCMS (M+H) = 719.1; retention time (0.1% TFA) = 3.57 minutes. 31 PNMR (CDCl 3 , 162 MHz) δ -1.60.

工程1:ヘンイコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(3.7g、12.28mmol)のDCM(20mL)混合液に、DMAP(0.150g、1.228mmol)を0℃で加え、混合物を0℃で0.5時間撹拌した。ヘンイコサン-1-オール(5.00g、15.98mmol)及びEDC(3.07g、15.9mmol)のDCM(40mL)溶液を0℃で加えた。混合物を室温で2時間撹拌した。LCMSは反応の完了を示した。反応混合物を水(50mL)で希釈し、DCM(30mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮して、ヘンイコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(7g、11.75mmol)を得、これをさらに精製することなく次の工程で使用した。
Step 1: Henicosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl)amino) To a mixture of -3-(3,5-difluorophenyl)propanoic acid (3.7 g, 12.28 mmol) in DCM (20 mL) was added DMAP (0.150 g, 1.228 mmol) at 0 °C, and the mixture was Stirred at ℃ for 0.5 hour. A solution of henicosan -1-ol (5.00 g, 15.98 mmol) and EDC (3.07 g, 15.9 mmol) in DCM (40 mL) was added at 0°C. The mixture was stirred at room temperature for 2 hours. LCMS showed the reaction was complete. The reaction mixture was diluted with water (50 mL) and extracted with DCM (30 mL x 3). The combined organic phases were washed with brine, dried over Na SO and concentrated to give henicosyl ( S )-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl ) . Propanoate (7 g, 11.75 mmol) was obtained which was used in the next step without further purification.

工程2:ヘンイコシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されているヘンイコシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(7g、11.75mmol)のDCM(50mL)溶液に、TFA(9.05mL、117mmol)を加えた。得られた混合物を5℃で2.5時間撹拌した。LCMSは、反応が完了したことを示した。1M NaOHで反応混合物のpHを約8に調整し、有機相を飽和NaCl(50mL)で洗浄し、乾燥させ(NaSO)、濃縮した。粗生成物をシリカゲルクロマトグラフィー(120g、Santai、DCM:MeOH=50:1)で精製して、ヘンイコシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4.4g、8.63mmol、収率73.5%)を油状物として得た。LCMS(M+H)=496.5;保持時間(0.1% TFA)=3.41分。
Step 2: Heneicosyl (S)-2-amino-3-(3,5-difluorophenyl) propanoate Stirred heneicosyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5 -difluorophenyl )propanoate (7 g, 11.75 mmol) in DCM (50 mL) was added TFA (9.05 mL, 117 mmol). The resulting mixture was stirred at 5°C for 2.5 hours. LCMS showed the reaction was complete. The pH of the reaction mixture was adjusted to ~8 with 1M NaOH, and the organic phase was washed with saturated NaCl (50 mL), dried (Na 2 SO 4 ), and concentrated. The crude product was purified by silica gel chromatography (120 g, Santai, DCM:MeOH=50:1) to give heneicosyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (4.4 g, 8.63 mmol, yield 73.5%) was obtained as an oil. LCMS (M+H) = 496.5; retention time (0.1% TFA) = 3.41 min.

工程3:ヘンイコシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート
撹拌されているヘンイコシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4.4g、8.88mmol)の無水DCM(50mL)溶液に、トリエチルアミン(1.299mL、9.32mmol)を-75℃で15分かけて滴下した。この混合物に、フェニルホスホロジクロリデート(1.854g、8.79mmol)の無水DCM(50mL)溶液を1時間かけて滴下した。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、1時間撹拌した。この混合物に、トリエチルアミン(1.361mL、9.76mmol)及び2,3,4,5,6-ペンタフルオロフェノール(1.617g、8.79mmol)のDCM(30mL)溶液を20分かけて加えた。混合物を0℃で16時間撹拌し、室温で1時間撹拌した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(1×25mL)で洗浄した。濾液を減圧下で濃縮した。残留物をtert-ブチルメチルエーテル(tert-butyl mether ether)(50mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(tert-butyl mether ether)(30mL)で洗浄し、合わせた濾液を濃縮した。粗固体を石油エーテル:EtOAc=3:1(30:10mL)でトリチュレーションし、濾過して、石油エーテル:EtOAc=2:1(20:10mL)で洗浄して、ヘンイコシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(1.01g、1.235mmol、収率13.91%)を白色固体として得た(31PNMRで測定して、>98% de)。1H NMR (400 MHz, CDCl3) δ 7.37 (t, J = 7.7 Hz, 2H), 7.22 (d, J = 8.1 Hz, 3H), 6.67 (t, J = 8.9 Hz, 1H), 6.58 (d, J = 6.1 Hz, 2H), 4.47-4.39 (m, 1H), 4.15-4.04 (m, 2H), 3.85 (t, J = 10.4 Hz, 1H), 3.12-3.02 (m, 2H), 1.25 (s, 38H), 0.88 (t, J = 6.6 Hz, 3H). 31PNMR (CDCl3, 162 MHz) δ -1.60.
Step 3: Henicosyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate Stirred Henicosyl(S)-2- To a solution of amino-3-(3,5-difluorophenyl)propanoate (4.4 g, 8.88 mmol) in anhydrous DCM (50 mL) was added triethylamine (1.299 mL, 9.32 mmol) at -75 °C over 15 min. dripped. To this mixture was added a solution of phenylphosphorodichloridate (1.854 g, 8.79 mmol) in anhydrous DCM (50 mL) dropwise over 1 hour. The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added a solution of triethylamine (1.361 mL, 9.76 mmol) and 2,3,4,5,6-pentafluorophenol (1.617 g, 8.79 mmol) in DCM (30 mL) over 20 minutes. . The mixture was stirred at 0° C. for 16 hours and at room temperature for 1 hour. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (1 x 25 mL). The filtrate was concentrated under reduced pressure. The residue was triturated with tert-butyl methyl ether (50 mL) and triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (30 mL) and the combined filtrates were concentrated. The crude solid was triturated with petroleum ether: EtOAc = 3:1 (30:10 mL), filtered, and washed with petroleum ether: EtOAc = 2:1 (20:10 mL) to give henicosyl (S)-3. -(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (1.01 g, 1.235 mmol, yield 13.91%) as a white solid. (>98% de as determined by 31 PNMR). 1 H NMR (400 MHz, CDCl3) δ 7.37 (t, J = 7.7 Hz, 2H), 7.22 (d, J = 8.1 Hz, 3H), 6.67 (t, J = 8.9 Hz, 1H), 6.58 (d, J = 6.1 Hz, 2H), 4.47-4.39 (m, 1H), 4.15-4.04 (m, 2H), 3.85 (t, J = 10.4 Hz, 1H), 3.12-3.02 (m, 2H), 1.25 (s , 38H), 0.88 (t, J = 6.6 Hz, 3H). 31 PNMR (CDCl 3 , 162 MHz) δ -1.60.

工程5:2-ブチルヘキシルL-フェニルアラニナート
撹拌されている2-ブチルヘキシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(8.2g、20.22mmol)のDCM(75mL)溶液に、TFA(20mL、260mmol)を0℃で加えた。5分後、混合物を室温で2時間撹拌した。TLCは、出発物質が消費されたことを示した。反応物を真空中で濃縮して、残留物を得、これに水(100mL)を加え、飽和NaCOでpH8~9に調整した。得られた混合物をDCM(200mL×3)で抽出し、ブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルカラム(DCM:MeOH=100:0\20:1)によって精製して、2-ブチルヘキシルL-フェニルアラニナート(6.0g、19.64mmol、収率97%)を白色固体として得た。1H NMR (400 MHz, CDCl3)δ 7.31 - 7.18 (m, 5H), 4.01 - 3.99 (m, 2H), 3.72 (dt, J = 25.8, 12.9 Hz, 1H), 3.06 (dd, J = 13.5, 5.4 Hz, 1H), 2.88 (dd, J = 13.5, 7.8 Hz, 1H), 1.60-1.51 (br, 2H), 1.28 (d, J = 17.6 Hz, 12H), 0.89 (t, J = 6.7 Hz, 6H).
Step 5: 2-Butylhexyl L-phenylalaninate To a stirred solution of 2-butylhexyl (tert-butoxycarbonyl)-L-phenylalaninate (8.2 g, 20.22 mmol) in DCM (75 mL) was added TFA. (20 mL, 260 mmol) was added at 0°C. After 5 minutes, the mixture was stirred at room temperature for 2 hours. TLC showed starting material was consumed. The reaction was concentrated in vacuo to give a residue, to which water (100 mL) was added and the pH was adjusted to pH 8-9 with saturated Na 2 CO 3 . The resulting mixture was extracted with DCM (200 mL x 3), washed with brine, dried over Na2SO4 , filtered, and concentrated. The residue was purified by silica gel column (DCM:MeOH=100:0\20:1) to give 2- butylhexyl L -phenylalaninate (6.0 g, 19.64 mmol, 97% yield) as a white solid. Obtained. 1 H NMR (400 MHz, CDCl 3 )δ 7.31 - 7.18 (m, 5H), 4.01 - 3.99 (m, 2H), 3.72 (dt, J = 25.8, 12.9 Hz, 1H), 3.06 (dd, J = 13.5 , 5.4 Hz, 1H), 2.88 (dd, J = 13.5, 7.8 Hz, 1H), 1.60-1.51 (br, 2H), 1.28 (d, J = 17.6 Hz, 12H), 0.89 (t, J = 6.7 Hz , 6H).

工程6:2-ブチルヘキシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
撹拌されている2-ブチルヘキシルL-フェニルアラニナート(7.6g、24.88mmol)の無水DCM(50mL)溶液に、トリエチルアミン(3.80mL、27.4mmol)を15分かけて-70℃で滴下した。この混合物に、フェニルホスホロジクロリデート(5.20g、24.63mmol)の無水DCM(30mL)溶液を1時間かけて加えた。反応混合物を-70℃でさらに30分間撹拌し、2時間かけて0℃まで加温し、0℃で1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(4.53g、24.63mmol)及びトリエチルアミン(3.80mL、27.4mmol)のDCM(20mL)溶液を20分かけて加え、0℃で4時間撹拌した。TLCは、反応が完了したことを示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(1×50mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(250mL)でトリチュレーションした。次いで、トリエチルアミン塩酸塩を濾別した。ケーキをtert-ブチルメチルエーテル(2×50mL)で洗浄し、合わせた濾液を濃縮した。粗生成物を5% EtOAcのヘキサン溶液(40mL)でトリチュレーションし、固体を濾過により回収して、2-ブチルヘキシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(2.5g、3.98mmol、収率16.01%)を白色固体として得た(31PNMRにより測定して>98% de)。1H NMR (400 MHz, CDCl3) δ 7.35 (t, J = 7.9 Hz, 2H), 7.25 - 7.11 (m, 6H), 7.04 (dd, J = 7.0, 2.4 Hz, 2H), 4.53 - 4.35 (m, 1H), 3.96 (ddd, J = 36.3, 10.8, 5.7 Hz, 2H), 3.80 - 3.70 (m, 1H), 3.10 (ddd, J = 20.0, 13.7, 5.8 Hz, 2H), 1.54 (s, 1H), 1.33 - 1.11 (m, 12H), 0.88 (t, J = 6.5 Hz, 6H). 31PNMR (CDCl3, 162 MHz) δ -1.53.
Step 6: 2-Butylhexyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate. Stirring of 2-butylhexyl L-phenylalaninate (7.6 g, 24.88 mmol) To a solution of anhydrous DCM (50 mL) was added triethylamine (3.80 mL, 27.4 mmol) dropwise at −70° C. over 15 minutes. To this mixture was added a solution of phenylphosphorodichloridate (5.20 g, 24.63 mmol) in anhydrous DCM (30 mL) over 1 hour. The reaction mixture was stirred at -70°C for an additional 30 minutes, warmed to 0°C over 2 hours, and stirred at 0°C for 1 hour. To this mixture was added a solution of 2,3,4,5,6-pentafluorophenol (4.53 g, 24.63 mmol) and triethylamine (3.80 mL, 27.4 mmol) in DCM (20 mL) over 20 min. Stirred at 0°C for 4 hours. TLC showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (1 x 50 mL). The filtrate was concentrated under reduced pressure and the residue was triturated with tert-butyl methyl ether (250 mL). Triethylamine hydrochloride was then filtered off. The cake was washed with tert-butyl methyl ether (2 x 50 mL) and the combined filtrates were concentrated. The crude product was triturated with 5% EtOAc in hexanes (40 mL) and the solid was collected by filtration to give 2-butylhexyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalanyl. Nato (2.5 g, 3.98 mmol, 16.01% yield) was obtained as a white solid (>98% de as determined by 31 PNMR). 1 H NMR (400 MHz, CDCl 3 ) δ 7.35 (t, J = 7.9 Hz, 2H), 7.25 - 7.11 (m, 6H), 7.04 (dd, J = 7.0, 2.4 Hz, 2H), 4.53 - 4.35 ( m, 1H), 3.96 (ddd, J = 36.3, 10.8, 5.7 Hz, 2H), 3.80 - 3.70 (m, 1H), 3.10 (ddd, J = 20.0, 13.7, 5.8 Hz, 2H), 1.54 (s, 1H), 1.33 - 1.11 (m, 12H), 0.88 (t, J = 6.5 Hz, 6H). 31 PNMR (CDCl 3 , 162 MHz) δ -1.53.

工程1:ジメチル2,2-ジペンチルマロネート
撹拌されている水素化ナトリウム(7.57g、189mmol)のDMF(100mL)懸濁液に、N雰囲気下、0℃でジメチルマロネート(10g、76mmol)を滴下した。30分後、1-ヨードペンタン(37.5g、189mmol)のDMF(30mL)溶液を加え、得られた混合物を室温で16時間撹拌した。反応混合物を水(200mL)でクエンチし、ジエチルエーテル(80mL)で2回抽出した。合わせた有機層を水(100mL×2)及びブライン(100mL×2)で洗浄し、NaSOで乾燥させ、濾過し、真空中でエバポレーションして、ジメチル2,2-ジペンチルマロネート(27g、49.6mmol、収率65.5%)を得、これをさらに精製することなく次の工程に使用した。LCMS(M+H)=273.2、保持時間(0.05% TFA):2.66分。
Step 1: Dimethyl 2,2-dipentyl malonate To a stirred suspension of sodium hydride (7.57 g, 189 mmol) in DMF (100 mL) was added dimethyl malonate (10 g, 76 mmol) at 0 °C under an atmosphere of N2 . ) was added dropwise. After 30 minutes, a solution of 1- iodopentane (37.5 g, 189 mmol) in DMF (30 mL) was added and the resulting mixture was stirred at room temperature for 16 hours. The reaction mixture was quenched with water (200 mL) and extracted twice with diethyl ether (80 mL). The combined organic layers were washed with water (100 mL x 2) and brine (100 mL x 2), dried over Na 2 SO 4 , filtered, and evaporated in vacuo to dimethyl 2,2-dipentyl malonate ( 27 g, 49.6 mmol, 65.5% yield) was obtained, which was used in the next step without further purification. LCMS (M+H) = 273.2, retention time (0.05% TFA): 2.66 minutes.

工程2:メチル2-ペンチルヘプタノエート
撹拌されているジメチル2,2-ジペンチルマロネート(27g、99mmol)、塩化リチウム(8.40g、198mmol)及び水(1.786mL、99mmol)のDMSO(150mL)混合液を、N雰囲気下、180℃で6時間加熱した。LCMSは、反応が完了したことを示した。混合物を室温に冷却し、HO(200mL)で希釈した。混合物をEtOAc(80mL)で2回抽出した。合わせた有機層をブライン(200mL)で洗浄し、NaSOで乾燥させ、濃縮して、メチル2-ペンチルヘプタノエート(16g、39.6mmol、収率39.9%)を得、これを精製することなく次の工程で使用した。LCMS(M+H)=215.3;保持時間(0.05% TFA):2.86分。
Step 2: Methyl 2-pentylheptanoate Stirred dimethyl 2,2-dipentyl malonate (27 g, 99 mmol), lithium chloride (8.40 g, 198 mmol) and water (1.786 mL, 99 mmol) in DMSO (150 mL). ) The mixture was heated at 180 °C for 6 h under N2 atmosphere. LCMS showed the reaction was complete. The mixture was cooled to room temperature and diluted with H2O (200 mL). The mixture was extracted twice with EtOAc (80 mL). The combined organic layers were washed with brine (200 mL), dried over Na SO and concentrated to give methyl 2 -pentylheptanoate (16 g, 39.6 mmol, 39.9% yield), which was used in the next step without purification. LCMS (M+H) = 215.3; retention time (0.05% TFA): 2.86 minutes.

工程5:2-ペンチルヘプチル-L-フェニルアラニナート
撹拌されている2-ペンチルヘプチル(tert-ブトキシカルボニル)-L-フェニルアラニナート(16.0g、36.9mmol)のDCM(80mL)溶液に、TFA(40mL、519mmol)を0℃で加えた。5分後、混合物を室温まで加温し、2時間撹拌した。TLCは、反応が完了したことを示した。反応物を濃縮乾固し、水(80mL)を加え、飽和NaCOでpHを8~9に調整し、DCM(80mL×3)で抽出した。合わせた有機相をブライン(100mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(DCM:MeOH=100:0~20:1)によって精製して、2-ペンチルヘプチル-L-フェニルアラニナート(8.6g、25.8mmol、収率69.9%)を黄色の油状物として得た。1H NMR (400 MHz, CDCl3) δ 7.33 - 7.27 (m, 2H), 7.22 (ddd, J = 14.6, 6.7, 4.0 Hz, 3H), 4.08 - 3.94 (m, 2H), 3.88 - 3.64 (m, 1H), 3.19 - 3.01 (m, 1H), 2.92 - 2.80 (m, 1H), 1.61 (d, J = 5.4 Hz, 1H), 1.49 (s, 2H), 1.35 - 1.20 (m, 16H), 0.89 (t, J = 6.9 Hz, 6H).
Step 5: 2-Pentylheptyl-L-phenylalaninate To a stirred solution of 2- pentylheptyl (tert-butoxycarbonyl)-L-phenylalaninate (16.0 g, 36.9 mmol) in DCM (80 mL), TFA (40 mL, 519 mmol) was added at 0°C. After 5 minutes, the mixture was warmed to room temperature and stirred for 2 hours. TLC showed the reaction was complete. The reaction was concentrated to dryness, water (80 mL) was added, pH was adjusted to 8-9 with saturated Na 2 CO 3 and extracted with DCM (80 mL×3). The combined organic phases were washed with brine (100 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (DCM:MeOH=100:0 to 20:1) to give 2-pentylheptyl-L-phenylalaninate (8.6 g, 25.8 mmol, 69.9% yield). was obtained as a yellow oil. 1 H NMR (400 MHz, CDCl 3 ) δ 7.33 - 7.27 (m, 2H), 7.22 (ddd, J = 14.6, 6.7, 4.0 Hz, 3H), 4.08 - 3.94 (m, 2H), 3.88 - 3.64 (m , 1H), 3.19 - 3.01 (m, 1H), 2.92 - 2.80 (m, 1H), 1.61 (d, J = 5.4 Hz, 1H), 1.49 (s, 2H), 1.35 - 1.20 (m, 16H), 0.89 (t, J = 6.9 Hz, 6H).

工程1:2-ヘキシルオクチル(tert-ブトキシカルボニル)-L-フェニルアラニナート
撹拌されている(tert-ブトキシカルボニル)-L-フェニルアラニン(5g、18.85mmol)のDCM(100mL)混合液に、DMAP(0.230g、1.885mmol)及びEDC(4.73g、24.69mmol)を0℃で加えた。30分後、2-ヘキシルオクタン-1-オール(5.26g、24.53mmol)を0℃で加え、室温で2時間撹拌した。TLCは、出発物質が消費されたことを示した。反応混合物を水(100mL)で希釈し、DCM(150mL×3)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮して、2-ヘキシルオクチル(tert-ブトキシカルボニル)-L-フェニルアラニナート(5.2g、6.76mmol、収率35.9%)を白色固体として得、これをさらに精製することなく次の工程に使用した。1H NMR (400 MHz, CDCl3) δ 7.26 (dq, J = 14.3, 7.1 Hz, 3H), 7.13 (d, J = 7.0 Hz, 2H), 4.97 (t, J = 11.8 Hz, 1H), 4.58 (dt, J = 16.2, 8.1 Hz, 1H), 4.26 - 3.90 (m, 2H), 3.07 (qt, J = 31.7, 15.8 Hz, 2H), 1.42 (s, 9H), 1.28 (dd, J = 22.6, 5.5 Hz, 20H), 0.88 (t, J = 6.8 Hz, 6H).
Step 1: 2-Hexyloctyl(tert-butoxycarbonyl)-L-phenylalaninate To a stirred mixture of (tert-butoxycarbonyl)-L-phenylalanine (5 g, 18.85 mmol) in DCM (100 mL) was added DMAP. (0.230 g, 1.885 mmol) and EDC (4.73 g, 24.69 mmol) were added at 0°C. After 30 minutes, 2-hexyl octan-1-ol (5.26 g, 24.53 mmol) was added at 0° C. and stirred at room temperature for 2 hours. TLC showed starting material was consumed. The reaction mixture was diluted with water (100 mL) and extracted with DCM (150 mL x 3). The combined organic phases were washed with brine, dried over Na 2 SO 4 and concentrated to give 2-hexyl octyl(tert-butoxycarbonyl)-L-phenylalaninate (5.2 g, 6.76 mmol, yield 35 .9%) was obtained as a white solid , which was used in the next step without further purification. 1 H NMR (400 MHz, CDCl 3 ) δ 7.26 (dq, J = 14.3, 7.1 Hz, 3H), 7.13 (d, J = 7.0 Hz, 2H), 4.97 (t, J = 11.8 Hz, 1H), 4.58 (dt, J = 16.2, 8.1 Hz, 1H), 4.26 - 3.90 (m, 2H), 3.07 (qt, J = 31.7, 15.8 Hz, 2H), 1.42 (s, 9H), 1.28 (dd, J = 22.6 , 5.5 Hz, 20H), 0.88 (t, J = 6.8 Hz, 6H).

工程6:2-ヘプチルノニル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
撹拌されている2-ヘプチルノニルL-フェニルアラニナート(8g、20.53mmol)の無水DCM(100mL)溶液に、トリエチルアミン(2.86mL、20.53mmol)を15分かけて-70℃で滴下した。この混合物に、フェニルホスホン酸ジクロリド(4.00g、20.53mmol)の無水DCM(50mL)溶液を1時間かけて加えた。反応混合物を室温でさらに30分間撹拌し、次いで、2時間かけて0℃まで加温し、さらに1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(3.78g、20.53mmol)及びTEA(2.86mL、20.53mmol)のDCM(30mL)溶液を20分かけて加え、0℃で16時間撹拌した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(25mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(150mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾別した。ケーキをtert-ブチルメチルエーテル(2×25mL)で洗浄し、合わせた濾液を減圧下で濃縮して、ジアステレオマーの同量の混合物を含有する粗固体を得た。ジアステレオマーをヘキサン(100mL)でトリチュレーションし、濾過して、2-ヘプチルノニル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(2.5g、3.16mmol、収率15.40%)を白色固体として得た(31PNMRで測定して、>97% de)。1H NMR (400 MHz, CDCl3) δ 7.43 - 7.31 (m, 2H), 7.26 - 7.15 (m, 6H), 7.11 - 6.98 (m, 2H), 4.46 (ddd, J = 15.7, 10.1, 5.8 Hz, 1H), 4.05 - 3.85 (m, 2H), 3.78 (t, J = 11.1 Hz, 1H), 3.20 - 2.97 (m, 3H), 1.52 (d, J = 16.7 Hz, 1H), 1.33 - 1.19 (m, 24H), 0.88 (t, J = 6.7 Hz, 6H). 31PNMR (CDCl3, 162 MHz) δ -1.54.
Step 6: 2-heptylnonyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate Stirred 2-heptylnonyl L-phenylalaninate (8 g, 20.53 mmol) in anhydrous DCM (100 mL) ) Triethylamine (2.86 mL, 20.53 mmol) was added dropwise to the solution at −70° C. over 15 minutes. To this mixture was added a solution of phenylphosphonic acid dichloride (4.00 g, 20.53 mmol) in anhydrous DCM (50 mL) over 1 hour. The reaction mixture was stirred at room temperature for an additional 30 minutes, then warmed to 0° C. over 2 hours and stirred for a further 1 hour. To this mixture was added a solution of 2,3,4,5,6-pentafluorophenol (3.78 g, 20.53 mmol) and TEA (2.86 mL, 20.53 mmol) in DCM (30 mL) over 20 min. Stirred at 0°C for 16 hours. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (25 mL). The filtrate was concentrated under reduced pressure, the residue was triturated with tert-butyl methyl ether (150 mL), and the triethylamine hydrochloride was filtered off. The cake was washed with tert-butyl methyl ether (2 x 25 mL) and the combined filtrates were concentrated under reduced pressure to give a crude solid containing an equal mixture of diastereomers. The diastereomer was triturated with hexane (100 mL) and filtered to give 2-heptylnonyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate (2.5 g, 3.16 mmol, Yield 15.40%) was obtained as a white solid (>97% de as determined by 31 PNMR). 1 H NMR (400 MHz, CDCl 3 ) δ 7.43 - 7.31 (m, 2H), 7.26 - 7.15 (m, 6H), 7.11 - 6.98 (m, 2H), 4.46 (ddd, J = 15.7, 10.1, 5.8 Hz , 1H), 4.05 - 3.85 (m, 2H), 3.78 (t, J = 11.1 Hz, 1H), 3.20 - 2.97 (m, 3H), 1.52 (d, J = 16.7 Hz, 1H), 1.33 - 1.19 ( m, 24H), 0.88 (t, J = 6.7 Hz, 6H). 31 PNMR (CDCl 3 , 162 MHz) δ -1.54.

工程2:メチル2-オクチルデカノエート
撹拌されているジメチル2,2-ジオクチルマロネート(12g、33.7mmol)、塩化リチウム(2.85g、67.3mmol)及び水(0.68mL)のDMSO(50mL)混合液を6時間還流撹拌した。LCMSは、所望の生成物の存在を示した。反応混合物を水(80mL)で希釈し、EtOAc(200mL×2)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(100% 石油エーテル)によって精製して、メチル2-オクチルデカノエート(11.16g、33.7mmol、収率100%)を得た。LCMS(M+H)=299;保持時間(0.1% TFA)=3.85分。
Step 2: Methyl 2-octyl decanoate Stirred dimethyl 2,2-dioctyl malonate (12 g, 33.7 mmol), lithium chloride (2.85 g, 67.3 mmol) and water (0.68 mL) in DMSO (50 mL) The mixture was stirred at reflux for 6 hours. LCMS showed the presence of the desired product. The reaction mixture was diluted with water (80 mL) and extracted with EtOAc (200 mL x 2). The combined organic phases were washed with brine, dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (100% petroleum ether) to give methyl 2-octyldecanoate (11.16 g, 33.7 mmol, 100% yield). LCMS (M+H) = 299; retention time (0.1% TFA) = 3.85 minutes.

工程4:2-ノニルウンデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート
撹拌されている(tert-ブトキシカルボニル)-L-フェニルアラニン(8.89g、33.5mmol)及びEDC(8.35g、43.5mmol)のDCM(150mL)混合液に、DMAP(0.409g、3.35mmol)を0℃で加えた。30分後、2-ノニルウンデカン-1-オール(10g、33.5mmol)を加え、得られた反応混合物を25℃で16時間撹拌した。TLCは、反応が完了したことを示した。反応混合物を水(80mL)で希釈し、DCM(100mL×2)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル:EtOAc=10:1)で精製して、2-ノニルウンデシル(tert-ブトキシカルボニル)-L-フェニルアラニナート(16g、29.3mmol、収率88%)を黄色の油状物として得た。1H NMR (400 MHz, CDCl3) δ 7.28-7.22 (m, 3H), 7.13 (d, J = 1.6 Hz, 2H), 4.98 (t, J = 4.0 Hz, 1H), 4.57 (m, 1H), 4.00 - 3.96 (m, 2H), 3.01 (qt, J = 31.7, 15.8 Hz, 2H), 1.41 (s, 9H), 1.26 (dd, J = 22.6, 5.5 Hz, 32H), 0.88 (t, J = 6.8 Hz, 6H).
Step 4: 2-Nonylundecyl(tert-butoxycarbonyl)-L-phenylalaninate To a stirred mixture of (tert-butoxycarbonyl)-L-phenylalanine (8.89 g, 33.5 mmol) and EDC (8.35 g, 43.5 mmol) in DCM (150 mL) was added DMAP (0.409 g, 3.35 mmol) at 0° C. After 30 min, 2- nonylundecan -1-ol (10 g, 33.5 mmol) was added and the resulting reaction mixture was stirred at 25° C. for 16 h. TLC showed the reaction was complete. The reaction mixture was diluted with water (80 mL) and extracted with DCM (100 mL×2). The combined organic phase was washed with brine, dried over Na 2 SO 4 and concentrated. The residue was purified by silica gel chromatography (petroleum ether: EtOAc = 10:1) to give 2-nonylundecyl (tert-butoxycarbonyl)-L-phenylalaninate (16 g, 29.3 mmol, 88% yield) as a yellow oil. 1H NMR (400 MHz, CDCl3 ) δ 7.28-7.22 (m, 3H), 7.13 (d, J = 1.6 Hz, 2H), 4.98 (t, J = 4.0 Hz, 1H), 4.57 (m, 1H), 4.00 - 3.96 (m, 2H), 3.01 (qt, J = 31.7, 15.8 Hz, 2H), 1.41 (s, 9H), 1.26 (dd, J = 22.6, 5.5 Hz, 32H), 0.88 (t, J = 6.8 Hz, 6H).

工程6:2-ノニルウンデシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート
撹拌されている2-ノニルウンデシルL-フェニルアラニナート(8g、17.95mmol)の無水DCM(100mL)溶液に、トリエチルアミン(2.502mL、17.95mmol)を15分かけて-70℃で滴下した。この混合物に、フェニルホスホン酸ジクロリド(3.50g、17.95mmol)の無水DCM(50mL)溶液を1時間かけて-70℃で加えた。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで加温し、さらに1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(3.30g、17.95mmol)及びTEA(2.502mL、17.95mmol)のDCM(30mL)溶液を20分かけて加え、0℃で16時間撹拌した。LCMSは、反応が完了したことを示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(25mL)で洗浄した。濾液を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(150mL)でトリチュレーションした。次いで、トリエチルアミン塩酸塩を濾別した。ケーキをtert-ブチルメチルエーテル(2×25mL)で洗浄し、合わせた濾液を減圧下で濃縮して、ジアステレオマーの同量の混合物を含有する粗固体を得た。混合物をヘキサン(15mL)でトリチュレーションし、濾過して、2-ノニルウンデシル((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)-L-フェニルアラニナート(1.5g、1.856mmol、収率10.34%)を白色固体として得た(31PNMRにより測定して、>98% de)。1H NMR (400 MHz, CDCl3) δ 7.35 (t, J = 7.8 Hz, 2H), 7.26 - 7.15 (m, 6H), 7.03 (dd, J = 13.7, 9.1 Hz, 2H), 4.45 (ddd, J = 15.6, 10.1, 5.8 Hz, 1H), 4.09 - 3.89 (m, 2H), 3.86 - 3.75 (m, 1H), 3.22 - 2.99 (m, 2H), 1.54 (s, 1H), 1.27 (dd, J = 27.8, 9.6 Hz, 32H), 0.88 (t, J = 6.7 Hz, 6H). 31PNMR (CDCl3, 162 MHz) δ -1.53.
Step 6: 2-Nonylundecyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate Stirred 2-nonylundecyl L-phenylalaninate (8 g, 17.95 mmol) in anhydrous DCM (100 mL) ) Triethylamine (2.502 mL, 17.95 mmol) was added dropwise to the solution at −70° C. over 15 minutes. To this mixture was added a solution of phenylphosphonic acid dichloride (3.50 g, 17.95 mmol) in anhydrous DCM (50 mL) at −70° C. over 1 hour. The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for a further 1 hour. To this mixture was added a solution of 2,3,4,5,6-pentafluorophenol (3.30 g, 17.95 mmol) and TEA (2.502 mL, 17.95 mmol) in DCM (30 mL) over 20 min. Stirred at 0°C for 16 hours. LCMS showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (25 mL). The filtrate was concentrated under reduced pressure and the residue was triturated with tert-butyl methyl ether (150 mL). Triethylamine hydrochloride was then filtered off. The cake was washed with tert-butyl methyl ether (2 x 25 mL) and the combined filtrates were concentrated under reduced pressure to give a crude solid containing an equal mixture of diastereomers. The mixture was triturated with hexane (15 mL) and filtered to give 2-nonylundecyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-phenylalaninate (1.5 g, 1.856 mmol, yield 10.34%) was obtained as a white solid (>98% de as determined by 31 PNMR). 1 H NMR (400 MHz, CDCl 3 ) δ 7.35 (t, J = 7.8 Hz, 2H), 7.26 - 7.15 (m, 6H), 7.03 (dd, J = 13.7, 9.1 Hz, 2H), 4.45 (ddd, J = 15.6, 10.1, 5.8 Hz, 1H), 4.09 - 3.89 (m, 2H), 3.86 - 3.75 (m, 1H), 3.22 - 2.99 (m, 2H), 1.54 (s, 1H), 1.27 (dd, J = 27.8, 9.6 Hz, 32H), 0.88 (t, J = 6.7 Hz, 6H). 31 PNMR (CDCl 3 , 162 MHz) δ -1.53.

実施例67:2-ブチルヘキシル(S)-2-(((S)-(((2R,3S,5R)-5-(6-アミノ-2-フルオロ-9H-プリン-9-イル)-2-エチニル-3-ヒドロキシテトラヒドロフラン-2-イル)メトキシ)(フェノキシ)ホスホリル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエートExample 67: 2-Butylhexyl (S)-2-(((S)-(((2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)- 2-ethynyl-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)-3-(3,5-difluorophenyl)propanoate

工程1:2-ブチルヘキシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(4g、13.28mmol)のDCM(60mL)に、DMAP(0.162g、1.328mmol)及びEDC(3.31g、17.26mmol)を0℃で加えた。得られた反応混合物を同じ温度で30分間撹拌し、次いで、2-ブチルヘキサン-1-オール(2.52g、15.93mmol)を加えた。得られた反応混合物を25℃で16時間撹拌した。LCMSは反応が完了したことを示した。反応物を水(50mL)で希釈し、DCM(100mL×2)で抽出した。合わせた有機層をブライン(40mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮して、2-ブチルヘキシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(4.6g、10.42mmol、収率78%)を白色固体として得、これをさらに精製することなく次の工程に使用した。LCMS:(M+Na)=464.0;保持時間(0.1% TFA)=2.59分。
Step 1: 2-Butylhexyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl) )-amino)-3-(3,5-difluorophenyl)propanoic acid (4 g, 13.28 mmol) in DCM (60 mL) with DMAP (0.162 g, 1.328 mmol) and EDC (3.31 g, 17.26 mmol). ) was added at 0°C. The resulting reaction mixture was stirred at the same temperature for 30 minutes, then 2-butylhexan-1-ol (2.52 g, 15.93 mmol) was added. The resulting reaction mixture was stirred at 25°C for 16 hours. LCMS showed the reaction was complete. The reaction was diluted with water (50 mL) and extracted with DCM (100 mL x 2). The combined organic layers were washed with brine (40 mL), dried over Na 2 SO 4 , filtered, concentrated to give 2-butylhexyl (S)-2-((tert-butoxycarbonyl)amino)-3- (3,5- difluorophenyl )propanoate (4.6 g, 10.42 mmol, 78% yield) was obtained as a white solid, which was used in the next step without further purification. LCMS: (M+Na) = 464.0; retention time (0.1% TFA) = 2.59 minutes.

工程2:2-ブチルヘキシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている2-ブチルヘキシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(4.6g、10.42mmol)のDCM(60mL)溶液に、TFA(15mL、195mmol)を0℃で滴下した。得られた反応混合物を25℃で16時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を濃縮し、残留物をNaHCO(40mL)で中和し、DCM(3×80mL)で抽出した。合わせた有機層をブライン(40mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=2/1)で精製して、2-ブチルヘキシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(3.3g、9.66mmol、収率93%)を淡黄色の固体として得た。LCMS(M+H)=342.1;保持時間(0.1% TFA)=1.76分。純度:100%(254nm)。
Step 2: 2-Butylhexyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate To a stirred solution of 2-butylhexyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl )propanoate (4.6 g, 10.42 mmol) in DCM (60 mL) was added TFA (15 mL, 195 mmol) dropwise at 0 °C. The resulting reaction mixture was stirred at 25 °C for 16 h. LCMS showed the reaction was complete. The reaction mixture was concentrated and the residue was neutralized with NaHCO 3 (40 mL) and extracted with DCM (3 x 80 mL). The combined organic layers were washed with brine (40 mL), dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate=2/1) to give 2-butylhexyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (3.3 g, 9.66 mmol, 93% yield) as a pale yellow solid. LCMS (M+H)=342.1; retention time (0.1% TFA)=1.76 min. Purity: 100% (254 nm).

工程1:2-ヘプチルノニル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(10g、33.2mmol)のDCM(120mL)に、DMAP(0.405g、3.32mmol)及びEDC(8.27g、43.1mmol)を0℃で加え、同じ温度で30分間撹拌した。次いで、この混合物に、2-ヘプチルノナン-1-オール(9.66g、39.8mmol)のDCM(10mL)溶液を加え、25℃で16時間撹拌した。LCMSは反応が完了したことを示した。反応混合物を水(50mL)で希釈し、DCM(200mL×3)で抽出した。合わせた有機層をブライン(50mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=20/1)により精製して、2-ヘプチルノニル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(12.5g、22.13mmol、収率66.7%)を白色固体として得た。LCMS:(M+Na)=548.2;保持時間(0.05% TFA)=3.83分;純度:93.08%(214nm)。
Step 1: 2-heptylnonyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate To a stirred solution of (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoic acid (10 g, 33.2 mmol) in DCM (120 mL) was added DMAP (0.405 g, 3.32 mmol) and EDC (8.27 g, 43.1 mmol) at 0° C. and stirred at the same temperature for 30 min. Then, to this mixture was added a solution of 2-heptylnonan-1-ol (9.66 g, 39.8 mmol) in DCM (10 mL) and stirred at 25° C. for 16 h. LCMS showed the reaction was complete. The reaction mixture was diluted with water (50 mL) and extracted with DCM (200 mL×3). The combined organic layers were washed with brine (50 mL), dried over Na 2 SO 4 , filtered and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate=20/1) to give 2-heptylnonyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl) propanoate (12.5 g, 22.13 mmol, 66.7% yield) as a white solid. LCMS: (M+Na)=548.2; retention time (0.05% TFA)=3.83 min; purity: 93.08% (214 nm).

工程2:2-ヘプチルノニル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている2-ヘプチルノニル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(12.5g、23.78mmol)のDCM(90mL)溶液に、TFA(20mL、260mmol)を0℃で滴下し、25℃で4時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を濃縮し、残留物をNaHCO(50mL)で中和した。混合物を、水(50mL)とDCM(300mL)とに分配した。水層をDCM(2×200mL)で抽出した。合わせた有機層をブライン(60mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=2/1)で精製して、2-ヘプチルノニル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(7g、15.98mmol、収率67.2%)を淡黄色の油状物として得た。LCMS(M+H)=426.4;保持時間(0.05% TFA)=2.12分;純度:97.15%(214nm)。
Step 2: 2-heptylnonyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirred 2-heptylnonyl (S)-2-((tert-butoxycarbonyl)amino)-3- To a solution of (3,5- difluorophenyl )propanoate (12.5 g, 23.78 mmol) in DCM (90 mL) was added TFA (20 mL, 260 mmol) dropwise at 0° C. and stirred at 25° C. for 4 hours. LCMS showed the reaction was complete. The reaction mixture was concentrated and the residue was neutralized with NaHCO 3 (50 mL). The mixture was partitioned between water (50 mL) and DCM (300 mL). The aqueous layer was extracted with DCM (2 x 200 mL). The combined organic layers were washed with brine (60 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 2/1) to give 2-heptylnonyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (7 g, 15.98 mmol). , yield 67.2%) as a pale yellow oil. LCMS (M+H) = 426.4; Retention time (0.05% TFA) = 2.12 min; Purity: 97.15% (214 nm).

工程1:2-オクチルデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(10g、33.2mmol)のDCM(120mL)に、DMAP(0.405g、3.32mmol)及びEDC(8.27g、43.1mmol)を0℃で加え、同じ温度で30分間撹拌した。次いで、この混合物に、2-オクチルデカン-1-オール(10.77g、39.8mmol)のDCM(10mL)溶液を加え、25℃で16時間撹拌した。LCMSは反応が完了したことを示した。反応混合物を水(50mL)で希釈し、DCM(200mL×2)で抽出した。合わせた有機層をブライン(50mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=20/1)により精製して、2-オクチルデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(13.5g、20.11mmol、収率60.6%)を白色固体として得た。LCMS:(M+Na)=576.2;保持時間(0.1% TFA)=4.81分;純度:82.50%(214nm)。
Step 1: 2-Octyldecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl) ) Amino)-3-(3,5-difluorophenyl)propanoic acid (10 g, 33.2 mmol) in DCM (120 mL) with DMAP (0.405 g, 3.32 mmol) and EDC (8.27 g, 43.1 mmol) ) was added at 0°C and stirred at the same temperature for 30 minutes. A solution of 2-octyldecan-1-ol (10.77 g, 39.8 mmol) in DCM (10 mL) was then added to the mixture and stirred at 25° C. for 16 h. LCMS showed the reaction was complete. The reaction mixture was diluted with water (50 mL) and extracted with DCM (200 mL x 2). The combined organic layers were washed with brine (50 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 20/1) to give 2-octyldecyl(S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluoro Phenyl )propanoate (13.5 g, 20.11 mmol, 60.6% yield) was obtained as a white solid. LCMS: (M+Na) = 576.2; retention time (0.1% TFA) = 4.81 min; purity: 82.50% (214 nm).

工程2:2-オクチルデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている2-オクチルデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(13.5g、24.38mmol)のDCM(100mL)溶液に、TFA(20mL、260mmol)を0℃で滴下し、25℃で16時間撹拌した。LCMSは、反応が完了したことを示した。反応物を濃縮し、残留物をNaHCO(50mL)で中和し、DCM(3×200mL)で抽出した。合わせた有機層をブライン(60mL)で洗浄し、NaSOで乾燥させ、濾過し、濃縮した。残留物をシリカゲルクロマトグラフィー(石油エーテル/酢酸エチル=2/1)で精製して、2-オクチルデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(7.1g、15.65mmol、収率64.2%)を淡黄色の油状物として得た。LCMS(M+H)=454.3;保持時間(0.05% TFA)=2.35分;純度:100%(254nm)。
Step 2: 2-Octyldecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirred 2-octyldecyl (S)-2-((tert-butoxycarbonyl)amino)- To a solution of 3-(3,5-difluorophenyl) propanoate (13.5 g, 24.38 mmol) in DCM (100 mL) was added TFA (20 mL, 260 mmol) dropwise at 0° C. and stirred at 25° C. for 16 hours. LCMS showed the reaction was complete. The reaction was concentrated and the residue was neutralized with NaHCO 3 (50 mL) and extracted with DCM (3×200 mL). The combined organic layers were washed with brine (60 mL), dried over Na 2 SO 4 , filtered, and concentrated. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 2/1) to give 2-octyldecyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate (7.1 g, 15.65 mmol, yield 64.2%) was obtained as a pale yellow oil. LCMS (M+H) = 454.3; retention time (0.05% TFA) = 2.35 min; purity: 100% (254 nm).

工程3:2-オクチルデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート
撹拌されている2-オクチルデシル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(7.1g、15.65mmol)のDCM(100mL)溶液に、トリエチルアミン(2.393mL、17.22mmol)を-70℃で滴下した。この混合物に、フェニルホスホロジクロリデート(3.27g、15.49mmol)の無水DCM(20mL)溶液を滴下した。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、1時間撹拌した。この混合物に、2,3,4,5,6-ペンタフルオロフェノール(2.88g、5.65mmol)及びトリエチルアミン(2.393mL、17.22mmol)のDCM(20mL)溶液を滴下した。粗混合物を0℃で16時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物を減圧下で濃縮し、残留物をtert-ブチルメチルエーテル(200mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(2×30mL)で洗浄し、合わせた濾液を減圧下で濃縮した。混合物をヘキサン(50mL)でトリチュレーションし、濾過により固体を回収した。濾液を濃縮し、残留物をヘキサン(25mL)でトリチュレーションし、濾過により固体を回収した。この手順を2回繰り返して2-オクチルデシル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(1.5g、1.570mmol、収率10.03%)を白色固体として得た(31PNMRにより測定して、>98% de)。LCMS(M+H)=776.0;保持時間(0.1% TFA)=4.75分。31PNMR (CDCl3, 162 MHz) δ -1.56.
Step 3: 2-Octyldecyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate Stirred 2-octyldecyl To a solution of (S)-2-amino-3-(3,5-difluorophenyl)propanoate (7.1 g, 15.65 mmol) in DCM (100 mL) was added triethylamine (2.393 mL, 17.22 mmol) at -70 °C. It was dripped. To this mixture was added dropwise a solution of phenylphosphorodichloridate (3.27 g, 15.49 mmol) in anhydrous DCM (20 mL). The reaction mixture was stirred at this temperature for a further 30 minutes, then warmed to 0° C. over 2 hours and stirred for 1 hour. To this mixture was added dropwise a solution of 2,3,4,5,6-pentafluorophenol (2.88 g, 15.65 mmol) and triethylamine (2.393 mL, 17.22 mmol) in DCM (20 mL). The crude mixture was stirred at 0°C for 16 hours. LCMS showed the reaction was complete. The reaction mixture was concentrated under reduced pressure, the residue was triturated with tert-butyl methyl ether (200 mL), and triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (2 x 30 mL) and the combined filtrates were concentrated under reduced pressure. The mixture was triturated with hexane (50 mL) and the solid was collected by filtration. The filtrate was concentrated, the residue was triturated with hexane (25 mL), and the solid was collected by filtration. Repeat this procedure twice to obtain 2-octyldecyl (S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (1.5 g). , 1.570 mmol, yield 10.03%) as a white solid (>98% de as determined by 31 PNMR). LCMS (M+H) = 776.0; Retention time (0.1% TFA) = 4.75 minutes. 31 PNMR (CDCl 3 , 162 MHz) δ -1.56.

工程1:2-ペンチルヘプチル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(8.71g、28.9mmol)のDCM(50mL)混合液に、EDC(7.22g、37.6mmol)及びDMAP(0.353g、2.89mmol)を0℃で加えた。30分後、2-ペンチルヘプタン-1-オール(7.00g、37.6mmol)のDCM(20mL)溶液を0℃で加え、反応物を15℃で16時間撹拌した。LCMSは、生成物が検出されたことを示した。反応混合物を水(30mL)で希釈し、DCM(25mL×2)で抽出した。合わせた有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮して、2-ペンチルベプチル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(11.2g、7.99mmol、収率27.6%)を黄色の油状物として得、これをさらに精製することなく次の工程に使用した。LCMS(2M+Na)=961.2;保持時間(10% TFA)=2.854分。
Step 1: 2-Pentylheptyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl) ) Amino)-3-(3,5-difluorophenyl)propanoic acid (8.71 g, 28.9 mmol) in DCM (50 mL) was added with EDC (7.22 g, 37.6 mmol) and DMAP (0.353 g). , 2.89 mmol) was added at 0°C. After 30 minutes, a solution of 2-pentylheptan-1-ol (7.00 g, 37.6 mmol) in DCM (20 mL) was added at 0° C. and the reaction was stirred at 15° C. for 16 hours. LCMS showed product detected. The reaction mixture was diluted with water (30 mL) and extracted with DCM (25 mL x 2). The combined organic phases were washed with brine, dried over Na SO and concentrated to yield 2 - pentylbeptyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl). ) Propanoate (11.2 g, 7.99 mmol, 27.6% yield) was obtained as a yellow oil, which was used in the next step without further purification. LCMS (2M+Na) = 961.2; retention time (10% TFA) = 2.854 minutes.

工程1:2-ノニルウンデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(6g、19.91mmol)のDCM(60mL)に、N,N-ジメチルピリジン-4-アミン(0.243g、1.991mmol)及び3-(((エチルイミノ)メチレン)アミノ)-N,N-ジメチルプロパン-1-アミン塩酸塩(4.97g、25.9mmol)を0℃で加えた。30分後、2-ノニルウンデカン-1-オール(7.73g、25.9mmol)のDCM(15mL)溶液を上記溶液に0℃で滴下し、15℃で一晩撹拌した。次いで、反応混合物を水(30mL)で希釈し、分配した。水相をDCM(35mL×2)で抽出し、合わせた有機相をブライン(20mL)で洗浄し、NaSOで乾燥させ、濾過し、真空中で濃縮して、2-ノニルウンデシル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(14.06g、24.17mmol、収率121%)を黄色の油状物として得、これを精製することなく次の工程に使用した。
Step 1: 2-Nonylundecyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate To a stirred solution of (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoic acid (6 g, 19.91 mmol) in DCM (60 mL) was added N,N-dimethylpyridin-4-amine (0.243 g, 1.991 mmol) and 3-(((ethylimino)methylene)amino)-N,N-dimethylpropan-1-amine hydrochloride (4.97 g, 25.9 mmol) at 0° C. After 30 min, a solution of 2-nonylundecan-1-ol (7.73 g, 25.9 mmol) in DCM (15 mL) was added dropwise to the above solution at 0° C. and stirred at 15° C. overnight. The reaction mixture was then diluted with water (30 mL) and partitioned. The aqueous phase was extracted with DCM (35 mL x 2) and the combined organic phases were washed with brine (20 mL ), dried over Na2SO4 , filtered and concentrated in vacuo to afford 2-nonylundecyl(S)-2-((tert-butoxycarbonyl)amino)-3-(3,5- difluorophenyl )propanoate (14.06 g, 24.17 mmol, 121% yield) as a yellow oil, which was used in the next step without purification.

工程1:2-ヘキシルオクチル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパン酸(5g、16.60mmol)、DMAP(0.203g、1.660mol)及び2-ヘキシルオクタン-1-オール(4.63g、21.60mmol)に、EDC(4.14g、21.61mmol)のDCM(20mL)溶液に0℃で加え、0℃で2時間撹拌した。LCMSは、所望の生成物の存在を示した。反応混合物を水(50mL)で希釈し、有機相をブラインで洗浄し、NaSOで乾燥させ、濃縮して、2-ヘキシオクチル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(8g、15.33mmol、収率92%)を油状物として得た。LCMS(M+Na)=520.2;保持時間(0.1% TFA)=3.42分。
Step 1: 2-Hexyloctyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate Stirred (S)-2-((tert-butoxycarbonyl) )-amino)-3-(3,5-difluorophenyl)propanoic acid (5 g, 16.60 mmol), DMAP (0.203 g, 1.660 mol) and 2-hexyloctan-1-ol (4.63 g, 21. 60 mmol) was added to a solution of EDC (4.14 g, 21.61 mmol) in DCM (20 mL) at 0°C and stirred at 0°C for 2 hours. LCMS showed the presence of the desired product. The reaction mixture was diluted with water (50 mL) and the organic phase was washed with brine, dried over Na 2 SO 4 and concentrated to yield 2-hexioctyl(S)-2-((tert-butoxycarbonyl)amino)- 3-(3,5- difluorophenyl )propanoate (8 g, 15.33 mmol, 92% yield) was obtained as an oil. LCMS (M+Na) = 520.2; retention time (0.1% TFA) = 3.42 minutes.

工程2:2-ヘキシルオクチル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート
撹拌されている2-ヘキシオクチル(S)-2-((tert-ブトキシカルボニル)アミノ)-3-(3,5-ジフルオロフェニル)プロパノエート(8g、16.07mmol)のDCM(30mL)溶液に、TFA(12.38mL、161mmol)を加え、得られた混合物を5℃で2.5時間撹拌した。LCMSは、反応が完了したことを示した。反応混合物のpHを1N NaOHで約8に調整し、水(30mL)で希釈し、20分間激しく撹拌し、有機相を分離し、飽和NaCl(50mL)で洗浄し、乾燥させ(NaSO)、濃縮した。粗生成物をシリカゲルクロマトグラフィー(120g、Santai、EtOAc:石油エーテル=1:50)によって精製して、2-ヘキシルオクチル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4.1g、7.08mmol、収率44.1%)を油状物として得た。LCMS(M+H)=398.4;保持時間(0.1% TFA)=1.92分。
Step 2: 2-Hexyloctyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate Stirred 2-hexyoctyl (S)-2-((tert-butoxycarbonyl)amino)-3 To a solution of -(3,5- difluorophenyl )propanoate (8 g, 16.07 mmol) in DCM (30 mL) was added TFA (12.38 mL, 161 mmol) and the resulting mixture was stirred at 5 °C for 2.5 h. did. LCMS showed the reaction was complete. The pH of the reaction mixture was adjusted to ~8 with 1N NaOH, diluted with water (30 mL), stirred vigorously for 20 min, the organic phase was separated, washed with saturated NaCl (50 mL) and dried ( Na2SO4 ) . ), concentrated. The crude product was purified by silica gel chromatography (120 g, Santai, EtOAc:petroleum ether = 1:50) to give 2-hexyloctyl (S)-2-amino-3-(3,5-difluorophenyl)propanoate ( 4.1 g, 7.08 mmol, yield 44.1%) was obtained as an oil. LCMS (M+H) = 398.4; retention time (0.1% TFA) = 1.92 minutes.

工程3:2-ヘキシルオクチル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート
撹拌されている2-ヘキシルオクチル(S)-2-アミノ-3-(3,5-ジフルオロフェニル)プロパノエート(4.1g、10.31mmol)のDCM(50mL)溶液に、ETN(1.509mL、10.83mmol)を-70℃で15分かけて滴下した。この混合物に、フェニルホスホロジクロリデート(2.154g、10.21mmol)の無水DCM(35mL)溶液を1時間かけて加えた。反応混合物をこの温度でさらに30分間撹拌し、次いで、2時間かけて0℃まで昇温させ、2時間撹拌した。この混合物に、ETN(1.581mL、11.34mmol)及び2,3,4,5,6-ペンタフルオロフェノール(1.879g、10.21mmol)のDCM(30mL)溶液を20分かけて加え、0℃で4時間撹拌した。LCMSは、反応が完了したことを示した。白色固体(トリエチルアミン塩酸塩)を濾別し、DCM(1×25mL)で洗浄した。濾液を減圧下で濃縮した。残留物をtert-ブチルメチルエーテル(50mL)でトリチュレーションし、トリエチルアミン塩酸塩を濾過により除去した。ケーキをtert-ブチルメチルエーテル(25mL)で洗浄し、合わせた濾液を減圧下で濃縮して、2.0gを得た。粗固体を石油エーテル(10mL)でトリチュレーションし、濾過し、石油エーテル(5mL)で洗浄して、2-ヘキシルオクチル(S)-3-(3,5-ジフルオロフェニル)-2-(((S)-(ペルフルオロフェノキシ)(フェノキシ)ホスホリル)アミノ)プロパノエート(800mg、1.112mmol、収率10.78%)を白色固体として得た(31PNMRにより測定して、>95% de)LCMS(M+H)=720.2、保持時間(0.1% TFA)=3.45分。31PNMR (CDCl3, 162 MHz) δ-1.56.
Step 3: 2-Hexyloctyl(S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate To a stirred solution of 2-hexyloctyl(S)-2-amino-3-(3,5-difluorophenyl)propanoate (4.1 g, 10.31 mmol) in DCM (50 mL) was added ET 3 N (1.509 mL, 10.83 mmol) dropwise over 15 min at −70° C. To this mixture was added a solution of phenyl phosphorodichloridate (2.154 g, 10.21 mmol) in anhydrous DCM (35 mL) over 1 h. The reaction mixture was stirred at this temperature for an additional 30 min, then allowed to warm to 0° C. over 2 h and stirred for 2 h. To this mixture was added a solution of ET 3 N (1.581 mL, 11.34 mmol) and 2,3,4,5,6-pentafluorophenol (1.879 g, 10.21 mmol) in DCM (30 mL) over 20 min and stirred at 0° C. for 4 h. LCMS showed the reaction was complete. The white solid (triethylamine hydrochloride) was filtered off and washed with DCM (1×25 mL). The filtrate was concentrated under reduced pressure. The residue was triturated with tert-butyl methyl ether (50 mL) and the triethylamine hydrochloride was removed by filtration. The cake was washed with tert-butyl methyl ether (25 mL) and the combined filtrate was concentrated under reduced pressure to give 2.0 g. The crude solid was triturated with petroleum ether (10 mL), filtered and washed with petroleum ether (5 mL) to give 2-hexyloctyl(S)-3-(3,5-difluorophenyl)-2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate (800 mg, 1.112 mmol, 10.78% yield) as a white solid (>95% de as determined by 31 PNMR) LCMS (M+H)=720.2, retention time (0.1% TFA)=3.45 min. 31 PNMR (CDCl 3 , 162 MHz) δ-1.56.

JP2022557823A 2020-03-23 2021-03-18 Compounds useful for treating HIV Pending JP2023518851A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062993300P 2020-03-23 2020-03-23
US62/993,300 2020-03-23
PCT/US2021/022880 WO2021194828A1 (en) 2020-03-23 2021-03-18 Compounds useful in hiv therapy

Publications (2)

Publication Number Publication Date
JP2023518851A JP2023518851A (en) 2023-05-08
JPWO2021194828A5 true JPWO2021194828A5 (en) 2024-03-29

Family

ID=75660300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022557823A Pending JP2023518851A (en) 2020-03-23 2021-03-18 Compounds useful for treating HIV

Country Status (4)

Country Link
US (1) US20230151049A1 (en)
EP (1) EP4126888A1 (en)
JP (1) JP2023518851A (en)
WO (1) WO2021194828A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022271878A1 (en) * 2021-06-22 2022-12-29 Rome Therapeutics, Inc. 4-ethynyl-3-hydroxy-tetrahydrofuranyl-adenine phosphoramidates and related compounds and their use in treating medical conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104640444B (en) * 2012-06-16 2016-12-14 河南美泰宝生物制药有限公司 Double liver target phosphoramidates and aminophosphonic acid ester prodrugs
CN107286190A (en) * 2016-04-13 2017-10-24 刘沛 The preparation of oxyl benzylamino phosphoric acid/phosphate derivatives of nucleosides and its medical usage
MX2020006864A (en) * 2017-12-27 2020-11-11 Univ Emory Combined modalities for nucleosides and/or nadph oxidase (nox) inhibitors as myeloid-specific antiviral agents.

Similar Documents

Publication Publication Date Title
JP7390417B2 (en) asymmetric auxiliary group
JP4121215B2 (en) Sulfostin analog, and method for producing sulfostine and its analog
EP3363805B1 (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
IL302559A (en) Synthesis of phosphate derivatives
Sampson et al. Synthesis of phosphonic acid derivatives by oxidative activation of phosphinate esters
JPWO2021194828A5 (en)
EP4090654A1 (en) Methods, processes and intermediates for preparing chroman compounds
Mucha et al. Transesterification of monophenyl phosphonamidates—chemical modelling of serine protease inhibition
MORA et al. A new approach to phosphoserine, phosphothreonine and phosphotyrosine synthons and to thiophospho analogs: Stepwise synthesis of mono‐and multiphosphorylated phosphopeptides related to src‐protein kinase
KR20200119230A (en) Synthesis method of cyclic depsipeptide
FR2721929A1 (en) STABLE, NON-HYDROLYZABLE ANALOGUES OF DIPHOSPHATES AND PROCESSES FOR PREPARING THE SAME
RU2817013C1 (en) Method for synthesis of cyclic depsipeptides
Fourmigue et al. New tertiary phosphines and bisphosphines-functionalized tetrathiafulvalenes
JP2020183374A (en) Novel phosphoester synthesis method
Lesiak et al. Synthesis of 2′-Deoxynucleoside 5′-Methylenebis-(phosphonate) s Using 2-(4-Nitrophenyl) ethyl Methylenebis (phosphonate) as the Phosphonylating Agent.
EP4308580A1 (en) Chiral synthons for the synthesis of chiral phosphorothioates
CA2325523A1 (en) Prodrugs of phosphorous-containing pharmaceuticals
WO2002014331A1 (en) Amino acid-derived phosphonamidic anhydrides and methods of preparing the same
IL176717A (en) Sphingomyelin, intermediates thereof and methods for preparation of same